Sentence,class,file
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/41/fd/mtm201670.PMC5147881.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ASTROBIOLOGY Volume 16, Number 11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/ast.2015.1422 873",Non-OADS,/arxiv_data1/oa_pdf/88/11/ast.2015.1422.PMC5148108.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Th e ISME Journal website (http: //www.nature.com/ismej)Rumen microbiome affects the feed efficiency of cows S Kruger Ben Shabat et al 2972 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/6d/08/ismej201662a.PMC5148187.pdf
Materials and methods Accession numbers The genomes used for the ancestral genome recon-struction were downloaded from version 4.0 of the Integrated Microbial Genomes (IMG) (http://img.jgi.,OADS,/arxiv_data1/oa_pdf/82/9d/ismej201667a.PMC5148189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on The I SME Journal website (http:/ /www.nature.",Non-OADS,/arxiv_data1/oa_pdf/82/9d/ismej201667a.PMC5148189.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/Molecular studies of mycorrhizal fungal diversity IR Sanders and A Rodriguez 2786 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/12/37/ismej201673a.PMC5148194.pdf
"Metagenomic data are available at the Sequence Read Archive (SRA, http://www.ncbi.nlm.nih.gov/ sra) under accession numbers SRX225604 (RS09-1)and SRX225750 (AS08-5), and assembled contigs can be accessed at the integrated microbial genomes (IMG) system (http://img.jgi.doe.gov) under TaxonObject IDs 3300000824 and 3300000825.",OADS,/arxiv_data1/oa_pdf/da/77/ismej201674a.PMC5148195.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ Supplementary Information accompanies this paper on The I SME Journal website (http:/ /www.nature.",Non-OADS,/arxiv_data1/oa_pdf/da/77/ismej201674a.PMC5148195.pdf
"The basal medium for the characterization ofstrain L21-Fru-AB Tcontained per litre: 60.0 g NaCl, 6.0 g MgCl 2×6 H 2O, 1.5 g KCl, 1.0 g Na 2SO 4, 1.0 g NH 4Cl, 0.4 g CaCl 2×2 H 2O, 0.4 g K 2HPO 4, 10.0 ml trace elements solution of DSMZ medium 141(http://www.dsmz.de/microorganisms/medium/pdf/ DSMZ_Medium141.pdf), 0.5 mg resazurin, 10.0 ml vitamins solution of DSMZ medium 141, 2.5 gNa 2CO 3, 0.3 g Na 2S×9 H 2O and 0.3 g L-cysteine- HCl × H 2O.",Non-OADS,/arxiv_data1/oa_pdf/90/f1/ismej201684a.PMC5148204.pdf
"For cultivation of these strains, the medium recipes and incubation conditions indicated in the catalogof the Leibniz Institute DSMZ (http://www.dsmz.de/ catalogues/catalogue-microorganisms.html) were used.",Non-OADS,/arxiv_data1/oa_pdf/90/f1/ismej201684a.PMC5148204.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1600723/DC1audio file S1.,Non-OADS,/arxiv_data1/oa_pdf/bc/b9/1600723.PMC5148209.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601658/DC1 Supplementary Materials and Methods fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/80/1601658.PMC5148210.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601942/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/43/69/1601942.PMC5148212.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1600889/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/fa/1600889.PMC5148213.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/58/26/mtm201680.PMC5148596.pdf
"PAPER How to keep high-risk studies ethical: classifying candidate solutions Nir Eyal Correspondence to Professor Nir Eyal, Department of Global Health and Population, Harvard TH ChanSchool of Public Health,Harvard University, 02115 Boston, MA, USA; neyal@hsph.harvard.edu Received 1 February 2016 Accepted 18 February 2016Published Online First 10 June 2016 ▸http://dx.doi.org/10.1136/ medethics-2016-103416 To cite: Eyal N. J Med Ethics 2017; 43:74–77.ABSTRACT This article lays out a wide spectrum of candidate ethicalsolutions for the challenge on which this JME symposium focuses: the bene ﬁt:risk ratio challenge to some early-phase HIV cure and remission studies.",Non-OADS,/arxiv_data1/oa_pdf/6f/71/medethics-2016-103428.PMC5148732.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 HHS.,Non-OADS,/arxiv_data1/oa_pdf/6f/71/medethics-2016-103428.PMC5148732.pdf
"1998.http://www.fda.gov/oc/ohrt/IRBS/belmont.html 3 Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical?",Non-OADS,/arxiv_data1/oa_pdf/6f/71/medethics-2016-103428.PMC5148732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/7c/main.PMC5148766.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.006 470,OADS,/arxiv_data1/oa_pdf/10/7c/main.PMC5148766.pdf
Amgen; [cited 2016Jan 7]; Available from: http://wwwext.amgen.com/media/ media_pr_detail.jsp?year=2015&releaseID=2052862 .,OADS,/arxiv_data1/oa_pdf/10/7c/main.PMC5148766.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/fe/main.PMC5148767.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.002 448,OADS,/arxiv_data1/oa_pdf/ad/fe/main.PMC5148767.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/5b/main.PMC5148768.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/5b/main.PMC5148768.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.005Urology Case Reports 10 (2017) 48 e50,Non-OADS,/arxiv_data1/oa_pdf/9a/5b/main.PMC5148768.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/c8/main.PMC5148769.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.005 457,OADS,/arxiv_data1/oa_pdf/47/c8/main.PMC5148769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/a1/main.PMC5148770.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/a1/main.PMC5148770.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.009Urology Case Reports 10 (2017) 42 e44,Non-OADS,/arxiv_data1/oa_pdf/25/a1/main.PMC5148770.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/eb/main.PMC5148771.pdf
Presentation  of  case A  53-year-old  non-smoking  male  teacher  presented  at  our  ter- tiary  center  outpatient’s  clinic  with  a  history  of  chronic  nasal http://dx.doi.org/10.1016/j.ijscr.2016.11.028 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/38/eb/main.PMC5148771.pdf
"Case  Rep.  2  (2014)  5,  http://dx.doi.org/10.1093/jscr/rju032 .",Non-OADS,/arxiv_data1/oa_pdf/38/eb/main.PMC5148771.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/37/main.PMC5148772.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/37/main.PMC5148772.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.016Urology Case Reports 10 (2017) 45 e47,Non-OADS,/arxiv_data1/oa_pdf/ee/37/main.PMC5148772.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/05/main.PMC5148773.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/05/main.PMC5148773.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.012Urology Case Reports 10 (2017) 51 e53,Non-OADS,/arxiv_data1/oa_pdf/84/05/main.PMC5148773.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/3f/main.PMC5148774.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.009 465,OADS,/arxiv_data1/oa_pdf/4e/3f/main.PMC5148774.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/97/main.PMC5148775.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.014 451,OADS,/arxiv_data1/oa_pdf/ee/97/main.PMC5148775.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.013 454,OADS,/arxiv_data1/oa_pdf/9e/71/main.PMC5148776.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/36/main.PMC5148777.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.006 462,OADS,/arxiv_data1/oa_pdf/9f/36/main.PMC5148777.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cardiovascular diseasePrimary preventionPatient outreach 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/9d/main.PMC5148778.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.014 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/9d/main.PMC5148778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/9d/main.PMC5148778.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/4e/9d/main.PMC5148778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3d/83/main.PMC5148779.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.005 445,OADS,/arxiv_data1/oa_pdf/3d/83/main.PMC5148779.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/44/main.PMC5148780.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.017 473,OADS,/arxiv_data1/oa_pdf/31/44/main.PMC5148780.pdf
"Their ileum and colon expression is induced from low- basal levels in response to bacterial colonization of germ-free (B6 and http://dx.doi.org/10.1016/j.redox.2016.11.001 Received 24 October 2016; Accepted 4 November 2016⁎Correspondence to: The First A ﬃliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, China.",Non-OADS,/arxiv_data1/oa_pdf/a0/0c/main.PMC5148781.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/0c/main.PMC5148781.pdf
"Cyclin D1, EGFR and p53 expression in tumor tissue was estimated by immunohistochemical (IHC) method andquantified as percentage positive nuclei.Received: 10 August 2016 Revised: 4 November 2016 Accepted: 24 November 2016 Heliyon 2 (2016) e00206 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Therefore heterogeneity of Article No~e00206 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
"The study was approved by the ethics committee of the Institution, Article No~e00206 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
"On correlating the quantitative expressions,the Pearson correlation analysis showed significant and positive correlation Article No~e00206 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Variables (n = 290) (%) Age (yrs) ≤60 220 (75.9) >60 70 (24.1) Sex Female 59 (20.3) Male 231 (79.7) Economic status Upper 7 (2.4) Middle 111 (38.3) Poor 172 (59.3) Tobacco chewing No 98 (33.8) Yes 192 (66.2) Betel nut chewing No 109 (37.6) Yes 181 (62.4) Smoking No 128 (44.1) Yes 162 (55.9) Performance status Good 165 (56.9) Poor 125 (43.1) Primary site Buccal mucosa 93 (32.1) Alveolus 45 (15.5) Hard palate 38 (13.1) Lip 27 (9.3) RMT 39 (13.4) Tongue 48 (16.6) Histology SCC 102 (35.2) ISCC 188 (64.8) (Continued ) Article No~e00206 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Marker expression (n = 290) (%) Cyclin D1 Negative 31 (10.7) Positive 197 (67.9) Strong positive 62 (21.4) EGFR Negative 13 (4.5) Positive 135 (46.6) Strong positive 142 (49.0) p53 Negative 35 (12.1) Positive 46 (15.9) Strong positive 209 (72.1) Article No~e00206 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Variables n(%) Cyclin D1 expression EGFR expression p53 expression Negative Positive Strong positive P value Negative Positive Strong positive P value Negative Positive Strong positive P value Age (yrs) ≤60 220 25 (11.4) 142 (64.5) 53 (24.1) 0.080 12 (5.5) 96 (43.6) 112 (50.9) 0.117 30 (13.6) 27 (12.3) 163 (74.1) 0.008 >60 70 6 (8.6) 55 (78.6) 9 (12.9) 1 (1.4) 39 (55.7) 30 (42.9) 5 (7.1) 19 (27.1) 46 (65.7) Sex Female 59 8 (13.6) 45 (76.3) 6 (10.2) 0.058 5 (8.5) 30 (50.8) 24 (40.7) 0.138 10 (16.9) 10 (16.9) 39 (66.1) 0.390Male 231 23 (10.0) 152 (65.8) 56 (24.2) 8 (3.5) 105 (45.5) 118 (51.1) 25 (10.8) 36 (15.6) 170 (73.6) Economic status Upper/Middle 118 12 (10.2) 79 (66.9) 27 (22.9) 0.866 1 (0.8) 63 (53.4) 54 (45.8) 0.016 15 (12.7) 19 (16.1) 84 (71.2) 0.953 Poor 172 19 (11.0) 118 (68.6) 35 (20.3) 12 (7.0) 72 (41.9) 88 (51.2) 20 (11.6) 27 (15.7) 125 (72.7) Tobacco chewing No 98 7 (7.1) 66 (67.3) 25 (25.5) 0.231 7 (7.1) 37 (37.8) 54 (55.1) 0.051 9 (9.2) 10 (10.2) 79 (80.6) 0.064 Yes 192 24 (12.5) 131 (68.2) 37 (19.3) 6 (3.1) 98 (51.0) 88 (45.8) 26 (13.5) 36 (18.8) 130 (67.7) Betel nut chewing No 109 11 (10.1) 73 (67.0) 25 (22.9) 0.869 7 (6.4) 43 (39.4) 59 (54.1) 0.116 12 (11.0) 14 (12.8) 83 (76.1) 0.457 Yes 181 20 (11.0) 124 (68.5) 37 (20.4) 6 (3.3) 92 (50.8) 83 (45.9) 23 (12.7) 32 (17.7) 126 (69.6) Smoking No 128 13 (10.2) 95 (74.2) 20 (15.6) 0.084 7 (5.5) 58 (45.3) 63 (49.2) 0.750 21 (16.4) 16 (12.5) 91 (71.1) 0.073 Yes 162 18 (11.1) 102 (63.0) 42 (25.9) 6 (3.7) 77 (47.5) 79 (48.8) 14 (8.6) 30 (18.5) 118 (72.8) (Continued ) Article No~e00206 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
(Continued ) Variables n(%) Cyclin D1 expression EGFR expression p53 expression Negative Positive Strong positive P value Negative Positive Strong positive P value Negative Positive Strong positive P value PS Good 165 21 (12.7) 117 (70.9) 27 (16.4) 0.039 8 (4.8) 86 (52.1) 71 (43.0) 0.067 26 (15.8) 29 (17.6) 110 (66.7) 0.037 Poor 125 10 (8.0) 80 (64.0) 35 (28.0) 5 (4.0) 49 (39.2) 71 (56.8) 9 (7.2) 17 (13.6) 99 (79.2) Primary site Buccal mucosa 93 8 (8.6) 67 (72.0) 18 (19.4) 0.560 5 (5.4) 34 (36.6) 54 (58.1) 0.064 3 (3.2) 8 (8.6) 82 (88.2) <0.001 Other 197 23 (11.7) 130 (66.0) 44 (22.3) 8 (4.1) 101 (51.3) 88 (44.7) 32 (16.2) 38 (19.3) 127 (64.5) Histology SCC 102 6 (5.9) 76 (74.5) 20 (19.6) 0.099 2 (2.0) 53 (52.0) 47 (46.1) 0.175 13 (12.7) 20 (19.6) 69 (67.6) 0.391 ISCC 188 25 (13.3) 121 (64.4) 42 (22.3) 11 (5.9) 82 (43.6) 95 (50.5) 22 (11.7) 26 (13.8) 140 (74.5) Grade WD 195 31 (15.9) 149 (76.4) 15 (7.7) <0.001 13 (6.7) 106 (54.4) 76 (39.0) <0.001 34 (17.4) 46 (23.6) 115 (59.0) <0.001 MD/PD 95 0 (0.0) 48 (50.5) 47 (49.5) 0 (0.0) 29 (30.5) 66 (69.5) 1 (1.1) 0 (0.0) 94 (98.9) Tumor size T2/T3 71 14 (19.7) 48 (67.6) 9 (12.7) 0.005 4 (5.6) 41 (57.7) 26 (36.6) 0.057 17 (23.9) 19 (26.8) 35 (49.3) <0.001 T4 219 17 (7.8) 149 (68.0) 53 (24.2) 9 (4.1) 94 (42.9) 116 (53.0) 18 (8.2) 27 (12.3) 174 (79.5) Node status N0 89 16 (18.0) 69 (77.5) 4 (4.5) <0.001 8 (9.0) 58 (65.2) 23 (25.8) <0.001 18 (20.2) 25 (28.1) 46 (51.7) <0.001 N1/N2 201 15 (7.5) 128 (63.7) 58 (28.9) 5 (2.5) 77 (38.3) 119 (59.2) 17 (8.5) 21 (10.4) 163 (81.1) (Continued ) Article No~e00206 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Variables Cyclin D1 expression EGFR expression p53 expression OR (95% CI) Pvalue OR (95% CI) Pvalue OR (95% CI) Pvalue Age (yrs) ≤60 Ref Ref Ref >60 1.09 (0.30 –3.99) 0.902 1.03 (0.54 –1.97) 0.928 0.16 (0.48 –2.34) 0.014 Sex Female Ref Ref Ref Male 0.27 (0.04 –1.73) 0.168 0.59 (0.25 –1.40) 0.234 1.24 (0.38 –4.01) 0.718 Economic status Upper/Middle Ref Ref Ref Poor 1.09 (0.34 –3.45) 0.887 0.98 (0.55 –1.74) 0.932 1.57 (0.73 –3.35) 0.247 Tobacco chewing No Ref Ref Ref Yes 4.96 (0.91 –22.84) 0.039 1.22 (0.40 –3.72) 0.724 8.92 (2.32 –34.28) 0.001 Betel nut chewing No Ref Ref Ref Yes 0.03 (0.00 –1.51) 0.078 0.97 (0.31 –3.04) 0.955 0.21 (0.05 –0.86) 0.031 Smoking No Ref Ref Ref Yes 3.00 (0.57 –15.82) 0.195 1.59 (0.73 –3.48) 0.243 1.47 (0.54 –3.74) 0.470 PS Good Ref Ref RefPoor 0.94 (0.31 –2.82) 0.912 0.70 (0.40 –1.23) 0.217 0.70 (0.32 –1.50) 0.355 Primary site Buccal mucosa Ref Ref Ref Other 0.34 (0.09 –1.34) 0.122 1.57 (0.88 –2.80) 0.126 4.96 (1.90 –13.04) 0.001 Histology SCC Ref Ref RefISCC 2.82 (0.67 –11.95) 0.159 0.88 (0.48 –1.61) 0.675 1.09 (0.51 –2.31) 0.833 Grade WD Ref Ref Ref MD/PD 0.02 (0.00 –0.15) <0.001 0.42 (0.22 –0.81) 0.009 0.03 (0.00 –0.24) 0.001 (Continued ) Article No~e00206 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Predictors Univariate Multivariate OR (95% CI) Pvalue OR (95% CI) Pvalue Age (yrs) ≤60 Ref Ref >60 1.22 (0.94 –1.60) 0.142 1.01 (0.74 –1.36) 0.972 Sex Female Ref Ref Male 0.96 (0.72 –1.28) 0.793 1.09 (0.75 –1.60) 0.657 Economic status Upper/Middle Ref Ref Poor 0.91 (0.72 –1.15) 0.409 1.19 (0.92 –1.54) 0.194 Tobacco chewing No Ref Ref Yes 1.26 (0.99 –1.61) 0.065 0.92 (0.59 –1.43) 0.701 Betel nut chewing No Ref Ref Yes 1.24 (0.97 –1.57) 0.085 1.22 (0.75 –1.97) 0.426 Smoking No Ref Ref Yes 0.96 (0.76 –1.21) 0.724 0.93 (0.65 –1.32) 0.668 Performance status Good Ref RefPoor 0.75 (0.60 –0.95) 0.017 0.87 (0.67 –1.12) 0.273 Primary site Buccal mucosa Ref Ref Other 1.59 (1.23 –2.04) <0.001 1.33 (1.01 –1.75) 0.044 Histology SCC Ref Ref ISCC 0.82 (0.64 –1.05) 0.123 0.90 (0.69 –1.17) 0.437 Grade WD Ref Ref MD/PD 0.62 (0.48 –0.80) <0.001 1.15 (0.82 –1.62) 0.415 (Continued ) Article No~e00206 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Predictors Recurrence Univariate Multivariate No (n = 234) (%)Yes (n = 56) (%)OR (95% CI) Pvalue OR (95% CI) Pvalue Age (yrs) ≤60 176 (75.2) 44 (78.6) Ref Ref >60 58 (24.8) 12 (21.4) 1.21 (0.60 –2.44) 0.598 0.95 (0.40 –2.25) 0.899 Sex Female 45 (19.2) 14 (25.0) Ref Ref Male 189 (80.8) 42 (75.0) 1.40 (0.71 –2.78) 0.337 2.18 (0.68 –7.02) 0.191 Economic status Upper/Middle 97 (41.5) 21 (37.5) Ref Ref Poor 137 (58.5) 35 (62.5) 0.85 (0.47 –1.55) 0.589 0.59 (0.28 –1.23) 0.159 Tobacco chewing No 76 (32.5) 22 (39.3) Ref RefYes 158 (67.5) 34 (60.7) 1.35 (0.74 –2.46) 0.334 0.66 (0.10 –4.44) 0.673 Betel nut chewing No 85 (36.3) 24 (42.9) Ref Ref Yes 149 (63.7) 32 (57.1) 1.32 (0.73 –2.38) 0.365 1.26 (0.18 –8.94) 0.817 Smoking No 101 (43.2) 27 (48.2) Ref Ref Yes 133 (56.8) 29 (51.8) 1.23 (0.68 –2.20) 0.494 1.29 (0.46 –3.62) 0.629 Performance status Good 136 (58.1) 29 (51.8) Ref Ref Poor 98 (41.9) 27 (48.2) 0.77 (0.43 –1.39) 0.391 1.51 (0.74 –3.11) 0.262 Primary site Buccal mucosa 83 (35.5) 10 (17.9) Ref Ref Other 151 (64.5) 46 (82.1) 0.40 (0.19 –0.82) 0.013 0.21 (0.09 –0.54) 0.001 Histology SCC 84 (35.9) 18 (32.1) Ref RefISCC 150 (64.1) 38 (67.9) 0.85 (0.45 –1.57) 0.597 1.31 (0.58 –2.95) 0.523 Grade WD 178 (76.1) 17 (30.4) Ref Ref MD/PD 56 (23.9) 39 (69.6) 0.14 (0.07 –0.26) <0.001 0.15 (0.06 –0.37) <0.001 (Continued ) Article No~e00206 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Predictors Univariate Multivariate OR (95% CI) Pvalue OR (95% CI) Pvalue Age (yrs) ≤60 Ref Ref >60 1.01 (0.53 –1.95) 0.968 0.95 (0.44 –2.05) 0.903 Sex Female Ref Ref Male 0.65 (0.33 –1.27) 0.204 0.82 (0.24 –2.82) 0.758 Economic status Upper/Middle Ref Ref Poor 1.65 (0.94 –2.88) 0.040 1.59 (0.71 –3.57) 0.263 Tobacco chewing No Ref Ref Yes 0.82 (0.46 –1.45) 0.488 1.11 (0.18 –6.92) 0.912 Betel nut chewing No Ref Ref Yes 0.75 (0.43 –1.31) 0.309 0.98 (0.13 –7.59) 0.984 Smoking No Ref Ref Yes 0.74 (0.42 –1.29) 0.287 1.15 (0.42 –3.18) 0.787 Performance status Good Ref RefPoor 0.66 (0.38 –1.14) 0.131 0.86 (0.39 –1.89) 0.705 Primary site Buccal mucosa Ref Ref Other 1.29 (0.64 –2.59) 0.475 0.83 (0.33 –2.07) 0.689 Histology SCC Ref Ref ISCC 0.53 (0.29 –0.95) 0.033 0.54 (0.23 –1.27) 0.159 Grade WD Ref Ref MD/PD 0.43 (0.23 –0.81) 0.009 1.61 (0.54 –4.83) 0.392 (Continued ) Article No~e00206 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
"Therefore in view of immense bulk of oral cancer patients in productive years of life and excessively with greater tendency to recur, it would be beneficial to Article No~e00206 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 32 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 33 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 34 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
Article No~e00206 35 http://dx.doi.org/10.1016/j.heliyon.2016.e00206 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/main.PMC5148783.pdf
"This may occur during the transportation or storage of hydrogen (H), or as aReceived: 4 November 2015 Revised: 10 October 2016 Accepted: 24 November 2016 Heliyon 2 (2016) e00209 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"It is known that atomic hydrogen within metals can serve as a strong reducing agent [24], recently it was found to reduce several metals including as Cu, Sb, Sn, Article No~e00209 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"It has also been proposed, that at the sub-surface level, the presence of H in the steel lattice could weaken the Article No~e00209 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"The diffusible hydrogen concentration within the steel samples, Article No~e00209 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This slightlyacidified electrolyte was chosen in order to ensure that any dissolved Fe remained Article No~e00209 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"In fact, it is the diffusible H atoms that constantly replenish the surface, as H atoms exit the Article No~e00209 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"Thiselectron transfer moderately impacts the electron density of the 2nd NN Fe atom, Article No~e00209 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
The Article No~e00209 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
The electrochemical/chemical effects of H on pitting to cracking Article No~e00209 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
http://dx.doi.org/10.5006/1811.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
Article No~e00209 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00209 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/08/main.PMC5148784.pdf
"PROOF ONLYDOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .1–8 Prednisolone and adrenal  insufficiencyM Quinkler  et al.Research Open Access6 1 1:6Endocrine ConnectionsCorrespondence  should be addressed  to M Quinkler  Email  marcusquinkler@t-online.dePrednisolone is associated with a  worse lipid profile than  hydrocortisone in patients with  adrenal insufficiency Marcus Quinkler1, Bertil Ekman2, Claudio Marelli3, Sharif Uddin4, Pierre Zelissen5  and Robert D Murray6 on behalf of the EU-AIR Investigators 1Endocrinology in Charlottenburg, Berlin, Germany 2Departments of Endocrinology and Medical and Health Sciences, Linköping University, Linköping, Sweden 3Shire International GmbH, Zug, Switzerland 4Shire, Lexington, Massachusetts, USA 5Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands 6Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK Abstract Objective : Prednisolone is used as glucocorticoid replacement therapy for adrenal  insufficiency (AI).",Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
"Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ EC-16-0081.Declaration of interest Marcus Quinkler, Bertil Ekman, Pierre Zelissen and Robert D Murray  received honoraria for talks and consultancy from ViroPharma/Shire.",Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0081 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research M Quinkler  et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ec-6-1.PMC5148794.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd ID: 16-0071; December 2016 DOI: 10.1530/EDM-16-0071Metastatic PTC in pregnancy C W Rowe and others Management of metastatic thyroid cancer in  pregnancy: risk and uncertainty Christopher W Rowe1,4, Kirsten Murray1, Andrew Woods2, Sandeep Gupta3,5,  Roger Smith1,4 and Katie Wynne1,4 1Departments of Endocrinology and Diabetes and 2Maternity and Gynaecology, John Hunter Hospital,  Newcastle, New South Wales, Australia, 3Department of Nuclear Medicine & PET, Hunter New England  Imaging, John Hunter and Calvary Mater Hospital, Newcastle, New South Wales, Australia,   4Schools of Medicine and Public Health, and 5Health Sciences, University of Newcastle, Newcastle,   New South Wales, Australia Summary Metastatic thyroid cancer is an uncommon condition to be present at the time of pregnancy, but presents a challenging  paradigm of care .",Non-OADS,/arxiv_data1/oa_pdf/5c/02/edmcr-2016-160071.PMC5148795.pdf
C W Rowe and others Metastatic PTC in pregnancyID: 16-0071; December 2016 DOI: 10.1530/EDM-16-0071 http://www.edmcasereports.com  2pregnancy.,Non-OADS,/arxiv_data1/oa_pdf/5c/02/edmcr-2016-160071.PMC5148795.pdf
"C W Rowe and othersID: 16-0071; December 2016 DOI: 10.1530/EDM-16-0071 Metastatic PTC in pregnancy http://www.edmcasereports.com  3was closely monitored by exercise tolerance, exertional  pulse oximetry and formal lung function testing, without  abnormality.",Non-OADS,/arxiv_data1/oa_pdf/5c/02/edmcr-2016-160071.PMC5148795.pdf
"C W Rowe and others Metastatic PTC in pregnancyID: 16-0071; December 2016 DOI: 10.1530/EDM-16-0071 http://www.edmcasereports.com  4complicated by metastatic thyroid cancer, an important  unquantifiable risk to maternal health is the potential for  accelerated tumour growth due to proliferative effects of  oestrogen, hCG and possibly progesterone on metastases,  as discussed previously.",Non-OADS,/arxiv_data1/oa_pdf/5c/02/edmcr-2016-160071.PMC5148795.pdf
C W Rowe and othersID: 16-0071; December 2016 DOI: 10.1530/EDM-16-0071 Metastatic PTC in pregnancy http://www.edmcasereports.com  5treatment.,Non-OADS,/arxiv_data1/oa_pdf/5c/02/edmcr-2016-160071.PMC5148795.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0093; November 2016 DOI: 10.1530/EDM-16-0093C609Y mutation of RET and  phaeochromocytomaR Speak and others Disease-modifying polymorphisms and   C609Y mutation of RET  associated with high  penetrance of phaeochromocytoma and low  rate of MTC in MEN2A Rowena Speak1, Jackie Cook4, Barney Harrison3 and John Newell-Price1,2 1Departments of Oncology and Metabolism, University of Sheffield, 2Endocrinology and 3Endocrine Surgery,   Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK, and   4Department of Genetics, Sheffield Children’s Hospital, Sheffield, UK Summary Mutations of the rearranged during transfection ( RET) proto-oncogene, located on chromosome 10q11.2, cause multiple  endocrine neoplasia type 2A (MEN2A).",Non-OADS,/arxiv_data1/oa_pdf/0a/68/edmcr-2016-160093.PMC5148796.pdf
"R Speak and others C609Y mutation of RET and  phaeochromocytomaID: 16-0093; November 2016 DOI: 10.1530/EDM-16-0093 http://www.edmcasereports.com  2thyroid cancer (MTC), phaeochromocytoma and  hyperparathyroidism.",Non-OADS,/arxiv_data1/oa_pdf/0a/68/edmcr-2016-160093.PMC5148796.pdf
R Speak and others ID: 16-0093; November 2016 DOI: 10.1530/EDM-16-0093C609Y mutation of RET and  phaeochromocytoma http://www.edmcasereports.com  3value of 4.5 ng/L to a peak value of 90.9 ng/L (0–18.9) after  pentagastrin stimulation.,Non-OADS,/arxiv_data1/oa_pdf/0a/68/edmcr-2016-160093.PMC5148796.pdf
"R Speak and others C609Y mutation of RET and  phaeochromocytomaID: 16-0093; November 2016 DOI: 10.1530/EDM-16-0093 http://www.edmcasereports.com  4Case 4 Histology revealed C cell hyperplasia but no MTC, with  no lymph node involvement.",Non-OADS,/arxiv_data1/oa_pdf/0a/68/edmcr-2016-160093.PMC5148796.pdf
"R Speak and others ID: 16-0093; November 2016 DOI: 10.1530/EDM-16-0093C609Y mutation of RET and  phaeochromocytoma http://www.edmcasereports.com  5Thyroid Association (ATA) and 2014 British Thyroid  Association Guidelines for the Management of Thyroid  Cancer suggest prophylactic thyroid surgery at the age of  5 be discussed with the parents of patients with moderate- risk mutations (ATA-MOD), including those with ∆609  mutations ( 8, 9).",Non-OADS,/arxiv_data1/oa_pdf/0a/68/edmcr-2016-160093.PMC5148796.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica LtdJ Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd5 6 Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
Supplementary data This is linked to the online version of the paper at http://dx.doi.org/10.1530/ EC-16-0065.Declaration of interest The authors declare that there is no conflict of interest that could be  perceived as prejudicing the impartiality of the research reported.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-16-0065 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research J Toulany  et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/a0/ec-5-70.PMC5148798.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC5149048.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.11.029 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/86/78/main.PMC5149048.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/83/main.PMC5149049.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.022 488,OADS,/arxiv_data1/oa_pdf/f8/83/main.PMC5149049.pdf
The data is stored in the NIST dSpace repository ( http://hdl.handle.net/11256/671 ).,OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
SoluteEffects.csv ﬁle containing computed solute effects on theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.11.092 2352-3409/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.commatsci.2016.09.040 nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
"Text ﬁles containing UNIX shell scripts that compute the data from the VASP output ﬁles How data was acquiredDensity functional theory calculations performed using VASP Data format Raw and analyzed data Data source locationUrbana, IL, USA and Warren, MI, USA Data accessibility Data are available in the NIST dSpace repository (http://hdl.handle.net/11256/ 671) Value of the data /C15The data gives the strain and chemical effects of Al, B, Cu, Mn, Si, C, and N solutes on the lattice parameter and single-crystal elastic stiffness coef ﬁcients Cijof bcc Fe.",OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
"The VASP input ﬁles INCAR and KPOINTS, and output ﬁles CONTCAR, OUTCAR, and OSZICAR for all the calculations are stored in the NIST dSpace repository (http://hdl.handle.net/11256/67 ), along with the analyzed data stored in the PureFe.csv and Solute- Effects.csv ﬁles.",OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
Supporting information Transparency data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/90/main.PMC5149050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6e/55/main.PMC5149051.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.005 485,OADS,/arxiv_data1/oa_pdf/6e/55/main.PMC5149051.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0c/81/main.PMC5149062.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.08.016 476,OADS,/arxiv_data1/oa_pdf/0c/81/main.PMC5149062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/ad/main.PMC5149063.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.11.010,OADS,/arxiv_data1/oa_pdf/b6/ad/main.PMC5149063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: NHANES National School Lunch ProgramSchool Breakfast ProgramChildrenDietary intakeContribution of school meals 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.016 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"CDC Growth Charts: United States, 2000. http://www.cdc.gov/growthcharts/clinical_charts.htm (Accessed June 2, 2016).",OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
( http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.,OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"U.S. Department of Agriculture, Food and Nutrition Service, Of ﬁce of Research, Nutrition and Analysis, Alexandria, VA (Available from: http://www.fns.usda.gov/sites/ default/ ﬁles/NHANES-NSLP.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"https://www.cbo.gov/publication/50737 (Accessed June 2, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
(Available from: http://www.mathematica-mpr.com/our-publications- and-ﬁndings/publications/meeting-new-nutrition-standards-how-much-do-school- lunches-really-have-to-change ).,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"Menu planning in the School Lunch Program, 2009. http://www.doe.in.gov/sites/default/ ﬁles/nutrition/nslp- 0209lunchtmealrequirements.pdf (Accessed June 2, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"National School Lunch Program: Participation and Lunches Served, 2016. http://www.fns.usda.gov/sites/ default/ ﬁles/pd/slsummar.pdf (Accessed June 2, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"Program History - National School Lunch Program (NSLP), 2014. http://www.fns.usda.gov/nslp/history (Accessed June 2, 2016).Food and Nutrition Service - U.S. Department of Agriculture.",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"School Breakfast Program Fact Sheet, 2013. http://www.fns.usda.gov/sites/default/ ﬁles/SBPfactsheet.pdf (Accessed June 1, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"School Breakfast Program Participation and Meals Served, 2016. http://www.fns.usda.gov/sites/default/ ﬁles/ pd/sbsummar.pdf (Accessed June 2, 2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
( http://www.mathematica-mpr.com/~/media/publications/pdfs/ nutrition/snda-iv_vol1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
( http://www.fns.,Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
"http://www.cdc.gov/nchs/ tutorials/Dietary/Basic/PopulationMeanIntakes/Info1.htm (Accessed November 9, 2016).85 K.W.",Non-OADS,/arxiv_data1/oa_pdf/ed/b6/main.PMC5149064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/75/main.PMC5149065.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.016 491,OADS,/arxiv_data1/oa_pdf/4e/75/main.PMC5149065.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/de/main.PMC5149066.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.003 482,OADS,/arxiv_data1/oa_pdf/47/de/main.PMC5149066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/69/main.PMC5149067.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.09.001 494,OADS,/arxiv_data1/oa_pdf/20/69/main.PMC5149067.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diabetes mellitusSelf-managementRural 1.,Non-OADS,/arxiv_data1/oa_pdf/96/1f/main.PMC5149068.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.015 2211-3355/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/96/1f/main.PMC5149068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/1f/main.PMC5149068.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/96/1f/main.PMC5149068.pdf
"While most HH patients are homozygous for the p.C282Y variant of the HFE gene, there is great phenotypic variability among C282Y homozygotes concerning both the degree of iron loading and the http://dx.doi.org/10.1016/j.redox.2016.11.013 Received 19 October 2016; Received in revised form 16 November 2016; Accepted 28 November 2016⁎Correspondence to: Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen 208, 4200-135 Porto, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/d4/46/main.PMC5149069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/46/main.PMC5149069.pdf
Digital images of 3 di ﬀerent ﬁelds at ×100 magni ﬁcation were analyzed using ImageJ software (available at http://rsbweb.nih.gov/ij/index.,OADS,/arxiv_data1/oa_pdf/d4/46/main.PMC5149069.pdf
"Avaible from: http://who.int/entity/oral_health/media/ en/orh_eastern_europe.pdf 6. WHO Oral health Country/Area Profile Programme, Chosen Region: Europe “euro”, 2008.",Non-OADS,/arxiv_data1/oa_pdf/49/36/MSM-28-397.PMC5149434.pdf
Avaible from: http://www.whocollab.od.mah.se/euro.html 8.,Non-OADS,/arxiv_data1/oa_pdf/49/36/MSM-28-397.PMC5149434.pdf
The International Society for Clinical Densitometry  http://www.iscd.org/official-positions/official-posi - tions/.,Non-OADS,/arxiv_data1/oa_pdf/02/fa/MSM-28-333.PMC5149437.pdf
2016; 5: 389. http://doi.org/10.12688/ f1000research.7506.1 2.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/MSM-28-370.PMC5149441.pdf
2008; 44:  118-27. http://dx.doi.org/10.1016/j.jdsr.2008.07.001 5. WHO.,OADS,/arxiv_data1/oa_pdf/8e/27/MSM-28-370.PMC5149441.pdf
2013; 42(2):108-16. http://dx.doi.org/10.5644/ama2006-124.79.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/MSM-28-370.PMC5149441.pdf
2010; 32(2): 3249-53. http://dx.doi.org/10.1590/S1413-81232010000800030.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/MSM-28-370.PMC5149441.pdf
2009; 51(3): 333-40. http://doi.org/10.2334/josnusd.51.333 17.,Non-OADS,/arxiv_data1/oa_pdf/8e/27/MSM-28-370.PMC5149441.pdf
Transplant  newsletter -2012. https://store.edqm.eu.,Non-OADS,/arxiv_data1/oa_pdf/9d/c2/MSM-28-373.PMC5149443.pdf
"It is clear, that the design of our study does not  fulfill all recommendations from the current guidelines on clinical investigation of medicinal products used in  the treatment of osteoarthritis [http://www.ema.euro- pa.eu] [20].",Non-OADS,/arxiv_data1/oa_pdf/23/4a/RU-54-28709.PMC5149568.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting al l non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"The consequences that human-associated micro-organisms, pathogenic or not, may have on the environ- ment and the local wildlife in the polar regions are difficultJorge Herna ´ndez and Daniel Gonza ´lez-Acun ˜a 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"This is an indication that the ESBLARGs mobilization to the polar regions Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"Acknowledgements We would like to give special thanks to the Instituto Anta ´rtico Chileno (INACH), which supported the projects INACH T 27-10 and T-12-13, and to Diane Haughney for editing language in the article.Jorge Herna ´ndez and Daniel Gonza ´lez-Acun ˜a 4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"Infect Ecol Epidemiol 2014; 21565, doi: http://dx.doi.org/10.3402/iee.v4.21565 23.",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"Clin Microbiol Rev 2005; 18: 657 /C186.ARGs mobilization to the polar regions Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
"Drugs 2003; 63: 353 /C165.Jorge Herna ´ndez and Daniel Gonza ´lez-Acun ˜a 6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32112 - http://dx.doi.org/10.3402/iee.v6.32112",Non-OADS,/arxiv_data1/oa_pdf/50/3b/IEE-6-32112.PMC5149653.pdf
Available from: http://www.freepatentsonline.com/7601136.,Non-OADS,/arxiv_data1/oa_pdf/26/f3/IJO-64-659.PMC5151156.pdf
"We have used  Camera FV‐5 and Cinema FV‐5 (FGAE Studios, Germany,  http://www.cinemafv5.com/index.php) for Android and  Camera Plus (Global Delight Technologies, Udupi, India, www.",Non-OADS,/arxiv_data1/oa_pdf/b4/01/IJO-64-663.PMC5151157.pdf
"10, 1464 –1472 http://dx.doi.org/10.1080/07420528.2016.1220388 Published with license by Taylor & Francis Group, LLC © 2016 Kneginja Richter, Sophia Adam, Lennard Geiss, Lukas Peter, and Guenter Niklewski.",Non-OADS,/arxiv_data1/oa_pdf/be/9a/icbi-33-1464.PMC5152533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/be/9a/icbi-33-1464.PMC5152533.pdf
"6, 503–507http://dx.doi.org/10.1080/00365513.2016.1200136",Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
Available from: https://www.nice.org.uk/guidance/dg13 [last accessed February 2016].,Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ ucm123682.htm#1 [last accessed November 2015].,Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
Available from: http://ec.europa.eu/health/medical-devi- ces/files/revision_docs/proposal_2012_541_en.pdf [last accessed October 2015].,Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
Available from: http://www.ema.eur- opa.eu/docs/en_GB/document_library/Scientific_guideline/2009/ 09/WC500002662.pdf [last accessed October 2015].,Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT01475669 [last accessed November 2015].,Non-OADS,/arxiv_data1/oa_pdf/38/5b/iclb-76-503.PMC5152534.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-N oDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, pr ovided the original work is properly cited, and is not altered, transformed, or built upon in any way.HUMAN FERTILITY, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/7e/db/ihuf-19-242.PMC5152535.pdf
"4, 242 –248 http://dx.doi.org/10.1080/14647273.2016.1222083",Non-OADS,/arxiv_data1/oa_pdf/7e/db/ihuf-19-242.PMC5152535.pdf
doi: http://dx.doi.org/10.1016/j.rbmo.2013.06.008 .,OADS,/arxiv_data1/oa_pdf/7e/db/ihuf-19-242.PMC5152535.pdf
doi: http://dx.doi.org/10.1016/j.rbmo.2013.06.,OADS,/arxiv_data1/oa_pdf/7e/db/ihuf-19-242.PMC5152535.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/db/ihuf-19-242.PMC5152535.pdf
"10, 849 –870 http://dx.doi.org/10.1080/02699206.2016.1209244 © 2016 G. Rasmussen.",Non-OADS,/arxiv_data1/oa_pdf/dc/36/iclp-30-849.PMC5152536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/dc/36/iclp-30-849.PMC5152536.pdf
"ORCID Gitte Rasmussen http://orcid.org/0000-0002-2940-0839 References Antaki, C. (2012).",OADS,/arxiv_data1/oa_pdf/dc/36/iclp-30-849.PMC5152536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided th e original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/b7/22/iafd-17-528.PMC5152538.pdf
12. http://wonder.cdc.gov/ucd-icd10.html.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/iafd-17-528.PMC5152538.pdf
Available at: http://pubs.usgs.gov/tm/ 2007/tm4e1/pdf/tm4-e1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/iafd-17-528.PMC5152538.pdf
18. https://www.census.gov/.,OADS,/arxiv_data1/oa_pdf/b7/22/iafd-17-528.PMC5152538.pdf
19. http://www.cdc.gov/brfss/.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/iafd-17-528.PMC5152538.pdf
"6, 440–443http://dx.doi.org/10.1080/07853890.2016.1186830",Non-OADS,/arxiv_data1/oa_pdf/d9/6b/iann-48-440.PMC5152539.pdf
"8, 1247 –1261 http://dx.doi.org/10.1080/01635581.2016.1224366",Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.cancer.gov/about-cancer/causes-prevention/risk/diet/arti ﬁcial-sweeteners-fact-sheet 2.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.mayoclinic.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Avail- able at http://www.oecd.org/chemicalsafety/risk-assess ment/oecdquantitativestructure-activityrelationshipspro jectqsars.htm .,OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/IngredientsAdditives GRASPackaging/ucm078345.htm .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available athttp://www.fda.gov/Food/GuidanceRegulation/Guidance DocumentsRegulatoryInformation/IngredientsAdditives GRASPackaging/ucm078315.htm 18.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
DOI: http://dx.doi.org/10.1787/9789264242692-en.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.efsa.europa.eu/en/efsajournal/pub/1052.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Avail- able at http://www.fda.gov/downloads/Food/GuidanceRe gulation/UCM222779.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Avail- able at http://www.oecd.org/chemicalsafety/testing/ 41829966.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Avail-able at http://pubchem.ncbi.nlm.nih.gov/compound/ Sucralose#section DTop.,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://ec.europa.eu/food/fs/ sc/scf/out68_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at: https://ntp.niehs.nih.gov/ntp/about_ntp/ partnerships/international/ summarypwg_report_ri_bio assays.pdf 103.,OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.ffcr.or.jp/sai dan/FFCRHOME.nsf/pages/e-kousei-sucra2 .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://ec.europa.eu/food/fs/ sHealthc/scf/out68_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
Available at http://www.foodstan dards.gov.au/_src ﬁles/Standard_1_3_1_Additives_Part_ 2_v98.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/0e/hnuc-68-1247.PMC5152540.pdf
"10, 1327 –1336 http://dx.doi.org/10.1080/14760584.2016.1176533 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/34/78/ierv-15-1327.PMC5152541.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/34/78/ierv-15-1327.PMC5152541.pdf
"7, 492–495http://dx.doi.org/10.1080/07853890.2016.1186828",Non-OADS,/arxiv_data1/oa_pdf/f4/d2/iann-48-492.PMC5152547.pdf
"1, 163 –180 http://dx.doi.org/10.1080/10408398.2016.1221794",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Federal AgencyType of Scienti ﬁc Integrity Developed Year Developed Key Target Group Website OSTP Published the federal policy on research misconduct in the Federal Register as a ﬁnal, government- wide policy2000 Federal agencies https://www.federalregister.gov/articles/ 2000/12/06/00-30852/executive-of ﬁce- of-the-president-federal-policy-on- research-misconduct-preamble-for-research OSTP Provided guidance to federal agencies to respond to the 2009 PresidentialMemorandum on Scienti ﬁc Integrity2010 Federal agencies https://www.whitehouse.gov/sites/default/ ﬁles/microsites/ostp/scienti ﬁc-integrity- memo-12172010.pdf OSTP Issued a scienti ﬁc integrity report card for individual federal agencies ontheir progress2013 Federal agencies http://www.peer.org/assets/docs/ SI_Report_Card_Comparison_Chart%20-%20Sorted%20by%20Score.pdf NSF Published the Research Misconduct regulation in the CFR2002 NSF employees and grant awardeeshttps://www.gpo.gov/fdsys/granule/CFR- 2012-title45-vol3/CFR-2012-title45-vol3-part689/content-detail.html NSF Released the Responsible Conduct of Research, requiring institutions toprovide appropriate training/oversight in the responsible andethical conduct of research toundergraduate students, graduate students, and postdoctoral fellows2009 Research institutions applying for NSF grantshttps://www.gpo.gov/fdsys/pkg/FR-2009- 08-20/html/E9-19930.htm NSF and NASJointly published the third edition of On Being a Scientist: A Guide toResponsible Conduct in Research2009 Graduate students and beginning researchers butapplies to all scientistshttp://www.nap.edu/catalog/12192/on- being-a-scientist-a-guide-to-responsible-conduct-in NSF Released draft Scienti ﬁc Integrity Policy 2011 Civil service employees; visiting scientists, engineers, andeducators; those working at NSF under the Intergovernmental PersonnelAct; and political appointeeshttp://www.nsf.gov/bfa/dias/policy/si/sipo licy.pdf NSF Supported research grants on scienti ﬁc integrity1990s –present Undergraduate and graduate studentshttp://digitalworlds.u ﬂ.edu/projects/gap/ HHS Policies and Principles for Assuring Scienti ﬁc Integrity2011 11 HHS operating divisions http://www.hhs.gov/sites/default/ ﬁles/ open/pres-actions/scientifc-integrity-prin ciples-12-19-11.pdf HHS ORI Commission on Research Integrity report, “Integrity and Misconduct in Research ”1995 Federal agency scientists and professional societieshttp://ori.hhs.gov/historical-background HHS ORI Development of biennial Research Conferences on Research Integrity2000 Research community https://ori.hhs.gov/rri_conference HHS ORI Research on Research Integrity Program2001 Research community http://ori.hhs.gov/rri-program HHS ORI Rapid Response for Technical Assistance program2001 Universities and institutions http://ori.hhs.gov/rapid-response-technical- assistance HHS ORI RCR Resource Development Program 2002 Research community https://ori.hhs.gov/rcr-resource-develop ment-program HHS ORI RCR Program for Academic Societies, a collaboration with the Associationof American Medical Colleges2002 Academic societies and their membershttps://ori.hhs.gov/program-academic-socie ties HHS ORI New regulation on PHS Policies on Research Misconduct (42 CFR Part93)2005 10 PHS of ﬁces and agencies https://ori.hhs.gov/sites/default/ ﬁles/ 42_cfr_parts_50_and_93_2005.pdf HHS ORI ORI Introduction to the Responsible Conduct of Research2003, updated in 2007Research community http://ori.hhs.gov/ori-introduction-responsi ble-conduct-research HHS ORI RCR Program for Graduate Schools, a collaboration with the Council ofGraduate Schools2007 Graduate schools and students http://cgsnet.org/scholarly-integrity-and- responsible-conduct-research-rcr?tabid D123 HHS ORI RCR Program for Postdoctoral Students 2007 Graduate students and postdoctoral fellowshttp://ori.hhs.gov/historical-background HHS ORI “The Lab: Avoiding Research Misconduct ”2011 Graduate students (movie available in English, Spanish,and Chinese)http://ori.hhs.gov/thelab HHS ORI Posts case studies on research misconduct on websiteOngoing Research community https://ori.hhs.gov/case_summary HHS NIH NIH OER oversees the policy for the NIH peer review process using a two-tiered systemOngoing Peer reviewers http://grants.nih.gov/grants/guide/notice- ﬁles/NOT-OD-11-120.html HHS NIH NIH Policies and Procedures for Promoting Scienti ﬁc Integrity2012 NIH employees and grantees https://ombudsman.nih.gov/Scienti ﬁcIntegri tynov2012.pdf (Continued on next page )164 A. KRETSER ET AL.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
(Continued ) Federal AgencyType of Scienti ﬁc Integrity Developed Year Developed Key Target Group Website HHS NIH PubMed Commons 2013 Authors http://www.ncbi.nlm.nih.gov/pubmedcom mons/ HHS NIH Joint workshop with Nature Publishing Group and AAAS on reproducibilityand rigor of research ﬁndings2014 Research community http://www.nih.gov/research-training/rigor- reproducibility/principles-guidelines-reporting-preclinical-research HHS NIH Launched a new website to help guide reviewers through the peer reviewprocess2015 Peer reviewers https://grants.nih.gov/grants/policy/review.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
htm HHS NIH Statement on Integrity in Peer Review 2015 Research community http://grants.nih.gov/grants/guide/notice- ﬁles/NOT-OD-15-106.html#sthash.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"XJY7n6c6.dpuf HHS NIH New guidelines on Enhancing Reproducibility Through Rigor andTransparency in Grant Applications2015 NIH employees and grantees http://grants.nih.gov/grants/guide/notice- ﬁles/NOT-OD-15-103.html HHS FDA Established the Of ﬁce of Scienti ﬁc Integrity2009 FDA employees http://www.fda.gov/AboutFDA/CentersOf ﬁ ces/OC/Of ﬁceofScienti ﬁcandMedicalPro grams/ucm197861.htm HHS FDA Issued 11 key principles of scienti ﬁc integrity2012 FDA employees http://www.fda.gov/AboutFDA/ReportsMa nualsForms/StaffManualGuides/ucm289975.htm HHS CDC Guidance on Scienti ﬁc Integrity 2016 CDC employees https://www.cdc.gov/od/science/docs/cdcsi guide_042516.pdf EPA Principles of Scienti ﬁc Integrity 1999 EPA employees http://www.epa.gov/osa/epas-principles-sci entiﬁc-integrity-fact-sheet EPA Scienti ﬁc Integrity Policy 2012 EPA employees http://www2.epa.gov/sites/production/ ﬁles/ 2014-02/documents/scienti ﬁc_integrity_ policy_2012.pdf EPA Community of Practice for Statistics 2014 EPA employees http://www.ncbi.nlm.nih.gov/pubmed/ 25795653 EPA Peer Review Handbook, fourth edition 2015 EPA employees http://www2.epa.gov/sites/production/ ﬁles/ 2015-09/documents/ ﬁnal_epa_peer_re view_handbook-_4th_ed_091415_dummy_link.pdf USDA Departmental Regulation 1074-001 on Scienti ﬁc Integrity2013 USDA employees and contractorshttp://www.ocio.usda.gov/sites/default/ ﬁles/docs/2012/DR%201074-001_0.pdf USDA Scienti ﬁ c Integrity Policy Handbook 2013 USDA employees and contractorshttp://www.usda.gov/documents/usda-sci entiﬁc-integrity-policy-handbook.pdf USDA Scienti ﬁc Integrity Allegations Summary ReportAnnually, beginning in 2013USDA employees and contractorshttp://www.usda.gov/documents/usda- updated-scienti ﬁc-integrity-summary- report.pdf USAID Scienti ﬁc Integrity Policy 2012 USAID staff and implementing partnershttps://www.usaid.gov/sites/default/ ﬁles/ documents/15396/integrity.pdf USAID Scienti ﬁc Research Policy 2014 USAID staff and implementing partnershttps://www.usaid.gov/sites/default/ ﬁles/ documents/15396/USAID%20Scienti ﬁc%20Research%20Pol icy%2012-3-14.pdf CDC, Centers for Disease Control and Prevention; CFR, Code of Federal Regulations; EPA, US Environmental Protection Agency; FDA, US Food and Drug Adm inistration; HHS, US Department of Health and Human Services; NAS, National Academy of Sciences; NIH, National Institutes of Health; NSF, National Science Founda tion; OER, Ofﬁce of Extramural Research; ORI, Of ﬁce of Research Integrity; OSTP, Of ﬁce of Science and Technology Policy; PHS, Public Health Service; RCR, Responsible Conduct Research; USDA, US Department of Agriculture; USAID,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 165",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"”In 2015, NIH launched a new website to help guide reviewers through the peer review process ( https://grants.nih.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"FoundationType of Scienti ﬁc Integrity Grant Year Developed Key Target Group Website Laura and John Arnold Foundation$66,859,986 in grant dollars for research integrity projects (includes the grants below)2011 –2015 Organizations and academia conducting research integrity projectshttp://www.arnoldfoundation.org/ grants/ Laura and John Arnold Foundation8 grants COS totaling $10,052,621 2013 –2018 COS http://www.arnoldfoundation.org/ grants/ Laura and John Arnold Foundation$100,000 grant to AAAS 2014 –2016 AAAS http://www.arnoldfoundation.org/ grants/ Laura and John Arnold Foundation$300,000 grant to The Center for Scienti ﬁc Integrity2015 –2017 Center for Scienti ﬁc Integrity http://retractionwatch.com/2015/08/ 03/new-300000-grant-marks-the- ﬁfth-anniversary-of-retraction- watch/ John Templeton Foundation$2,109,856 grant to COS 2014 –2015 COS http://www.arnoldfoundation.org/ grants/ John Templeton Foundation$80,000 grant to the BITSS 2015 BITSS http://www.prweb.com/releases/ 2015/05/prweb12727015.htm John D. and Catherine T. MacArthur Foundation$400,000 grant to the Center for Scienti ﬁc Integrity2014 Center for Scienti ﬁc Integrity http://retractionwatch.com/2014/12/ 15/retraction-watch-growing-thanks-400000-grant-macarthur-foundation/ Alfred P. Sloan Foundation Digital Information Technology program2011 Researchers, technologists, engineers, academic publishers, and university administratorshttp://www.sloan.org/ ﬁleadmin/ media/ ﬁles/annual_reports/2013- Annual-Report.pdf Alfred P. Sloan Foundation $168,600 grant to COS 2014 COS https://cos.io/about_sponsors/ AAAS, American Association for the Advancement of Science; BITSS, Berkeley Initiative for Transparency in the Social Sciences; COS, Center for Open Science.CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 169",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Nonpro ﬁt OrganizationType of Scienti ﬁc Integrity Developed Year Developed Key Target Group Website NAS Report ( “The Role and Activities of Scienti ﬁc Societies in Promoting Research Integrity ”) recommending the development ofactivities/materials to improve integrity of research1989 Scienti ﬁc organizations representing the researchcommunity and scienti ﬁc journalshttp://www.aaas.org/sites/default/ ﬁles/con tent_ ﬁles/ The%20Role%20and%20Activities%20of%20Scientiﬁc%20Societies%20in%20Promoting %20Research%20Integrity.pdf NAS Good Science and Responsible Scientists 1992 Scienti ﬁc community http://www.aaas.org/sites/default/ ﬁles/con tent_ ﬁles/ The%20Role%20and%20Activities%20of%20Scientiﬁc%20Societies%20in%20Promoting %20Research%20Integrity.pdf NAS Responsible Science: Ensuring the Integrity of the Research Process,Volume I1992 Research community http://www.nap.edu/openbook.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
php?record_id D1864&page DR1 NAS Integrity in Scienti ﬁc Research: Creating an Environment That PromotesResponsible Conduct2002 Research community http://iom.nationalacademies.org/Reports/ 2002/Integrity-in-Scienti ﬁc-Research-Cre ating-an-Environment-That-Promotes- Responsible-Conduct.aspx NAS On Being a Scientist: A Guide to Responsible Conduct in Research2009 Research community http://www.nap.edu/catalog/12192/on- being-a-scientist-a-guide-to-responsible-conduct-in NAS Workshop: “Conﬂict of Interest and Medical Innovation: Ensuring IntegrityWhile Facilitating Innovation in Medical Research ”2014 Research community http://www.nap.edu/catalog/18723/con ﬂict-of-interest-and-medical-innovation- ensuring-integrity-while-facilitating NAS Workshop: “Does the Public Trust Science?,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Trust and Con ﬁdence at the Intersections of the Life Sciences andSociety ”2015 Research community http://nas-sites.org/publicinterfaces/round table/events/trust/ , http://www.nap.edu/catalog/21798/trust-and-con ﬁdence-at-the-interfaces- of-the-life-sciences-and-society NAS Colloquia: “Reproducibility of Research: Issues and Proposed Remedies ”2017 Research community http://www.nasonline.org/programs/sack ler-colloquia/upcoming-colloquia/ COS Open Science Framework 2014 (ongoing) Research community http://openscienceframework.org/ COS COS communities: Publishing Initiatives, Metascience, Infrastructure, andInterest Groups2014 (ongoing) Research community https://cos.io/communities/ COS Workshop: “Creating Standards for Reproducible Research ”2014 Research community https://bitssblog.wordpress.com/2014/11/ 06/creating-standards-for-reproducible- research-overview-of-cos-meeting/ Center for Scienti ﬁc IntegrityRetraction Watch 2010 Research community http://retractionwatch.com/ COS, Center for Open Science; NAS, National Academy of Sciences.170 A. KRETSER ET AL.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"A major product of the Center is a database of retractions generated by the work of Retraction Watch ( http://retractionwatch.com/ ), the ﬁrst publicly available database to compile retracted scienti ﬁc publications (Retraction Watch, 2016 ).",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Professional SocietiesType of Scienti ﬁc Integrity DevelopedYear Developed Key Target Group Website COPE Maintains database of research/ publication misconduct cases discussed at the COPE Forum1997 Research Community http://publicationethics.org/cases COPE eLearning course Ongoing development COPE members who are editors and publishershttp://publicationethics.org/resources/e- learning COPE Code of Conduct and Best Practice Guidelines for Journal Editors2011 COPE members http://publicationethics.org/ ﬁles/Code_of_ conduct_for_journal_editors_Mar11.pdf CSE “Promoting Integrity in Scienti ﬁc Journal Publications ”2006 –present (ongoing)Scienti ﬁc editors http://www.councilscienceeditors.org/ resource-library/editorial-policies/white- paper-on-publication-ethics/ AAAS 5 VHS videos on ethical scienti ﬁc research and a Discussion andResource Guide1996 Research community http://www.aaas.org/page/integrity-scien tiﬁc-research-video-series AAAS The Role and Activities of Scienti ﬁc Societies in Promoting Research Integrity2000 Scienti ﬁc societies http://www.aaas.org/sites/default/ ﬁles/con tent_ ﬁles/ The%20Role%20and%20Activities%20of %20Scientiﬁc%20Societies%20in%20Promoting %20Research%20Integrity.pdf AAAS Joint workshop with Nature Publishing Group and NIH on reproducibility and rigor of research ﬁndings2014 Research community http://www.nih.gov/research-training/rigor- reproducibility/principles-guidelines- reporting-preclinical-research FASEB Set of recommendations on enhancing research reproducibility2016 Research community and journalistshttps://www.faseb.org/Portals/2/PDFs/opa/ 2016/FASEB_Enhancing%20Research%20Reproducibility.pdf ASA Statement on Maintaining Integrity of U.S. Presidential Appointments2004 President of the United Stateshttp://www.asanet.org/about-asa/how-asa- operates/council-statements/integrity-presidential-appointment-scientists ASA Statement on Academic Independence and Scienti ﬁc Integrity2006 Scienti ﬁc community http://www.asanet.org/about-asa/how-asa- operates/council-statements/academic- independence-and-scienti ﬁc-integrity ACS Position Statement on Scienti ﬁc Integrity in Public Policy2014 –2017 Research community http://www.acs.org/content/acs/en/policy/ publicpolicies/promote/scienti ﬁcintegr ity.html ACS “Catching Errors: Peer Review and Retractions in Publishing ”webinar2015 ACS members http://www.acs.org/content/acs/en/acs- webinars/popular-chemistry/catching-errors.html AAAS, American Association for the Advancement of Science; ACS, American Chemical Society; COPE, Committee on Publication Ethics; CSE, Council of S cience Editors; FASEB, Federation of American Societies for Experimental Biology; NIH, National Institutes of Health; ASA, American Sociological Association .CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 173",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"AcademiaType of Scienti ﬁc Integrity DevelopedYear Developed Key Target Group Website ICTS Course on the responsible conduct of research2007 Students at Washington University in St. Louis and members from ICTS partner institutionshttp://ethicsresearchcore.org/education/rcr/ CCRE Professional Integrity program 2012 Investigators who have engaged in wrongdoing or unprofessionalbehaviorhttp://icts.wustl.edu/icts-researchers/education CCRE Library of Research Ethics Case Studies Ongoing Research community http://ethicsresearchcore.org/education/case-studies/ CASBS Group on Best Practices in Science 2013 Research community https://bps.stanford.edu/?page_id D1977 CASBS Best Practices in Science conference 2015 Scientists actively conducting research on scienti ﬁc integrityhttp://bps.stanford.edu/?page_id D4587 BITSS Leamer-Rosenthal Prizes for Open Social Science2015 Emerging researchers and leaders in educationhttps://bitssblog.wordpress.com/prizes/ BITSS, Berkeley Initiative for Transparency in the Social Sciences; CASBS, Center for Advanced Study in the Behavioral Sciences; CCRE, Center for Cl inical Research Ethics; ICTS, Institute of Clinical and Translational Sciences.CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 175",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Acknowledgments This paper is intended to be a living document and updates will be posted on the ILSI North America website ( http://ilsina.org ; E-mail: ilsina@ilsi.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.aaas.org/sites/default/ ﬁles/content_ ﬁles/ The%20Role%20and%20Activities%20of%20Scienti ﬁc%20Societies %20in%20Promoting%20Research%20Integrity.pdf [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.aaas.org/news/2006-forum [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"About AAAS.Available from: http://www.aaas.org/about- aaas[Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.aaas.org/page/integrity-scienti ﬁc-research-video- series [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Availablefrom: http://www.asanet.org/about-asa/ how-asa-operates/council-state ments/integrity-presidenti al-appointment-scientists [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Avail- able from: http://www.asanet.org/about-asa/how-asa-operates/council- statements/academic-independence-and-scienti ﬁc-integrity [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: http://www.nap.edu/catalog/18723/con ﬂict-of- interest-and-medical-innovation-ensuring-integrity-while-facilitating .,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://bitssblog.wordpress.com/prizes/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.bitss.org/lr-prizes/leamer-rosenthal-prizes-nomina tion-process/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://bitssblog.wordpress.com/ about/mission/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://bps.stanford.edu/?page_id D4587 [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://casbs.stanford.edu/ about-casbs [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://bps.stanford.edu/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://bps.stanford.edu/?page_id D1977 [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: https://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.cdc.gov/about/organization/mission.htm [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: http://www.cdc.gov/od/science/aboutus/index.,OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://publicationethics.org/ about [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://publicationethics.org/ cases [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Code of Conduct and Best Practice Guidelines for Journal Editors.Available from: http://publicationethics.org/ ﬁles/Code_of_con duct_for_journal_editors_Mar11.pdf [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"E-Learning.Available from: http://publicationethics.org/ resources/e-learning [Accessed August 3, 2016].CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 177",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Research.Available from: http://publicationethics.org/ resources/research [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Seminars.Available from: http://publicationethics.org/ resources/seminars [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"COS Communities.Available from: https://cos.io/communi ties/[Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Sponsors of COS.Available from: https://cos.io/about_spon sors/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Scholarly Integrity and Responsible Conduct of Research (RCR).Available from: http://cgsnet.org/schol arly-integrity-and-responsible-conduct-research-rcr?tabid D123 [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"1.0 Introduction.Available from: http://www.councilsciencee ditors.org/resource-library/editorial-policies/white-paper-on-publica tion-ethics/1-0-introduction/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
About CSE.Available from: http://www.councilscienceeditors.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: https://www.epa.gov/sites/production/ ﬁles/2015-10/documents/ october_19-20_2015_hsrb_meeting_-_ ﬁnal_agenda.pdf .,OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"US Environmental Protection Agency Scienti ﬁc Integrity Pol- icy.Available from: http://www2.epa.gov/sites/production/ ﬁles/2014- 02/documents/scienti ﬁc_integrity_policy_2012.pdf [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"About EPA: Our Mission and What We Do.Available from: http://www2.epa.gov/aboutepa/our-mission-and-what-we-do [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Federal Policy on Research Mis- conduct; Preamble for Research Misconduct Policy: A Notice by the Science and Technology Policy Of ﬁce on 12/06/2000.Available from: https://www.federalregister.gov/articles/2000/12/06/00-30852/executive-of ﬁce-of-the-president-federal-policy-on-research-misconduct-pre amble-for-research [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://www.faseb.org/Portals/2/PDFs/opa/2016/FASE B_Enhancing%20Research%20Reproducibility.pdf [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"FASEB ’s Mission.Available from: https://www.faseb.org/ About-FASEB/Our-Mission.aspx [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Research Integrity.Available from: https://www.faseb.org/ Science-Policy-and-Advocacy/Science-Policy-and-Research-Issues/Research-Integrity.aspx [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"SMG 9001.1: FDA Staff Manual Guides, Volume IV, Agency Program Directives, General or Multidiscipline Scienti ﬁc Integrity, Sci- entiﬁc Integrity at FDA.Available from: http://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/ucm289975.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"About FDA: Of ﬁce of Scienti ﬁc Integrity.Available from: http://www.fda.gov/AboutFDA/CentersOf ﬁces/OC/Of ﬁceofScienti ﬁ candMedicalPrograms/ucm197861.htm [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"What We Do.Available from: http://www.fda.gov/ AboutFDA/WhatWeDo/ [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Case Summaries.Available from: https://ori.hhs.gov/ case_summary [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://ori.hhs.gov/thelab [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Program for Academic Societies.Available from: https://ori.hhs.gov/program-academic-societies [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Rapid Response for Technical Assistance.Available from: http://ori.hhs.gov/rapid-response-technical-assistance [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"RCR Resource Development Program.Available from: https://ori.hhs.gov/rcr-resource-development-program [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"RRI Program.Available from: http://ori.hhs.gov/rri-pro gram [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Federal Register: 42 CFR Parts 50 and 93 Public Health Ser- vice Policies on Research Misconduct; Final Rule.Available from:https://ori.hhs.gov/sites/default/ ﬁles/42_cfr_parts_50_and_93_2005.,OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"About HHS.Available from: http://www.hhs.gov/about/ index.html [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
HHS Agencies & Of ﬁces.Available from: http://www.hhs.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"United States Department of Health and Human Services Policies and Principles for Assuring Scienti ﬁc Integrity.Available from: http://www.hhs.gov/sites/default/ ﬁles/open/pres-actions/scientifc-integ rity-principles-12-19-11.pdf [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"A v a i l a b l e from: https://www.whitehouse.gov/sites/default/ ﬁles/microsites/ ostp/scienti ﬁc-integrity-memo-12172010.pdf [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Center for Clinical Resea rch Ethics: Education.Available from: http://icts.wustl.edu/icts-researchers/education [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://icts.wustl.edu/icts-researchers/funding/funding- opportunities [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Center for Clinical Research Ethics: Research Ethics Case Studies.Available from: http://ethicsresearchcore.org/education/case- studies/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Director ’s Message.Available from: http://icts.wustl.edu/ icts-researchers/about/directors-message [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Responsible Conduct of Re search (RCR) Course.Available from: http://ethicsresearchcore.org/education/rcr/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Grants.Available from: http://www.arnoldfoundation.org/ grants/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Research Integrity.Available from: http://www.arnoldfoun dation.org/initiative/research-integrity/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: http://www.nap.edu/openbook.php?record_id D1864&page DR1.178 A. KRETSER ET AL.,OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Avail- able from: http://www.nap.edu/catalog/12192/on-being-a-scientist-a- guide-to-responsible-conduct-in .,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: http://www.nap.edu/catalog/12615/ensur ing-the-integrity-accessibility-and-stewardship-of-research-data-in-the-digital-age .,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.nasonline.org/programs/sackler-colloquia/ about-the-sackler-colloquia.html [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Arthur M. Sackler Colloquia: Upcoming Colloquia.Avail- able from: http://www.nasonline.org/programs/sackler-colloquia/ upcoming-colloquia/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"National Academy of Sciences website.Available from: http://www.nasonline.org [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
NIH Policies and Procedures for Pro- moting Scienti ﬁc Integrity.Available from: https://ombudsman.nih.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Notice Number NOT-OD-11-120: Revised Policy: Managing Conﬂict of Interest in the Initial Peer Review of NIH Grant and Coopera- tive Agreement Applications.Available from: http://grants.nih.gov/grants/ guide/notice- ﬁles/NOT-OD-11-120.html [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Notice Number NOT-OD-15-103: Enhancing Reproducibil- ity Through Rigor and Transparency.Available from: http://grants.nih.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Notice Number NOT-OD-15-106: Applicant Responsibili- ties in Maintaining the Integrity of NIH Peer Review.Available from: https://grants.nih.gov/grants/guide/notice- ﬁles/NOT-OD-15-106.html [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Rigor and Reproducibility: Principles and Guidelines for Reporting Preclinical Research.Available from: http://www.nih.gov/ research-training/rigor-reproducib ility/principles-guidelines-report ing-preclinical-research [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Who We Are.Available from: http://www.nih.gov/about- nih/who-we-are [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Award Abstract 0924751: The Nature of Ethical Decision- Making in Research (R. Wayne Fuqua, Principal Investigator; David Hartmann, Co-Principal Investigator; and Thomas Van Valey,Co-Principal Investigator).Available from: http://www.nsf.gov/award search/showAward?AWD_ID D0924751&HistoricalAwards Dfalse [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Award Abstract 1449479: Collaborative Research: Founda- tions of Social and Ethical Responsibility Among Undergraduate Engi-neering Students: Comparing Across Time, Institutions, andInterventions (Brent Jesiek, Principal Investigator; Carla Zoltowski, Co-Principal Investigator).Available from: http://www.nsf.gov/award search/showAward?AWD_ID D1449479&HistoricalAwards Dfalse [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"About the National Science Foundation.Available from: http://www.nsf.gov/about/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Historical Background.Available from: http://ori.hhs.gov/his torical-background [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"RRI Conferences.Available from: https://ori.hhs.gov/rri_con ference [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: http://www.peer.org/assets/docs/About_SI_Report_ Card_and_Disclaimer.pdf [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Scienti ﬁc Integrity Report Card Comparison Charts.Avail- able from: http://www.peer.org/assets/docs/SI_Report_Card_ Comparison_Chart%20-%20Sorted%20by%20Score.pdf [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"New Prizes Will Recognize and Reward Transparency in Social Science Research (Press Release May 18, 2015).Available from:http://www.prweb.com/releases/2015/05/prweb12727015.htm[Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://pubmedcommonsblog.ncbi.nlm.nih.gov/2015/ 12/17/commenting-on-pubmed-a-successful-pilot/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"New $300,000 Grant Marks the Fifth Anniver- sary of Retraction Watch.Available from: http://retractionwatch.com/ 2015/08/03/new-300000-grant-marks-the- ﬁfth-anniversary-of-retrac tion-watch/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"A v a i l a b l e from: http://retractionwatch.com/the-center-for-scienti ﬁc-integrity/ [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Available from: https://ori.hhs.gov/ori-intro .,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Increasing Scienti ﬁc Openness and Integ- rity.Available from: https://www.templeton.org/what-we-fund/grants/ increasing-scienti ﬁc-openness-and-integrity [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"45 CFR 689: Research Misconduct.Available from: http://www.gpo.gov/fdsys/gran ule/CFR-2012-title45-vol3/CFR-2012-title45-vol3-part689/content-detail.html [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Who We Are.Available from: https://www.usaid.gov/who- we-are [Accessed August 3, 2016].",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Departmental Regulation DR Number 1074-001: Scienti ﬁc Integrity.Available from: http://www.ocio.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"USDA Agency Scienti ﬁc Integ- rity Of ﬁcers.Available from: http://www.usda.gov/wps/portal/usda/ usdahome?contentidonly Dtrue&contentid Docs-agency-scienti ﬁc-integ rity-of ﬁcers.xml [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
USDA Scienti ﬁc Integrity Policy Handbook (Guidance for Implementation of DR 1074-001).Available from: http://www.usda.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Annual USDA Scienti ﬁc Integrity Allegations Summary Report May 2014 –April 2015.Available from: http://www.usda.gov/documents/usda-updated-scienti ﬁc-integrity-summary-report.pdf [Accessed August 3, 2016].",OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
Memorandum for the Heads of Executive Departments and Agencies 3-9-09; Subject: Scien- tiﬁc Integrity (Press Release).Available from: https://www.whitehouse.,Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"Available from: https://en.wikipedia.org/wiki/United_States_De partment_of_Health_and_Human_Services [Accessed August 3, 2016].180 A. KRETSER ET AL.",Non-OADS,/arxiv_data1/oa_pdf/5b/0c/bfsn-57-163.PMC5152548.pdf
"4, 395 –406 http://dx.doi.org/10.1080/15438627.2016.1222275 © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/9e/gspm-24-395.PMC5152550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/be/9e/gspm-24-395.PMC5152550.pdf
"ORCID Thore-Björn Haag http://orcid.org/0000-0002-0657-8546 References Aoki, H., Kohno, T., Fujiya, H., Kato, H., Yatabe, K., Morikawa, T., & Seki, J.",Non-OADS,/arxiv_data1/oa_pdf/be/9e/gspm-24-395.PMC5152550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.DEVELOPMENTAL NEUROPSYCHOLOGY 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/92/2e/hdvn-41-245.PMC5152552.pdf
"4, 245 –260 http://dx.doi.org/10.1080/87565641.2016.1243109",Non-OADS,/arxiv_data1/oa_pdf/92/2e/hdvn-41-245.PMC5152552.pdf
"ORCID Deborah A. Bilder http://orcid.org/0000-0003-2202-5746 References Anderson, P. J., & Leuzzi, V. (2010).",Non-OADS,/arxiv_data1/oa_pdf/92/2e/hdvn-41-245.PMC5152552.pdf
"http://informahealthcare.com/amy ISSN: 1350-6129 (print), 1744-2818 (electronic) Amyloid, 2016; 23(3): 168–177 !",Non-OADS,/arxiv_data1/oa_pdf/4f/47/iamy-23-168.PMC5152553.pdf
"12, 1399 –1408 http://dx.doi.org/10.1080/13543776.2016.1231805 This work was authored as part of the Contributor ’s official duties as an Employee of the United States Government and is therefore a work of the United States Government.",Non-OADS,/arxiv_data1/oa_pdf/78/ce/ietp-26-1399.PMC5152556.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/78/ce/ietp-26-1399.PMC5152556.pdf
"Available from: http://www.fda.gov/EmergencyPreparedness/ Counterterrorism/MedicalCo untermeasures/AboutMCMi/ ucm443245.htm G-CSF (Neupogen, filgrastim) was the first agent to be approved by US FDA to increase survival in patients acutely exposed to doses of radiation eliciting hematopoietic ARS.",Non-OADS,/arxiv_data1/oa_pdf/78/ce/ietp-26-1399.PMC5152556.pdf
"12, 1512 –1519 http://dx.doi.org/10.1080/00365521.2016.1216588",Non-OADS,/arxiv_data1/oa_pdf/62/30/igas-51-1512.PMC5152561.pdf
"Densitometric analysis of the immunoblots was performed using ImageJ software (availablein the public domain at http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health (NIH), Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/00/c5/i1552-5783-57-15-6482.PMC5152563.pdf
"Semiautomated cone identiﬁcation was performed (Image-based Tool for Counting Nuclei, ITCN; available at http://rsb.info.nih.gov/ij/plugins/itcn.html; in the public domain).",OADS,/arxiv_data1/oa_pdf/74/a8/i1552-5783-57-15-6624.PMC5152564.pdf
"COPD:JOURNALOFCHRONICOBSTRUCTIVEPULMONARYDISEASE ,VOL.,NO.,– http://dx.doi.org/./.. ORIGINALRESEARCH EﬀectofAclidiniumBromideonExacerbationsinPatientswithModerate-to-Severe COPD:APooledAnalysisofFivePhaseIII,Randomized,Placebo-ControlledStudies JadwigaA.Wedzichaa,AlvarAgustib,GavinDonaldsona,FerranChuecosc,RosaLamarcac,andEstherGarciaGilc aAirwaysDiseaseSection,NationalHeartandLungInstitute,ImperialCollegeLondon,London,UK;bInstitutdelTòrax,HospitalClínic,IDIBAPS, UniversitatdeBarcelonaandCIBEREnfermedadesRespiratorias,Barcelona,Spain;cAstraZenecaR&DCentre,Barcelona,Spain ARTICLE HISTORY ReceivedDecember AcceptedMarch KEYWORDS GOLD;long-acting muscarinicantagonist; symptomsABSTRACT Weinvestigatedtheeffectofthelong-actingmuscarinicantagonistaclidiniumbromideonchronicobstruc- tive pulmonary disease (COPD) exacerbations by pooling data from five randomized, placebo-controlled,parallel-group Phase III studies of 3–6 months’duration.",Non-OADS,/arxiv_data1/oa_pdf/e9/4b/icop-13-669.PMC5152596.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttribution-NonCommercial-NoDerivativesLicense( http://creativecommons.org/licenses/by-nc-nd/./ ),which permitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited,andisnotaltered,tran sformed,orbuiltuponinanyway.",OADS,/arxiv_data1/oa_pdf/e9/4b/icop-13-669.PMC5152596.pdf
Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2015_Feb18.pdf .,OADS,/arxiv_data1/oa_pdf/e9/4b/icop-13-669.PMC5152596.pdf
Available from: http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/e9/4b/icop-13-669.PMC5152596.pdf
[updated 2014 Jan; cited 2014Nov12].Availablefrom: http://www.goldcopd.com/guidelines-global- strategy-for-diagnosis-management.html .,Non-OADS,/arxiv_data1/oa_pdf/e9/4b/icop-13-669.PMC5152596.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
Contents lists available at ScienceDirect Atherosclerosis journal homepage: www.elsevier.com/locate/atherosclerosis http://dx.doi.org/10.1016/j.atherosclerosis.2016.10.026 0021-9150/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).Atherosclerosis 255 (2016) 25 e30,Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"References [1] NCD Risk Factor Collaboration (NCD-RisC), Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19 $2 million participants, The Lancet 387 (10026) (2016) 1377 e1396, http://dx.doi.org/10.1016/S0140-6736(16)30054-X .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"Flegal, Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010, JAMA 307 (5) (2012) 483 e490, http://dx.doi.org/10.1001/jama.2012.40 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"Saúde Pública 31 (9) (2015) 2017 e2025, http://dx.doi.org/10.1590/0102- 311X00173814 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"365 (20) (2011) 1876 e1885, http://dx.doi.org/10.1056/NEJMoa1010112 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
[13] http://www.stata-journal.com/article.html?article ¼st0238 .,OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"43 (4) (2014) 1082 e1088, http://dx.doi.org/10.1093/ije/dyu077 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"365 (20) (2011) 1876 e1885, http://dx.doi.org/10.1056/NEJMoa1010112 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"37 (1) (2006) 87 e92,http://dx.doi.org/10.1161/ 01.STR.0000196964.24024.ea .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"257 (5) (2005) 430 e437, http://dx.doi.org/10.1111/j.1365- 2796.2005.01485.x .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"34 (8) (2014) 1778 e1783, http://dx.doi.org/10.1161/ATVBAHA.114.303753 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"[22] Y. Li, F.-F. Wei, L. Thijs, et al., Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations, Circulation 130 (6) (2014)466e474, http://dx.doi.org/10.1161/CIRCULATIONAHA.113.004876 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"Rep. 16 (11) (2014) 489, http://dx.doi.org/10.1007/s11906-014- 0489-x .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"118 (1) (2016)173e182, http://dx.doi.org/10.1161/CIRCRESAHA.115.306647 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"118 (1) (2016) 145 e156, http://dx.doi.org/10.1161/CIRCRESAHA.115.306656 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"43 (10) (2011) 940 e947, http://dx.doi.org/10.1038/ng.920 .",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"Geisel, S. Coassin, N. Heßler, et al., Update of the effect estimates for common variants associated with carotid intima media thickness within fourindependent samples: the Bonn IMT Family Study, the Heinz Nixdorf Recall Study, the SAPHIR Study and the Bruneck Study, Atherosclerosis 249 (2016) 83e87,http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.042 .A.M.B.",Non-OADS,/arxiv_data1/oa_pdf/70/c2/main.PMC5152614.pdf
"Methods Characteristics of study participants Study participants were enrolled in one of 12 trials [13 –26] (Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/FPC/B114 ) who fulfilled all of the fol- lowing inclusion criteria: have a Diagnostic and Statistical Manual of Mental Disorders , 4th ed.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
Additional inclusion and exclusion criteria can be found at http://clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"Cross-reference between the top association results with GTEx, BRAINEAC, and EnigmaVis findings To examine tissue expression p atterns and explore possible functional evidence for the associated variants, such as their being a known eQTL or having been found to be associated with neural imaging-derived phenotypes, the top associated genes and variants were queried in the GTEx portal ( http:// www.gtexportal.org /), Data Source: GTEx Analysis Release V6 (dbGaP Accession phs000424.v6.p1) [39], BRAINEAC (http://bra ineac.org/ ) [40], and EnigmaVis ( http://enigma.ini.usc.",OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"1, Supplemental digital content 2, http://links.lww.com/FPC/B115 and Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"http://links.lww.com/FPC/B116 for Manhattan and quantile –quantile plots for the total PANSS score, the positive Marder factor score, the negative Marder factor score, and CGI-S, respectively) and 20 +regions including aarF domain containing kinase 1 ( ADCK1 ) that showed a trend toward association ( P<1.0×10−6).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"The full list of variants with P<1×10−5in either the meta- analysis or any of the three cohorts is available in Supplementary Table 2 (Supplemental digital content 4, http://links.lww.com/FPC/B117 ).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"Haplotype association for markers from ADCK1 region was also available from Supplementary Text S1 (Supplemental digital content 5, http://links.lww.",OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"and DRD3 were not replicated ( P>0.05) in the meta- analysis of paliperidone response (Supplementary Table 3, Supplemental digital content 6, http://links.lww.com/FPC/ B119 ), except rs6314 of HTR2A, where it was nominally associated with changes in CGI-S ( P=0.01), Marder negative factor score ( P=0.08), and total PANSS score (P=0.1), with G allele being the better response allele.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"3, Supplemental digital content 7, http://links.lww.com/FPC/B120 and Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"4, Supplemental digital content 8, http://links.lww.com/ FPC/B121 for Manhattan and quantile –quantile plots for the total PANSS score, the positive Marder factor score, the negative Marder factor score, and CGI-S univariate analyses and multivariate analysis, respectively) and SNPs with unadjusted P-value less than 1 ×10−6are shown in Table 4.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"The full list of variants with association P- v a l u e sl e s st h a n1 ×10−5in any of univariate or multivariate MLM analyses is shown in Supplementary Table 4 (Supplemental digital content 9, http://links.lww.com/FPC/B122 ).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"The complete list of nomin- ally enriched pathways with Pcorrless than 0.1 is shown in Supplementary Table 5 (Supplemental digital content 10, http://links.lww.com/FPC/B123 ) and the genes driving the enriched pathways are listed in Supplementary Table 6 (Supplemental digital content 11, http://links.lww.com/FPC/ B124 ).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"5, Supplemental digital content 12, http://links.lww.com/FPC/B125 ), whereas rs56240334 was not captured in the Stein et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"Other candidate genes with subtle eQTL relationships with rs56240334 in the ADCK1 genomic region shown by BRAINEAC are listed in Supplementary Table 7 (Supplemental digital content 13, http://links.lww.com/FPC/ B126 ) and their tissue expression patterns are described inTable 4 Summary of MLM GWAS analyses –SNPs with an uncorrected P<1×10–6 AnalysisaSNPbCHR BPcA1A2 Function Gene MAF P_Wald A P_Wald B P_Wald C P_Wald D P_Wald E E rs9815738 3 88 204 733 T C Intronic C3orf38 0.128 0.003487063 0.1973521 0.5341269 0.1540512 7 .26E −07 E rs80052780 4 139 268 123 T G ncRNA_intronic LINC00499 0.013 0.02287048 0.2214565 0.05833061 0.873 9969 3.92E −07 A|E rs138538719 5 156 005 166 A C Intronic SGCD 0.042 6.63E −09 0.000696006 2.02E −08 0.000133965 5.27E −08 C rs62380867 5 156 046 246 G A Intronic SGCD 0.037 1.18E −07 0.000115132 1.47E −08 0.000187544 1.09E −07 B|E rs61854820 10 58 054 642 T C Intergenic MTRNR2L5 (dist =694 155), ZWINT (dist =62 557) 0.018 0.01019835 6.43E −08 2.06E −05 0.01262834 3.98E −07 D rs644939 12 101 453 989 A G Intronic ANO4 0.219 3.14E −05 0.01938486 6.74E −05 5.63E −07 3.04E −05 A rs8008002 14 75 865 683 T C Intergenic LOC731223 (dist =102 572), JDP2 (dist =28 826) 0.387 7 .64E −07 0.08044018 2.84E −05 0.003978385 6.15E −06 A|D rs59721556 14 78 112 393 A G Intergenic SPTLC2 (dist =29 283), ALKBH1 (dist =26 356) 0.186 1.33E −07 0.004598278 4.22E −06 2.61E −07 1.68E −06 A|E rs74065827 14 78 369 285 T G Intronic ADCK1 0.08 1.01E −07 0.0012415 5.28E −07 4.47E −08 6.50E −07 C rs34272020 14 78 374 172 T C Exonic ADCK1 0.085 2.12E −07 0.000654494 2.73E −07 5.30E −08 1.21E −06 D rs56374507 14 78 380 533 G T Intronic ADCK1 0.086 2.21E −07 0.001179908 3.16E −07 2.98E −08 6.63E −07 Top variants were clumped using parameters: P1=0.000001; P2=0.05; r2=0.2.",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"6 (Supplemental digital content 14, http://links.lww.com/FPC/B127 ).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"Othervariants with a suggestive assoc iation signal for paliperidone response are discussed in the Supplementary Text S2 (Supplemental digital content 15, http://links.lww.com/FPC/ B128 ).",Non-OADS,/arxiv_data1/oa_pdf/a8/72/fpc-27-7.PMC5152628.pdf
"S 1, Supplemental digital content 1, http://links.lww.com/FPC/B103 ).",Non-OADS,/arxiv_data1/oa_pdf/d3/e4/fpc-27-1.PMC5152629.pdf
"S2, Supple- mental digital content 2, http://links.lww.com/FPC/B104 ).",Non-OADS,/arxiv_data1/oa_pdf/d3/e4/fpc-27-1.PMC5152629.pdf
Available at: http://www.mims.com.,Non-OADS,/arxiv_data1/oa_pdf/d3/e4/fpc-27-1.PMC5152629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons AttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits non-commercial re-use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/a5/kww110.PMC5152664.pdf
"Geneva, Switzerland: World Health Organization; 2014. http://www.who.int/ nutrition/topics/globaltargets_lowbirthweight_policybrief.pdf .",Non-OADS,/arxiv_data1/oa_pdf/20/a5/kww110.PMC5152664.pdf
"This is an Open Access article distributed under the terms of the Creative Commons AttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits non-commercial re-use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/8c/kww111.PMC5152667.pdf
Atlanta GA: Centers for Disease Control and Prevention; 2015. http://www.cdc.gov/ ﬂu/about/qa/disease.htm .,Non-OADS,/arxiv_data1/oa_pdf/4f/8c/kww111.PMC5152667.pdf
"This is an Open Access article distributed under the terms of the Cre- ative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the  work, in any medium, provided the original work is not altered or transformed in any way, and  that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/39/ofw198.PMC5152670.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs179/en/.,Non-OADS,/arxiv_data1/oa_pdf/82/39/ofw198.PMC5152670.pdf
Available at: https://www.av.se/arbetsmiljoarbete-och-inspektioner/ publikationer/foreskrifter/mikrobiologiska-arbetsmiljorisker-smitta-toxinpaver - kan-overkanslighet-afs-20051-foreskrifter/?hl=afs 2005:1 (Swedish).,Non-OADS,/arxiv_data1/oa_pdf/82/39/ofw198.PMC5152670.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/56/ofw197.PMC5152704.pdf
Available at: https://spleen.org.au/VSR/faq.html .,Non-OADS,/arxiv_data1/oa_pdf/f3/56/ofw197.PMC5152704.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/aa/ofw199.PMC5152708.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/96/ofw201.PMC5152709.pdf
Available at: https://www.whitehouse.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.,Non-OADS,/arxiv_data1/oa_pdf/21/96/ofw201.PMC5152709.pdf
Available at: http://www.choosingwisely.org/about-us/.,Non-OADS,/arxiv_data1/oa_pdf/21/96/ofw201.PMC5152709.pdf
Available at: http://www.choosingwisely.org/cli-nician-lists/#parentSociety=Infectious_Diseases_Society_of_America.,Non-OADS,/arxiv_data1/oa_pdf/21/96/ofw201.PMC5152709.pdf
"Available at: http://www.primarycarereports.co.uk/ mrc_to_fund_retrieval_transport_and_diagnosis_of_donated_brains.html, accessed 2 July 2014.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/HEX-19-805.PMC5152721.pdf
"Available at: http://www.bbc.co.uk/news/health-27241433, accessed 2 July 2014. ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/HEX-19-805.PMC5152721.pdf
"Vienna: Life Science Governance, 2011, http://www.univie.ac.at/LSG/ papers2011/LSG%20Working%20Paper.pdf31 Tutton R. Gift relationships in genetic research.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/HEX-19-805.PMC5152721.pdf
"560  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2016;49:560-563 https://doi.org/10.5946/ce.2016.048 Print ISSN 2234-2400 • On-line ISSN 2234-2443 An Intractable Caustic Esophageal Stricture Successfully Managed  with Sequential Treatment Comprising Incision with an Insulated- Tip Knife, Balloon Dilation, and an Oral Steroid Woong Ki Lee, Byung Sun Kim, Min A Yang, So Hee Yun, Young Jae Lee, Ji Woong Kim and Jin Woong Cho Division of Gastroenterology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea  Bougie or balloon dilation is a good short-term treatment for caustic esophageal strictures, although recurrence after dilation occurs in  approximately 30% of these cases.",Non-OADS,/arxiv_data1/oa_pdf/59/07/ce-2016-048.PMC5152773.pdf
"The electrical current was generated using an Received:  March 14, 2016     Revised:  July 19, 2016   Accepted:  July 22, 2016 Correspondence:  Jin Woong Cho Division of Gastroenterology, Department of Internal Medicine, Presbyterian  Medical Center, 365 Seowon-ro, Wansan-gu, Jeonju 54987, Korea Tel: +82-63-230-1310, Fax: +82-63-230-1309, E-mail:  jeja-1004@daum.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/07/ce-2016-048.PMC5152773.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   579LETTER TO THE EDITOR Clin Endosc  2016;49:579 https://doi.org/10.5946/ce.2016.098 Print ISSN 2234-2400 / On-line ISSN 2234-2443 Fecal Microbiota Transplantation and the Brain Microbiota in  Neurological DiseasesOpen Access To the Editor: The review by Choi and Cho, published in the May 2016  issue of Clinical Endoscopy , describes the therapeutic role of  fecal microbiota transplantation (FMT) in non-gastrointesti - nal (GI) disorders that include neurological and psychiatric  conditions such as autism, chronic fatigue syndrome, mood  disorders, multiple sclerosis, and Parkinson’s disease.1 The Au - thors report clinical evidence that describes how restoration  of the gut microbiota, and correction of gut dysbiosis through  FMT, is associated with improvement of symptoms in neu - ropsychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/ee/e1/ce-2016-098.PMC5152774.pdf
"Received:  July 12, 2016     Accepted:  August 13, 2016 Correspondence: Marco Ruggiero Silver Spring Sagl, via Raimondo Rossi 24, Arzo-Mendrisio 6864, Switzerland Tel: +41-91-646-7683, Fax: +41-91-646-7683, E-mail:  marco.drruggiero@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/e1/ce-2016-098.PMC5152774.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   533REVIEW Clin Endosc  2016;49:533-538 https://doi.org/10.5946/ce.2016.032 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endocuff-Assisted Colonoscopy—A Novel Accessory in Improving  Adenoma Detection Rate: A Review of the Literature Rashmee Patil1, Mel A. Ona2, Emmanuel Ofori2 and Madhavi Reddy2 1Department of Internal Medicine, Mount Sinai West, New York, NY, 2Department of Gastroenterology and Hepatology, The Brooklyn Hospital  Center, The Icahn School of Medicine at Mount Sinai, Brooklyn, NY, USA Endocuff (Arc Medical Design) is a U.S. Food and Drug Administration-approved device that is attached like a cap to the distal tip of the  colonoscope; it is used to improve adenoma detection rates during colonoscopy.",Non-OADS,/arxiv_data1/oa_pdf/5f/e4/ce-2016-032.PMC5152775.pdf
"MATERIALS AND METHODS  Extensive English language literature search was conducted  using PubMed, Medline, and Google to identify peer-re -Received:  January 27, 2016     Revised:  March 29, 2016   Accepted:  April 11, 2016 Correspondence:  Rashmee Patil Department of Internal Medicine, Mount Sinai West, 1000 10th Ave, New Y ork,  NY 10019, USA Tel: +1-409-656-6475, Fax: +1-409-656-6475, E-mail:  rashmee84@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/e4/ce-2016-032.PMC5152775.pdf
"502  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Pancreatobiliary endoscopy in altered gastointestinal anatomy Clin Endosc  2016;49:502-505 https://doi.org/10.5946/ce.2016.146 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Challenges of Endoscopic Management of Pancreaticobiliary  Complications in Surgically Altered Gastrointestinal Anatomy Tin Moe Wai1 and Eun Young Kim2 1Department of Gastroenterology, Yangon General Hospital, University of Medicine (1), Yangon, Myanmar, 2Division of Gastroenterology,  Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea Pancreaticobiliary complications following various surgical procedures, including liver transplantation, are not uncommon and are  important causes of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/1e/88/ce-2016-146.PMC5152776.pdf
"Pancreatic leaks can be Received:  September 2, 2016     Accepted:  September 4, 2016 Correspondence:  Eun Y oung Kim Division of Gastroenterology, Department of Internal Medicine, Catholic Uni - versity of Daegu School of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu,  Daegu 42472, Korea Tel: +82-53-650-4092, Fax: +82-53-624-3281, E-mail:  kimey@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/88/ce-2016-146.PMC5152776.pdf
"500  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy COMMENTARY Clin Endosc  2016;49:500-501 https://doi.org/10.5946/ce.2016.142 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access Colonoscopy is the most effective and popular method for  the screening, prevention, and diagnosis of colorectal cancer  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/67/0e/ce-2016-142.PMC5152777.pdf
"Yang et al.5 reported  that longer cecal intubation time was associated with lower Received:  October 21, 2016     Revised:  November 7, 2016   Accepted:  November 10, 2016 Correspondence:  Beom Jae Lee Division of Gastroenterology, Department of Internal Medicine, Korea Universi - ty Medical Center, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea Tel: +82-2-2626-3004, Fax: +82-2-853-1943, E-mail:  L85210@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.What Is the Mean Procedure Time to Optimize Colonoscopy?",Non-OADS,/arxiv_data1/oa_pdf/67/0e/ce-2016-142.PMC5152777.pdf
"564  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2016;49:564-569 https://doi.org/10.5946/ce.2016.020 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Multidrug-Resistant Tuberculous Mediastinal Lymphadenitis,  with an Esophagomediastinal Fistula, Mimicking an Esophageal  Submucosal Tumor Dongwuk Kim, Juwon Kim, Daegeun Lee, Ha Sung Chang, Hyunsung Joh, Won-Jung Koh and Jun Haeng Lee Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Mediastinal tuberculous lymphadenitis rarely mimics esophageal submucosal tumor, particularly in the case of multidrug-resistant  tuberculosis (MDR-TB).",Non-OADS,/arxiv_data1/oa_pdf/13/b3/ce-2016-020.PMC5152778.pdf
"The findings on an initial chest radiograph were normal; the Received:  January 5, 2016     Revised:  March 29, 2016   Accepted:  March 29, 2016 Correspondence: Jun Haeng Lee Department of Medicine, Samsung Medical Center, Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-3409, Fax: +82-2-3410-6983, E-mail: stomachlee@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/b3/ce-2016-020.PMC5152778.pdf
Available  from: http://www.who.int/tb/publications/global_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/13/b3/ce-2016-020.PMC5152778.pdf
"542  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2016;49:542-547 https://doi.org/10.5946/ce.2015.113 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Feedback Survey of the Effect, Burden, and Cost of the National  Endoscopic Quality Assessment Program during the Past 5 Y ears in  Korea Yu Kyung Cho1, Jeong Seop Moon2, Dong Su Han3, Yong Chan Lee4, Yeol Kim5, Bo Young Park5, Il-Kwun Chung6, Jin-Oh Kim7,   Jong Pil Im8, Jae Myung Cha9, Hyun Gun Kim7, Sang Kil Lee4, Hang Lak Lee3, Jae Young Jang9, Eun Sun Kim10, Yunho Jung6,  Chang Mo Moon11 and Ethics and Quality Control Committee of Korean Society of Gastrointestinal Endoscopy 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, 2Department of Internal Medicine, Inje  University Seoul Paik Hospital, Inje University College of Medicine, Seoul, 3Department of Internal Medicine, Hanyang University Guri Hospital,  Hanyang University College of Medicine, Guri, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 5Cancer Early  Detection Branch, National Cancer Control Institute, National Cancer Center, Goyang, 6Department of Internal Medicine, Soonchunhyang  University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, 7Department of Internal Medicine, Soonchunhyang  University College of Medicine, Seoul, 8Department of Internal Medicine, Seoul National University College of Medicine and  Liver Research  Institute, Seoul, 9Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, 10Department of Internal Medicine, Korea  University College of Medicine, Seoul, 11Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea Background/Aims:  In Korea, the nationwide gastric cancer screening program recommends biennial screening for individuals aged  40 years or older by way of either an upper gastrointestinal series or endoscopy.",Non-OADS,/arxiv_data1/oa_pdf/ea/dc/ce-2015-113.PMC5152779.pdf
"Clin Endosc  2016;49:542-547 Key Words:  Endoscopy; Quality; Mass screening; Stomach neoplasms Open Access INTRODUCTION In Korea, a nationwide gastric cancer screening program  was started in 1999 as part of the National Cancer Screening  Program (NCSP).1 The NCSP recommends biennial gastric  cancer screening for men and women aged 40 years or older  by way of either an upper gastrointestinal series or endosco - py.2 The gastric cancer screening program has reduced the Received:  September 8, 2015     Revised:  October 6, 2015   Accepted:  October 6, 2015 Correspondence:  Jeong Seop Moon Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje Uni - versity College of Medicine, 9 Mareunnae-ro, Jung-gu, Seoul 04551, Korea  Tel: +82-2-2270-0012, Fax: +82-2-2279-4021, E-mail:  moonjs2@unitel.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/dc/ce-2015-113.PMC5152779.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   515FOCUSED REVIEW SERIES: Pancreatobiliary endoscopy in altered gastointestinal anatomy Clin Endosc  2016;49:515-529 https://doi.org/10.5946/ce.2016.144 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endoscopic Ultrasound-Guided Pancreatobiliary Endoscopy in  Surgically Altered Anatomy  Pichamol Jirapinyo and Linda S. Lee Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA Endoscopic retrograde cholangiopancreatography (ERCP) has become the mainstay of therapy for pancreatobiliary diseases.",Non-OADS,/arxiv_data1/oa_pdf/fc/b0/ce-2016-144.PMC5152780.pdf
"This article reviews common types of Received:  October 10, 2016     Accepted:  November 5, 2016 Correspondence:  Linda S. Lee Division of Gastroenterology, Brigham and Women’s Hospital, 75 Francis Street,  Boston, MA 02115, USA Tel: +1-617-278-0359, Fax: +1-617-525-8740, E-mail:  lslee@partners.org cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/b0/ce-2016-144.PMC5152780.pdf
http://dx.doi.org/10.1016/ j.gie.2016.05.035.,OADS,/arxiv_data1/oa_pdf/fc/b0/ce-2016-144.PMC5152780.pdf
http://dx.doi.org/10.1016/ j.gie.2016.07.031.,OADS,/arxiv_data1/oa_pdf/fc/b0/ce-2016-144.PMC5152780.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   555ORIGINAL ARTICLE Clin Endosc  2016;49:555-559 https://doi.org/10.5946/ce.2015.110 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Predicting Colonoscopy Time: A Quality Improvement Initiative Deepanshu Jain1, Abhinav Goyal1 and Stacey Zavala2 1Department of Internal Medicine, 2Division of Gastroenterology, Department of Internal Medicine, Albert Einstein Medical Center,  Philadelphia, PA, USA Background/Aims:  There is lack of consensus on the optimal time allotted for colonoscopy, which increases patient wait times.",Non-OADS,/arxiv_data1/oa_pdf/fc/fa/ce-2015-110.PMC5152781.pdf
"By extrapolating  our knowledge from factors affecting cecum intubation, we  postulate that endoscopist’s experience, bowel preparation  quality, indication for colonoscopy, and types of interventions Received:  August 27, 2015     Revised:  November 8, 2015   Accepted:  January 3, 2016 Correspondence:  Deepanshu Jain Department of Internal Medicine, Albert Einstein Medical Center, 5501 Old Y ork  Road, Suite 363 (Klein Building), Philadelphia, PA 19141, USA Tel: +1-215-715-5844, Fax: +1-215-455-1933, E-mail:  deepanshu.jain.25@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/fa/ce-2015-110.PMC5152781.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx .,Non-OADS,/arxiv_data1/oa_pdf/fc/fa/ce-2015-110.PMC5152781.pdf
Available from: http://www.cancer.org/cancer/colonan - drectumcancer/detailedguide/colorectal-cancer-key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/fc/fa/ce-2015-110.PMC5152781.pdf
http://dx.doi.org/10.5946/ce.2015.079.,Non-OADS,/arxiv_data1/oa_pdf/fc/fa/ce-2015-110.PMC5152781.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   575CASE REPORT Clin Endosc  2016;49:575-578 https://doi.org/10.5946/ce.2016.043 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Acute Pancreatitis Following Endoscopic Ampullary Biopsies  without Attempted Cannulation of the Ampulla of Vater  Spyridon Michopoulos1, Dimitra Kozompoli1, Sparti Ntai2, Georgios Kalantzis1, Evanthia Zampeli1 and Kalliopi Petraki3 Departments of 1Gastroenterology and 2Radiology, Alexandra Hospital, Athens University Medical School, Athens, 3Department of Pathology,  Metropolitan Hospital, Neo Faliro, Greece A 51-year-old man underwent diagnostic work-up for an abnormal-appearing ampulla of Vater.",Non-OADS,/arxiv_data1/oa_pdf/49/20/ce-2016-043.PMC5152782.pdf
"Eight biopsies were obtained from the area Received:  February 26, 2016     Revised:  May 7, 2016   Accepted:  June 7, 2016 Correspondence:  Spyridon Michopoulos Department of Gastroenterology, Alexandra Hospital, Athens University Medical  School, 6 Agias Kyriakis St Kifissia, Athens, Greece Tel: +30-2103381387, Fax: +30-2132162895, E-mail: michosp5@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/20/ce-2016-043.PMC5152782.pdf
"530  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Pancreatobiliary endoscopy in altered gastointestinal anatomy Clin Endosc  2016;49:530-532 https://doi.org/10.5946/ce.2016.125 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Percutaneous Transhepatic Cholangioscopy in Bilioenteric  Anastomosis Stricture Hyoung-Chul Oh Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea Bilioenteric anastomosis strictures are a serious complication of biliary surgery, and often result in recurrent cholangitis, choledocholithiasis,  biliary cirrhosis, and hepatic failure.",Non-OADS,/arxiv_data1/oa_pdf/31/75/ce-2016-125.PMC5152783.pdf
"The incidence of complications for therapeu - tic cholangioscopies has been reported to be 6.7%, of which  cholangitis and bile duct injuries are the commonest compli - cations.9Received:  August 24, 2016     Revised:  August 31, 2016   Accepted:  September 1, 2016 Correspondence:  Hyoung-Chul Oh Division of Gastroenterology, Department of Internal Medicine, Chung-Ang  University Hospital, Chung-Ang University College of Medicine, 102 Heuk - seok-ro, Dongjak-gu, Seoul 06973, Korea Tel: +82-2-6356-3637, Fax: +82-2-6299-1383, E-mail:  ohcgi@cau.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/75/ce-2016-125.PMC5152783.pdf
"548  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy ORIGINAL ARTICLE Clin Endosc  2016;49:548-554 https://doi.org/10.5946/ce.2015.115 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endosonographic Features of Gastric Schwannoma: A Single Center  Experience Jong Min Yoon1, Gwang Ha Kim1, Do Youn Park2, Na Ri Shin2, Sangjeong Ahn2, Chul Hong Park1, Jin Sung Lee1, Key Jo Lee1,   Bong Eun Lee1 and Geun Am Song1 Departments of 1Internal Medicine and 2Pathology, Pusan National University School of Medicine, Busan, Korea  Background/Aims:  Gastric schwannomas are rare benign mesenchymal tumors that are difficult to differentiate from other  mesenchymal tumors with malignant potential, such as gastrointestinal stromal tumors.",Non-OADS,/arxiv_data1/oa_pdf/ad/63/ce-2015-115.PMC5152784.pdf
"Endoscopic ultrasonography (EUS) is a valuable imaging  modality for diagnosing and evaluating gastric mesenchymal  tumors, because they appear as hypoechoic masses contiguous  with the proper muscle layer of the normal gut wall on EUS.6 Received:  September 10, 2015     Revised:  December 1, 2015   Accepted:  December 5, 2015 Correspondence:  Gwang Ha Kim Department of Internal Medicine, Pusan National University Hospital, Pusan  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 49241,  Korea Tel: +81-51-240-7869, Fax: +81-51-244-8180, E-mail:  doc0224@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/63/ce-2015-115.PMC5152784.pdf
"Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   539REVIEW Clin Endosc  2016;49:539-541 https://doi.org/10.5946/ce.2016.004 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Diagnosis of Obscure Gastrointestinal Bleeding Satoshi Tanabe Division of Therapeutic Endoscopy, Department of Advanced Medicine, Research and Development Center for New Medical Frontiers,  Kitasato University School of Medicine, Sagamihara, Japan Obscure gastrointestinal bleeding (OGIB) is defined as gastrointestinal bleeding from a source that cannot be identified on upper or  lower gastrointestinal endoscopy.",Non-OADS,/arxiv_data1/oa_pdf/2b/4f/ce-2016-004.PMC5152785.pdf
"In case abnormalities are detected on abdominal CT, Received:  December 3, 2015     Revised:  January 20, 2016   Accepted:  January 20, 2016 Correspondence:  Satoshi Tanabe Division of Therapeutic Endoscopy, Department of Advanced Medicine, Re - search and Development Center for New Medical Frontiers, Kitasato University  School of Medicine, 1-15-1 Kitasato, Minami, Sagamihara 252-0374, Japan Tel: +81-42-778-8111, Fax: +81-42-778-8390, E-mail:  s-tanabe@kitasato-u.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/4f/ce-2016-004.PMC5152785.pdf
"570  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy CASE REPORT Clin Endosc  2016;49:570-574 https://doi.org/10.5946/ce.2016.022 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Giant Brunner’s Gland Hamartoma of the Duodenal Bulb Presenting  with Upper Gastrointestinal Bleeding and Obstruction Ju Hyoung Lee, Kyeong Min Jo, Tae Oh Kim, Jong Ha Park, Seung Hyun Park, Jae Won Jung, So Chong Hur and Sung Yeun Yang Division of Gastroenterology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine,  Busan, Korea Brunner’s gland hamartomas are small benign lesions that are most commonly found in the bulb of the duodenum.",Non-OADS,/arxiv_data1/oa_pdf/1e/58/ce-2016-022.PMC5152786.pdf
"His height and weight  were 180.9 cm and 145.8 kg, and he had a body mass index of Received:  December 21, 2015     Revised:  August 11, 2016   Accepted:  August 25, 2016 Correspondence:  Sung Yeun Yang Division of Gastroenterology, Department of Internal Medicine, Inje University  Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeun-daero,  Haeundae-gu, Busan 48108, Korea  Tel: +82-51-797-0200, Fax: +82-51-797-0298, E-mail: ysydrim@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/58/ce-2016-022.PMC5152786.pdf
Copyright © 2016 Korean Society of Gastrointestinal Endoscopy   495COMMENTARY Clin Endosc  2016;49:495-497 https://doi.org/10.5946/ce.2016.137 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access What do quality assessments have to do with practicing  gastroenterologist?,Non-OADS,/arxiv_data1/oa_pdf/0b/22/ce-2016-137.PMC5152787.pdf
"Approximately 80% of responders answered that all  aspects of endoscopic quality had improved, including the  qualifications of endoscopists, endoscopic unit facilities and  equipment, endoscopic procedures and outcomes, and repro -Received:  September 12, 2016     Revised:  October 28, 2016   Accepted:  October 31, 2016 Correspondence:  Y oon Tae Jeen Division of Gastroenterology and Hepatology, Department of Internal Medicine,  Institute of Digestive Disease and Nutrition, Korea University Anam Hospital, 73  Inchon-ro, Seongbuk-gu, Seoul 02841, Korea  Tel: +82-2-920-6555, Fax: +82-2-953-1943, E-mail:  ytjeen@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.The Importance of an Endoscopic Quality Assessment Program  Reflecting Real Practice In Kyung Yoo and Yoon Tae Jeen Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Digestive Disease and Nutrition, Korea University  College of Medicine, Seoul, Korea See ""Feedback Survey of the Effect, Burden, and Cost of the National Endoscopic Quality Assessment Program during the Past 5 Y ears  in Korea"" by Yu Kyung Cho, Jeong Seop Moon, Dong Su Han, et al., on page 542-547.",Non-OADS,/arxiv_data1/oa_pdf/0b/22/ce-2016-137.PMC5152787.pdf
"506  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Pancreatobiliary endoscopy in altered gastointestinal anatomy Clin Endosc  2016;49:506-509 https://doi.org/10.5946/ce.2016.124 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endoscopic Retrograde Cholangiopancreatography in Post  Gastrectomy Patients Chang-Hwan Park Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea Endoscopic retrograde cholangiopancreatography (ERCP) in post-gastrectomy patients with Billroth II (BII) reconstruction and Roux- en-Y (RY) reconstruction presents a challenge to therapeutic endoscopists.",Non-OADS,/arxiv_data1/oa_pdf/50/14/ce-2016-124.PMC5152788.pdf
"Presently, ERCP for post-gas - trectomy patients is carried out with various devices including  a single-balloon enteroscope, double-balloon enteroscope,  spiral enteroscope, and cap-fitted endoscope.4-7 TYPES OF GASTRECTOMY Billroth I gastrectomy The Billroth I gastrectomy involves a distal gastrectomy  with an anastomosis of the gastric remainder to the duode - num.8 The duodenum is straightened, and the major and mi - nor papillae become closer to the stomach  due to loss of the  superior duodenal angle.9 Performing ERCP for patients with  the Billroth I gastrectomy is nearly as similar as for patients  with unaltered gastrointestinal anatomy.9 Billroth II gastrectomy The BII gastrectomy is one of the most common procedures  for surgical treatment of duodenal ulcers and gastric cancer.10  The distal stomach is resected and the proximal stomach is  anastomosed to the proximal jejunum in an end-to-side ar - rangement.9 To divert the bile away from the remainder of the  stomach, a side-to-side jejunojejunostomy between the affer -Received:  August 22, 2016     Revised:  October 3, 2016   Accepted:  October 13, 2016 Correspondence:  Chang-Hwan Park Department of Internal Medicine, Chonnam National University Medical  School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea Tel: +82-62-220-6296, Fax: +82-62-228-1330, E-mail:  p1052ccy@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/14/ce-2016-124.PMC5152788.pdf
"498  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy COMMENTARY Clin Endosc  2016;49:498-499 https://doi.org/10.5946/ce.2016.134 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access Gastrointestinal subepithelial lesions (SELs) are masses or  bulges covered by normal appearing mucosa and are usually  found incidentally during endoscopy.1 There are various types  of gastric SELs, ranging from benign lesions to lesions with  malignant potential.",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/ce-2016-134.PMC5152789.pdf
"Histopathologically, all tumors were S100 positive  and 96.3% showed cuff-like lymphoid infiltration at the pe -Received:  September 7, 2016     Accepted:  November 8, 2016 Correspondence: Kee Don Choi Department of Gastroenterology, Asan Digestive Disease Research Institute,  Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro  43beon-gil, Songpa-gu, Seoul 05505, Korea Te l: +82-2-3010-5813, Fax: +82-2-476-0824, E-mail: keedon@amc.seoul.kr  cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Is Endoscopic Ultrasonography Adequate for the Diagnosis of Gastric  Schwannomas?",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/ce-2016-134.PMC5152789.pdf
"510  Copyright © 2016 Korean Society of Gastrointestinal Endoscopy FOCUSED REVIEW SERIES: Pancreatobiliary endoscopy in altered gastointestinal anatomy Clin Endosc  2016;49:510-514 https://doi.org/10.5946/ce.2016.138 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Endoscopic Retrograde Cholangiopancreatography in Bilioenteric  Anastomosis Eun Taek Park Division of Hepatobiliary and Pancreas, Department of Internal Medicine, Gospel Hospital, Kosin University College of Medicine, Busan, Korea For diagnosis and treatment of pancreatobiliary diseases, endoscopic retrograde cholangiopancreatography (ERCP) is useful  method nowadays and its technically success rate is usually in about 90%-95% of patients with normal gastric and pancreaticobiliary  anatomy.",Non-OADS,/arxiv_data1/oa_pdf/8b/ff/ce-2016-138.PMC5152790.pdf
"The incidence of this complication showed  no significant difference between patients with benign or Received:  September 20, 2016     Accepted:  October 24, 2016 Correspondence:  Eun Taek Park Division of Hepatobiliary and Pancreas, Department of Internal Medicine, Gos - pel Hospital, Kosin University College of Medicine, 262 Gumcheon-ro, Seo-gu,  Busan 49267, Korea Tel: +82-51-990-6214, Fax: +82-51-990-5055, E-mail:  euntpark@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/ff/ce-2016-138.PMC5152790.pdf
Available at: http://data.worldbank.org/income-level/HIC (cited 24 February 2015).,OADS,/arxiv_data1/oa_pdf/08/ac/10.1177_0049475516630210.PMC5152792.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/af/5c/10.1177_0003319716630499.PMC5152794.pdf
Retrieved from http://onlinelibrary.wiley.co m/doi/10.1002 /0471219282.,Non-OADS,/arxiv_data1/oa_pdf/b0/f4/10.1177_1059712316664120.PMC5152796.pdf
@ERSpublications Accuracy of VoluSense Pediatrics http://ow.ly/BIFS304sheG Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/6f/35/00062-2016.PMC5152798.pdf
@ERSpublications Pneumococcal urinary antigen test in pneumonia http://ow.ly/sm8R303lOe0 Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/58/b2/00011-2016.PMC5152836.pdf
@ERSpublications The levels of LTB4 are increased in the sputum of subgroups of asthma patientshttp://ow.ly/Xu6I303jVb5 Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/53/d9/00088-2015.PMC5152838.pdf
"@ERSpublications GOLD criteria overestimate COPD, with >30% of cases having normal spirometry using GLI2012 reference values http://ow.ly/IyGr302sZTs Copyright ©ERS 2016.",Non-OADS,/arxiv_data1/oa_pdf/9c/b5/00084-2015.PMC5152847.pdf
@ERSpublications Undiagnosed lower extremity and carotid artery disease is common in COPD and aggravates over COPD GOLD stages http://ow.ly/w96f303lHTu Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/be/9a/00037-2016.PMC5152848.pdf
http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd- 2016/ Date last updated: December 2015.,Non-OADS,/arxiv_data1/oa_pdf/be/9a/00037-2016.PMC5152848.pdf
@ERSpublications NIV is a useful tool during weaning in chronic critically ill patients independent of their premorbid condition http://ow.ly/j4Av304sEoJ The content of this work is ©the authors or their employers.,Non-OADS,/arxiv_data1/oa_pdf/8d/a6/00061-2016.PMC5152849.pdf
"@ERSpublications Rise in sputum complement (C3a, C5a) levels during COPD exacerbation is associated with recovery time http://ow.ly/ZaPj303xxPf Copyright ©ERS 2016.",Non-OADS,/arxiv_data1/oa_pdf/8a/20/00027-2016.PMC5152850.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/08/main.PMC5152926.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.05.009 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/08/main.PMC5152926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 158 e166,Non-OADS,/arxiv_data1/oa_pdf/81/08/main.PMC5152926.pdf
": CD005136, http://dx.doi.org/10.1002/14651858.CD005136.pub3 .",Non-OADS,/arxiv_data1/oa_pdf/81/08/main.PMC5152926.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/2e/54/10.1177_2058460116681209.PMC5152933.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/b9/86/10.1177_2058460116681042.PMC5152934.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/6e/06/10.1177_2058460116674749.PMC5152935.pdf
"These char-acteristics, together with the availability of both DIAdigital maps and reference spectral libraries in growingpublic repositories (PeptideAtlas, http://www.peptidea-tlas.org), positions DIA-MS as a promising tool towardshighly reproducible and standardized protein proﬁling.",OADS,/arxiv_data1/oa_pdf/e1/bd/10.1177_1744806916679658.PMC5153021.pdf
"28This spectral library provides the ﬁrst available resource of its kind for future DIA-MSexperiments in any tissue such as regions of the painaxis (the spectral library is deposited in PeptideAtlas;http://www.peptideatlas.org, No.",OADS,/arxiv_data1/oa_pdf/e1/bd/10.1177_1744806916679658.PMC5153021.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1e/34/10.1177_2331216516681168.PMC5153026.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a4/c2/10.1177_2048004016682177.PMC5153147.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/aa/copd-11-3145.PMC5153253.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3145–3152International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3145OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12331 5 Drop in lung function during asthma and COPD  exacerbations – can it be assessed without  spirometry?",Non-OADS,/arxiv_data1/oa_pdf/1c/aa/copd-11-3145.PMC5153253.pdf
"In asthma attacks, there is firm evidence for a favorable effect  of systemic corticosteroids,6 for COPD exacerbations the evidence refers mainly to  clinical trials in hospitalized patients.4 In COPD guidelines, the criteria for starting Correspondence: hasse Melbye general Practice research Unit,  Department of Community Medicine,  Mh Building, UIT The arctic University  of norway, 9037 Tromsø, norway Tel +47 77 9521 3200 email hasse.melbye@uit.n o Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Melbye et al Running head recto: Drop in lung function during asthma and COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S123315",Non-OADS,/arxiv_data1/oa_pdf/1c/aa/copd-11-3145.PMC5153253.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1c/aa/copd-11-3145.PMC5153253.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/aa/copd-11-3145.PMC5153253.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/copd-11-3093.PMC5153254.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3093–3099International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3093OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11789 0 Clinical and radiological outcome following  pneumothorax after endoscopic lung volume  reduction with valves D gompelmann1,2 n Benjamin1 K Kontogianni1 FJF herth1,2 CP heussel2–4 h hoffmann2,5 r eberhardt1,2 1Pneumology and Critical Care  Medicine, Thoraxklinik at University  of heidelberg, 2german Center  for  lung research, 3Diagnostic and  Interventional radiology, Thoraxklinik  at University of heidelberg,   4Diagnostic and Interventional  radiology, University hospital  heidelberg, 5Thoracic surgery,   Thoraxklinik at University of  heidelberg, heidelberg, germanyIntroduction:  Valve implantation has evolved as a therapy for patients with advanced  emphysema.",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/copd-11-3093.PMC5153254.pdf
uni-heid elberg.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gompelmann et al Running head recto: Outcome following pneumothorax after valve therapy DOI: http://dx.doi.org/10.2147/COPD.S117890,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/copd-11-3093.PMC5153254.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/copd-11-3093.PMC5153254.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/copd-11-3093.PMC5153254.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 231–239Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 231 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S98696 Clinical effects of prior trastuzumab on  combination eribulin mesylate plus trastuzumab as  first-line treatment for human epidermal growth  factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II,  single-arm, multicenter study Shannon Puhalla1 Sharon Wilks2 Adam M Brufsky1 Joyce O’Shaughnessy3 Lee S Schwartzberg4 Erhan Berrak5 James Song5 Linda Vahdat6 1Department of Hematology and  Oncology, University of Pittsburgh  Medical Center, Pittsburgh, PA,   2Department of Hematology  Oncology, US Oncology-Cancer Care Centers of South T exas, San Antonio, TX,  3Department of Medical  Oncology, T exas Oncology-Baylor Charles A. Sammons Cancer Center US Oncology, Dallas, TX,  4Department  of Hematology/Oncology, West Cancer Center, University of T ennessee Health Science Center,  Memphis, TN,  5Department of  Medical Affairs, Formerly of Eisai Inc.,  Woodcliff Lake, NJ,  6Department  of Medicine, Weill Cornell Medical College, New Y ork, NY, USAAbstract: Eribulin mesylate, a novel nontaxane microtubule dynamics inhibitor in the  halichondrin class of antineoplastic drugs, is indicated for the treatment of patients with  metastatic breast cancer who previously received ≥2 chemotherapy regimens in the metastatic  setting.",Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
"Keywords: oncology, breast neoplasms, advanced breast cancer, chemotherapy, eribulin  mesylate, trastuzumab, HER2Correspondence: Shannon Puhalla Department of Hematology and Oncology, University of Pittsburgh Medical Center, Magee Womens Cancer Program, 300 Halket Street, Room 3524, Pittsburgh, PA 15213, USATel +1 412 641 3494Email puhallasl@upmc.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Puhalla et alRunning head recto: Prior trastuzumab + eribulin/trastuzumab for HER2+ MBCDOI: http://dx.doi.org/10.2147/BCTT.S98696",Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
Available from: http://seer.cancer.gov/statfacts/html/breast.html.,Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 239 Prior trastuzumab + eribulin/trastuzumab for HER2+ MBC,Non-OADS,/arxiv_data1/oa_pdf/a9/3c/bctt-8-231.PMC5153255.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/a4/dddt-10-3977.PMC5153256.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3977–3981Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3977Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11780 6 impact of prostaglandin glaucoma drops on  platelet-activating factor action: an in vitro study Marilita M Moschos1 eirini nitoda1 irini P chatziralli1 georgios D Panos2 constantinos a  Demopoulos3 11st Department of Ophthalmology,   Medical school, national and  Kapodistrian University of athens,   athens, greece; 2Department of  Ophthalmology, geneva University  hospitals ( hUg), University of  geneva, geneva, switzerland;   3laboratory of Biochemistry, national  and Kapodistrian University of athens,   athens, greeceAim:  The aim of this study was to investigate the effect of different prostaglandin analogs on  platelet-activating factor (PAF) levels.",Non-OADS,/arxiv_data1/oa_pdf/28/a4/dddt-10-3977.PMC5153256.pdf
"Keywords:  glaucoma, platelet-activating factor, prostaglandin analogs, treatment, platelet  aggregation Introduction Glaucoma is estimated to be the second leading cause of severe vision loss and blindness  worldwide, affecting ~60.5 million people and accounting for 2.65% of the population  aged .40 years in 2010.1,2 The medical treatment for glaucoma includes prostaglandin  analogs, which are approved as the first-line treatment for glaucoma in the European  Glaucoma Society guidelines, carbonic anhydrase inhibitors, β-receptor antagonists,  adrenergic agonists, and parasympathomimetics.3,4 Prostaglandins are a family of  lipid compounds that are derived enzymatically from essential fatty acids, with each  containing 20 carbon atoms, including a 5-carbon ring.5 In eye, they are synthesized by  the trabecular endothelial and the ciliary muscle cells from membrane phospholipids  and arachidonic acid, exhibiting anti-inflammatory action.6,7 They seem to alter both  the function and structure of the uveoscleral pathways, inducing extracellular matrix  remodeling, widening of the intermuscular spaces, and dissolution of collagens types I  and III.8 Besides prostaglandin E2, various inflammatory molecules, including cytok - ines, cyclooxygenase 2, tumor necrosis factor-alpha, interleukins, platelet-activating  factor (PAF), vascular endothelial growth factor, and C-reactive protein have been  implicated in the mechanisms of glaucoma, highlighting the role of inflammation in  the pathogenesis of the disease.9,10 correspondence: Marilita M Moschos 1st Department of Ophthalmology,  Medical school, national and  Kapodistrian University of athens,  6, ikaria street, ekali, athens 14578,  greece Tel +30 69 4488 7319 Fax +30 21 0412 2319 email moschosmarilita@yahoo.f r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Moschos et al Running head recto: Effect of prostaglandin analogs on PAF DOI: http://dx.doi.org/10.2147/DDDT.S117806",Non-OADS,/arxiv_data1/oa_pdf/28/a4/dddt-10-3977.PMC5153256.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/28/a4/dddt-10-3977.PMC5153256.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/a4/dddt-10-3977.PMC5153256.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4005–4016Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4005Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12152 0 Determination of the starting dose in the first-in- human clinical trials with monoclonal antibodies:  a systematic review of papers published between  1990 and 2013 hoon Y oung suh1 carl c Peck2 Kyung-Sang Yu1 howard lee1,3 1Department of clinical Pharmacology  and Therapeutics, college of  Medicine, seoul national University  hospital, seoul, Korea; 2Department  of Bioengineering and Therapeutic  sciences, school of Pharmacy,   University of california, san  Francisco, ca, Usa; 3Department of  Transdisciplinary studies, graduate  school of convergence science and  T echnology, seoul national University,   seoul, KoreaAbstract:  A systematic review was performed to evaluate how the maximum recommended  starting dose (MRSD) was determined in first-in-human (FIH) studies with monoclonal antibodies  (mAbs).",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"The emphasis in the FDA  guidance is placed on the no observed adverse effects level (NOAEL) assessed in correspondence: howard lee Department of clinical Pharmacology  and Therapeutics, college of Medicine,  seoul national University hospital,  101 Daehak-ro, Jongno-gu, Seoul, Korea Tel +82 2 3668 7602 Fax +82 2 742 9252 email howardlee@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Suh et al Running head recto: Starting dose in first-in-human trials with monoclonal antibodies DOI: http://dx.doi.org/10.2147/DDDT.S121520",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"Available from: http://www.fda.gov/downloads/ drugs/guidances/ucm078932.pd f. Accessed July 6, 2005.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"London, UK: European  Medicines Agency; 2007: Available from: http://www.ema.europa.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/3c/dddt-10-4005.PMC5153257.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/da/ijn-11-6575.PMC5153258.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6575–6590International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6575OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11903 3 The nasal delivery of nanoencapsulated statins – an  approach for brain delivery adryana clementino1,2 Mellissa Batger3 gabriela garrastazu2,3 Michele Pozzoli3 elena Del Favero4 Valeria rondelli4 Bianca gutfilen5 Thiago Barboza5 Maria B sukkar3 sergio a l souza5 laura cantù4 Fabio sonvico1,3 1Department of Pharmacy,   University of Parma, Parma, Italy;   2National council for scientific and  T echnological Development – cNPq,   Brasilia, Brazil; 3graduate school of  health – Pharmacy, University of  T echnology sydney, Ultimo, N sW,   australia; 4Department of Medical  Biotechnologies and Translational  Medicine, lITa, University of Milan,   segrate, Italy; 5laboratório de  Marcação de células e Moléculas,   Department of radiology, Faculty of  Medicine, Federal University of rio  de Janeiro, rio de Janeiro, BrazilPurpose:  Along with their cholesterol-lowering effect, statins have shown a wide range of  pleiotropic effects potentially beneficial to neurodegenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/d8/da/ijn-11-6575.PMC5153258.pdf
"Statins reduce cholesterol serum levels by reversibly inhibiting HMG- CoA reductase, an essential enzyme in cholesterol biosynthesis, reducing the risk of  serious cardiovascular events.1,2 Along with their lipid-lowering effects, statins have correspondence: Fabio sonvico graduate school of health – Pharmacy,  University of Technology sydney,  Building 7, level 4, 67 Thomas street,  PO Box 123, Ultimo, NsW 2007,  australia Tel +61 2 9514 8303 email fabio.sonvico@uts.edu.a u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Clementino et al Running head recto: Nanoencapsulated statins for brain delivery via nasal route DOI: http://dx.doi.org/10.2147/IJN.S119033",Non-OADS,/arxiv_data1/oa_pdf/d8/da/ijn-11-6575.PMC5153258.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d8/da/ijn-11-6575.PMC5153258.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/da/ijn-11-6575.PMC5153258.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance 2016:9 275–289Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 275 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S117886Probiotics improve the efficacy of standard triple  therapy in the eradication of Helicobacter pylori:  a meta-analysis Christine S M Lau1,2  Amanda Ward2  Ronald S Chamberlain1–4 1Department of Surgery, Saint  Barnabas Medical Center, Livingston,   NJ, USA; 2Saint George’s University  School of Medicine, Grenada, West Indies;  3Department of Surgery,   Banner MD Anderson Cancer Center,  Gilbert, AZ, USA;  4Department of  Surgery, New Jersey Medical School,  Rutgers University, Newark, NJ, USAIntroduction: Helicobacter pylori colonization is present in half of the world’ s population and  can lead to numerous gastrointestinal diseases if left untreated, including peptic ulcer disease  and gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
"Keywords: probiotics, Helicobacter pylori, triple therapy, meta-analysis Introduction Helicobacter pylori, previously referred to as Campylobacter pylori, is a Gram-nega- tive, spiral bacterium that is present on the gastric epithelium mucus layer.1 H. pylori  colonization almost always leads to acute gastritis, with neutrophilic and mononuclear Correspondence: Ronald S Chamberlain Department of Surgery, Banner MD Anderson Cancer Center, 2940 East Banner Gateway Dr, Gilbert, AZ 85234, USATel +1 480 256 4737Fax +1 480 256 4734   Email Ronald.Chamberlain@bannerhealth.comJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Lau et alRunning head recto: Probiotics and H. pyloriDOI: http://dx.doi.org/10.2147/IDR.S117886",Non-OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
"Infection and Drug Resistance 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 289 Probiotics and H. pyloriFigure S6 Funnel plot assessing publication bias (analyzing the effect of probiotics on the efficacy of triple therapy in the eradication of Helicobacter pylori).,Non-OADS,/arxiv_data1/oa_pdf/e3/58/idr-9-275.PMC5153259.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/7d/ijn-11-6353.PMC5153260.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6353–6364International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6353OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9260 8The role of the intestinal microvasculature in  inflammatory bowel disease: studies with a  modified Caco-2 model including endothelial cells  resembling the intestinal barrier in vitro Jennifer Y Kasper1 Maria Iris hermanns1 christian cavelius2 Annette Kraegeloh2 Thomas Jung3 Rolf Danzebrink3 Ronald E Unger1 Charles James Kirkpatrick1 1Institute of Pathology, University  Medical Center, Mainz, 2Leibniz  Institute for New Materials,   3NanoGate AG, Goettelborn,   Saarbrücken, GermanyAbstract:  The microvascular endothelium of the gut barrier plays a crucial role during  inflammation in inflammatory bowel disease.",Non-OADS,/arxiv_data1/oa_pdf/c1/7d/ijn-11-6353.PMC5153260.pdf
"These multicellular   in vitro models could help gain more insight into inflammatory processes, for example,  the intestinal barrier during inflammatory bowel disease (IBD) after treatment with, correspondence: Jennifer Y Kasper Dynamische Biomaterialien INM, Leibniz- Institut für Neue Materialien, Campus  D2.2 D, 66123 Saarbrücken, Germany Tel +49 681 930 0301 email jennifer.kasper@leibniz-inm.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kasper et al Running head recto: Role of the intestinal microvasculature in IBD DOI: http://dx.doi.org/10.2147/IJN.S92608",Non-OADS,/arxiv_data1/oa_pdf/c1/7d/ijn-11-6353.PMC5153260.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c1/7d/ijn-11-6353.PMC5153260.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/7d/ijn-11-6353.PMC5153260.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3097–3110Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3097OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12323 9 a randomized controlled trial of a mindfulness- based intervention program for people with  schizophrenia: 6-month follow-up li-Qun Wang1 Wai T ong chien2 lai King Yip2 Thanos Karatzias3 1school of Nursing, Jilin Medical  college, Jilin, 2school of Nursing,   The hong Kong Polytechnic University,   hung hom, Kowloon, hong Kong  sar, People’s republic of china;   3Faculty of health, life and social  sciences, edinburgh Napier University,   edinburgh, scotland, UKAbstract:  Mindfulness-based interventions have been increasingly evidenced to be effective  in different mental illnesses but limited in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
"Different  approaches to psychosocial interventions provide significant benefits in improving  patients’ symptoms, drug compliance, and relapse, but inconsistent and inconclusive  results/effects in other psychosocial health conditions.1,3 As recommended by a recent guideline of the National Institute for Health and  Clinical Excellence in the UK,2 core interventions for early stage (eg, ,5 years) or  acute schizophrenia should include psychoeducation, medication management, and correspondence: Wai Tong chien school of Nursing, The hong Kong  Polytechnic University, hung hom,  Kowloon, hong Kong sar, People’s  republic of china Tel +852 2766 5648 Fax +852 2334 1124 email wai.tong.chien@polyu.edu.h k Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: RCT of mindfulness-based intervention in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S123239",Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
Neuropsychiatric Disease and Treatment 2016:12submit your manuscript | www.dovepress.co m Dove press Dove press 3099rcT of mindfulness-based intervention in schizophrenia of completion of or adherence to their intervention assigned.19  This controlled trial was registered at ClinicalTrials.go v (Ref:  NCT01667601; https://register.clinicaltrials.go v).,Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
Australia:  University of Sydney; 2013.Available from: http://www.ctc.usyd.edu.,Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/49/ndt-12-3097.PMC5153261.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2016:8 83–90Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 83 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S116924 Pattern of chemotherapy-related adverse effects  among adult cancer patients treated at Gondar  university Referral Hospital, Ethiopia: a cross- sectional study Sewunet Admasu Belachew1 Daniel Asfaw Erku2 Abebe Basazn Mekuria3 Begashaw Melaku  Gebresillassie1 1Department of Clinical Pharmacy,   2Department of Pharmaceutical  Sciences, 3Department of  Pharmacology, School of Pharmacy,   university of Gondar, Gondar,  EthiopiaBackground: Adverse drug reactions (ADRs) are a global problem and constitute a major  clinical problem in terms of human suffering.",Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
"3,4 For the treatment of cancer, various Correspondence: Sewunet Admasu  BelachewDepartment of Clinical Pharmacy,  School of Pharmacy, university of Gondar, Gondar 196, EthiopiaTel +251 91 407 6544Fax +251 58 114 1240Email sewunet.admasu@gmail.comJournal name: Drug, Healthcare and Patient Safety Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Belachew et alRunning head recto: Chemotherapy-related adverse effects pattern in EthiopiaDOI: http://dx.doi.org/10.2147/DHPS.S116924",Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
Available from: http://who.umc.org/graphics/24734.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
Available from: http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
"Drug, Healthcare and Patient Safety 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 90 Belachew et al 22.,Non-OADS,/arxiv_data1/oa_pdf/6b/fa/dhps-8-083.PMC5153262.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/ott-9-7385.PMC5153263.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7385–7395OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7385Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11637 3 association between proto-oncogene mutations  and clinicopathologic characteristics and  overall survival in colorectal cancer in east  azerbaijan, iran roya Dolatkhah1 Mohammad hossein somi2 iraj asvadi Kermani1 Morteza Bonyadi3 Bita sepehri2 Kamal Boostani2 saleh azadbakht2 nikou Fotouhi2 Faris Farassati4 saeed Dastgiri1,5 1hematology and Oncology research  center, Tabriz University of Medical  sciences, Tabriz, iran; 2liver and  gastrointestinal Diseases research  center, Tabriz University of Medical  sciences, Tabriz, iran; 3center of  excellence for Biodiversity, Faculty of  natural sciences, University of Tabriz,   Tabriz, iran; 4Molecular Medicine  laboratory, University of Kansas  Medical school, Kansas city, K s, Usa;   5Tabriz health services research  center, Tabriz University of Medical  sciences, Tabriz, iranBackground:  Colorectal cancer (CRC) is the third-most common cancer in Iran.",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/ott-9-7385.PMC5153263.pdf
"The crude correspondence: saeed Dastgiri hematology and Oncology research  center, Tabriz University of Medical  sciences, Tabriz, iran Tel +98 413 334 3844 Fax +98 413 336 1358 email saeed.dastgiri@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Dolatkhah et al Running head recto: Proto-oncogene mutations in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S116373",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/ott-9-7385.PMC5153263.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/ott-9-7385.PMC5153263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/7a/ott-9-7385.PMC5153263.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 177–186Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 177 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S120344Age- and sex-related differences in the  anthropometry and neuromuscular fitness of  competitive taekwondo athletes Pantelis Theodoros  Nikolaidis1 Krzysztof Buśko2 Filipe Manuel Clemente3 Ioannis Tasiopoulos1 Beat Knechtle4 1Exercise Physiology Laboratory,   Nikaia, Greece; 2Department of  Biomechanics, Institute of Sport- National Research Institute, Warsaw,  Poland;  3School of Sport and Leisure,   Polytechnic Institute of Viana do Castelo, Melgaço, Portugal;  4Institute  of Primary Care, University of Zurich,  Zurich, SwitzerlandAbstract: Anthropometry and neuromuscular fitness have been shown to relate with taekwondo  (TKD) performance; however, little information is available on the variation of these fitness  components by sex and age in athletes practicing this sport.",Non-OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
"9 Also, a trend for taller body height and less BF was highlighted in elite female Correspondence: Pantelis Theodoros  NikolaidisExercise Physiology Laboratory, Thermopylon 7, Nikaia 18450, GreeceTel +30 210 69 7782 0298Fax +30 210 490 7557Email pademil@hotmail.comJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Nikolaidis et alRunning head recto: Neuromuscular fitness in taekwondoDOI: http://dx.doi.org/10.2147/OAJSM.S120344",Non-OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/b3/oajsm-7-177.PMC5153264.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/12/opth-10-2433.PMC5153265.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2433–2441Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2433Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S11840 9 Systemic side effects of eye drops: a pharmacokinetic  perspective Andre Farkouh1 Peter Frigo2 Martin Czejka1,3 1Division of Clinical Pharmacy and  Diagnostics, Faculty of Life Sciences,   University of vienna, 2Department  of Gynecologic endocrinology and  Reproductive Medicine, Medical  University of vienna, 3Austrian  Society of Applied Pharmacokinetics,   vienna, AustriaAbstract:  When administering eye drops, even when completely correctly applied, several  routes of absorption are possible and excess amounts can sometimes cause an unwanted sys - temic bioavailability of the drops when not completely absorbed into the eye.",Non-OADS,/arxiv_data1/oa_pdf/e0/12/opth-10-2433.PMC5153265.pdf
"The volume of commercial drop dispensers (25–50 µL) generally exceeds the capac - ity of the conjunctival sac (only 10 µL), so that the major portion of the liquid drains  out of the eye and onto the eyelids and cheeks, where further absorption may occur.2  Generally, the capacity of the conjunctival sac depends on several factors, such as Correspondence: Andre Farkouh Division of Clinical Pharmacy and  Diagnostics, Faculty of Life Sciences,  University of vienna, Althanstrasse 14,  A-1090 vienna, Austria Tel +43 1 4277 555 79 email andre.farkouh@univie.ac.a t Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Farkouh et al Running head recto: Systemic side effects of eye drops DOI: http://dx.doi.org/10.2147/OPTH.S118409",Non-OADS,/arxiv_data1/oa_pdf/e0/12/opth-10-2433.PMC5153265.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e0/12/opth-10-2433.PMC5153265.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/12/opth-10-2433.PMC5153265.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 319–328International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 319 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S84784 Dialysis-related amyloidosis: challenges and  solutions R Scarpioni M Ricardi V Albertazzi S De AmicisF RastelliL Zerbini Department of Nephrology and  Dialysis, Azienda Unità Sanitaria Local (AUSL) Hospital “Guglielmo da Saliceto”, Piacenza, ItalyAbstract: Amyloidosis refers to the extracellular tissue deposition of fibrils composed of low- molecular-weight subunits of a variety of proteins.",Non-OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
"1Correspondence: Roberto Scarpioni Department of Nephrology and Dialysis, “Guglielmo da Saliceto” AUSL Hospital, Via Taverna, 49, Piacenza 29121, ItalyTel +39 523 302 176Fax +39 523 302 174Email rscarpioni@hotmail.comJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Scarpioni et alRunning head recto: Amyloidosis in dialysisDOI: http://dx.doi.org/10.2147/IJNRD.S84784",Non-OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 328 Scarpioni et al  44.,Non-OADS,/arxiv_data1/oa_pdf/0f/dc/ijnrd-9-319.PMC5153266.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2016:4 163–174Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 163 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S115500Combination effects of sorafenib with PI3K  inhibitors under hypoxia in colorectal cancer Dimple R Bhatia   Padma Thiagarajan School of Biosciences and T echnology,   Vellore Institute of T echnology University, Vellore, Tamil Nadu, IndiaAim: This study reports the influence of hypoxia on response of colorectal cancer cells to  anticancer effects of sorafenib in combination with PI3K inhibitors GDC-0941 and BEZ-235.",Non-OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"Correspondence: Dimple R Bhatia   School of Biosciences and Technology,  VIT University, Katpadi Road, Vellore 632014, Tamil Nadu, India   Email dimplebhatia2009@gmail.comJournal name: Hypoxia Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 4Running head verso: Bhatia and ThiagarajanRunning head recto: Combination of sorafenib with PI3K inhibitors under hypoxiaDOI: http://dx.doi.org/10.2147/HP .S115500",Non-OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"Hypoxia 2016:4submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 174 Bhatia and Thiagarajan well as normoxia, synergistic effects that are observed with  the combination of compounds are mainly due to inhibition of effector proteins of the target pathways of these compounds, namely, PI3K/AKT and Raf/ERK.",Non-OADS,/arxiv_data1/oa_pdf/77/5f/hp-4-163.PMC5153268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/5b/ee/ijn-11-6499.PMC5153269.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nanomedicine International Journal of Nanomedicine 2016:11 6499–6506Reduced Staphylococcus aureus  biofilm formation  in the presence of chitosan-coated iron oxide  nanoparticles Si-feng Shi1,2 Jing-fu Jia3 Xiao-kui Guo4 Ya-ping Zhao3 De-sheng Chen2 Y ong-yuan Guo2 Xian-long Zhang2 1Department of Orthopedics, the  Affiliated Hospital of Xu Zhou  Medical University, Xu Zhou, Jiangsu,   2Department of Orthopedic Surgery,   Shanghai sixth People’s Hospital,   Shanghai Jiao T ong University,   Shanghai, 3School of Chemistry  and Chemical T echnology, Shanghai  Jiao T ong University, Shanghai,   4Department of Medical Microbiology  and Parasitology, Institutes of Medical  Sciences, Shanghai Jiao T ong University  School of Medicine, Shanghai, People’s  Republic of China Correspondence: Si-feng Shi   Department of Orthopedics, the  Affiliated Hospital of XuZhou Medical  University, XuZhou, No 99, West Huaihai  Road, XuZhou, Jiangsu 221000, People’s  Republic of China   Email shisifeng20071@163.co m    Xian-long Zhang   Department of Orthopaedic Surgery,  Shanghai Sixth People’s Hospital,   Shanghai Jiao T ong University,   No 600 Yi Shan Road, Xu Hui   District, Shanghai, People’s   Republic of China   T el +86 21 6436 9181   Email zhangxianlong20101@163.co mAbstract:  Staphylococcus aureus  can adhere to most foreign materials and form biofilm on the  surface of medical devices.",Non-OADS,/arxiv_data1/oa_pdf/5b/ee/ijn-11-6499.PMC5153269.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5b/ee/ijn-11-6499.PMC5153269.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/ee/ijn-11-6499.PMC5153269.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3101–3108International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3101OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12364 3 an evaluation of early medication use for COPD:  a population-based cohort study Jamie Falk1 natalia Dik2 shawn Bugden1 1College of Pharmacy, rady Faculty  of health sciences, 2Manitoba Centre  for health Policy, Department  of Community health sciences,   University of Manitoba, Winnipeg,   MB, CanadaPurpose:  The aim of this study was to evaluate the first initiation, sequence of addition, and  appropriate prescribing of COPD medications in Manitoba, Canada.",Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
"The presence of multiple comorbidities is common among  COPD patients, with the vast majority of patients using multiple classes of chronic  non-COPD medications.1–3 In addition to significant effects on morbidity, COPD is  the third leading cause of death in the world.4 Unfortunately, with the exceptions of  smoking cessation and oxygen therapy in hypoxic patients, no interventions to date  have been able to reduce the likelihood of death in patients with COPD.5 Furthermore,  based on current clinical trial data, the magnitude of effect of pharmacological treat - ments for COPD has been shown to be relatively limited.6,7Correspondence: Jamie Falk College of Pharmacy, rady Faculty  of health sciences, apotex Centre,  University of Manitoba, 750 McDermot  avenue, Winnipeg, MB r3e 0T5, Canada Tel +1 204 318 5280 Fax +1 204 789 3744 email jamison.falk@umanitoba.c a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Falk et al Running head recto: An evaluation of early medication use for COPD DOI: http://dx.doi.org/10.2147/COPD.S123643",Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
Available  from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
Available from:   http://www.gov.mb.ca/health/mdbif /.,Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/9a/copd-11-3101.PMC5153270.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/3c/ijn-11-6533.PMC5153271.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6533–6545International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6533OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11806 5 Nanomechanical measurement of adhesion  and migration of leukemia cells with phorbol  12-myristate 13-acetate treatment Zhuo long Zhou1 Jing Ma2 Ming-hui T ong1 Barbara Pui chan1 alice sze Tsai Wong2 alfonso hing Wan Ngan1 1Department of Mechanical  engineering, 2school of Biological  sciences, University of hong Kong,   hong Kong, People’s republic  of chinaAbstract:  The adhesion and traction behavior of leukemia cells in their microenvironment is  directly linked to their migration, which is a prime issue affecting the release of cancer cells from  the bone marrow and hence metastasis.",Non-OADS,/arxiv_data1/oa_pdf/f4/3c/ijn-11-6533.PMC5153271.pdf
"Bone marrow stromal cells (BMSCs), including  osteoblasts, endothelial cells, and fibroblasts (FBs), and extracellular matrix proteins  (ECMPs), such as collagens, glycoproteins (fibronectin, laminins, and vitronectin),  proteoglycans, and glycosaminoglycans, coexist with the SCs and leukocytes inside the  BM, and they help regulate the self-renewal of HSCs and leukocytes and their release  into the bloodstream.2 Cell proliferation, differentiation, and migration responses to  the signal communication between HSCs, BMSCs, and ECMPs are mainly through  adhesion molecules.3,4 Among those adhesion proteins, integrins and transmembrane  proteoglycans are the main receptors and coreceptors for the matrix,5 while cadherins are  adhesion proteins mediating cell–cell contact.6 It has been reported that low expression  of E-cadherin adhesion proteins is implicated in the abnormal interaction of leukemic correspondence: Zhuo long Zhou Department of Mechanical engineering,  3-29 haking Wong Building, University of  hong Kong, Pokfulam road, hong Kong,  People’s republic of china Tel +852 2859 02624 email zhouzhuolong@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhou et al Running head recto: Leukemia cell adhesion and migration after PMA treatment DOI: http://dx.doi.org/10.2147/IJN.S118065",Non-OADS,/arxiv_data1/oa_pdf/f4/3c/ijn-11-6533.PMC5153271.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f4/3c/ijn-11-6533.PMC5153271.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/3c/ijn-11-6533.PMC5153271.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/90/ijn-11-6547.PMC5153272.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6547–6559International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6547OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12093 9 Intranasal delivery of rotigotine to the brain with  lactoferrin-modified PEG-PLGA nanoparticles for  Parkinson’s disease treatment chenchen Bi1,* aiping Wang1,* Y ongchao chu1 sha liu1 hongjie Mu1 Wanhui liu1 Zimei Wu1 Kaoxiang sun1 Y ouxin li1,2 1School of Pharmacy, Collaborative  Innovation center of advanced  Drug Delivery system and Biotech  Drugs in Universities of shandong,   Key laboratory of Molecular  Pharmacology and Drug Evaluation  (Yantai University), Ministry of  education, 2state Key laboratory  of long-acting and Targeting Drug  Delivery system, shandong luye  Pharmaceutical Co, Ltd., Yantai,   People’s Republic of China *These authors contributed equally  to this workAbstract:  Sustainable and safe delivery of brain-targeted drugs is highly important for successful  therapy in Parkinson’s disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/d4/90/ijn-11-6547.PMC5153272.pdf
"It is a non-ergoline, enantioselective dopamine agonist, with preference correspondence: Kaoxiang sun School of Pharmacy, Yantai University,  No 30 Qingquan road, Yantai, 264005  Shandong Province, People’s Republic of  china Tel +86 535 394 6400 email sunkx@ytu.edu.c n  Youxin li Shandong Luye Pharmaceutical Co,  ltd, No 9 Baoyuan road, Yantai  264003, Shandong Province, People’s  republic of china Tel +86 535 394 6187 email liyouxin@luye.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Bi et al Running head recto: Intranasal delivery of rotigotine with lactoferrin-modified PEG-PLGA NPs DOI: http://dx.doi.org/10.2147/IJN.S120939",Non-OADS,/arxiv_data1/oa_pdf/d4/90/ijn-11-6547.PMC5153272.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d4/90/ijn-11-6547.PMC5153272.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/90/ijn-11-6547.PMC5153272.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1173–1177Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1173 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S105506Transsacrococcygeal approach to ganglion impar:  radiofrequency application for the treatment of  chronic intractable coccydynia Cemil Adas1  Ugur Ozdemir2  Huseyin T oman3  Nurettin Luleci4  Emel Luleci5  Hilal Adas6 1Anesthesiology and Reanimation  Clinic, Şişli Hamidiye Etfal Education  and Research Hospital, Istanbul,   2Department of Anesthesiology and  Reanimation, Faculty of Medicine,  Şifa University, Izmir,  3Department  of Anesthesiology and Reanimation,  Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale,   4Department of Anesthesiology and  Reanimation, Faculty of Medicine,  Algology Clinic, Maltepe University,   5Department of Health Education,   Faculty of Health Education, Marmara University,  6Anesthesiology and  Reanimation Clinic, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital,  Istanbul, T urkeyObjective: Coccydynia is defined as pain in the coccygeal region.",Non-OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
"3,4 Coccydynia is a rare condition of various etiologies, affecting females five times  more than males and is also associated with obesity.1,5 Trauma is the most common Correspondence: Huseyin Toman   Department of Anesthesiology and  Reanimation, Faculty of Medicine, Canakkale Onsekiz Mart University, Kepez, Canakkale 17110, Turkey   Tel +90 505 450 5956   Email huseyintoman01@hotmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Adas et alRunning head recto: RFT application for the treatment of coccydyniaDOI: http://dx.doi.org/10.2147/JPR.S105506",Non-OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1177 RFT application for the treatment of coccydynia as for any other application.,Non-OADS,/arxiv_data1/oa_pdf/dc/b5/jpr-9-1173.PMC5153273.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1191–1195Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1191 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125270Pharmacotherapeutic considerations for chronic  pain in chronic kidney and end-stage renal disease Roy O Mathew1 Jeffrey J Bettinger2 Erica L Wegrzyn3 Jeffrey Fudin3,4 1Department of Medicine, Wm.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
"Jennings Bryan Dorn VA Medical Center, 6439 Garners Ferry Rd, Columbia, SC, USAEmail Roy.Mathew@va.gov Jeffrey Fudin Remitigate, LLC, 357 Delaware Avenue #214 Delmar, NY, USAEmail jeffrey.fudin@remitigate.comJournal name: Journal of Pain Research  Article Designation: EDITORIALY ear: 2016V olume: 9Running head verso: Mathew et alRunning head recto: Pharmacotherapeutic considerations for chronic painDOI: http://dx.doi.org/10.2147/JPR.S125270",Non-OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1195 Pharmacotherapeutic considerations for chronic pain  24.,Non-OADS,/arxiv_data1/oa_pdf/c7/47/jpr-9-1191.PMC5153274.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 291–300Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 291 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S102207Isavuconazole for the treatment of invasive  aspergillosis and mucormycosis: current evidence,  safety, efficacy, and clinical recommendations Suganthini Krishnan  Natesan1,2 Pranatharthi H Chandrasekar 1 1Division of Infectious Diseases,   Department of Internal Medicine,   Wayne State University, 2John D  Dingell VA Medical Center, Detroit,  MI, USAAbstract: The majority of invasive mold infections diagnosed in immunocompromised cancer  patients include invasive aspergillosis (IA) and mucormycosis.",Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
"One of the most recent  additions to the antifungal armamen- tarium is isavuconazole (ISZ), a novel triazole agent that has shown good clinical efficacy Correspondence: Suganthini Krishnan  NatesanDivision of Infectious Diseases, John D Dingell VA Medical Center, 4646 John R, Room C3917, Detroit, MI 48201, USATel +1 313 576 3057Fax +1 313 576 1242Email skrishn@med.wayne.eduJournal name: Infection and Drug Resistance  Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Natesan and ChandrasekarRunning head recto: Isavuconazole for the treatment of invasive aspergillosis and mucormycosisDOI: http://dx.doi.org/10.2147/IDR.S102207",Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 300 Natesan and Chandrasekar  67.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/Committees-MeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM430747.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT00413218.,Non-OADS,/arxiv_data1/oa_pdf/42/b8/idr-9-291.PMC5153275.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/60/d2/copd-11-3059.PMC5153276.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3059–3067International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3059OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12077 6 exacerbations and health care resource utilization  in patients with airflow limitation diseases  attending a primary care setting: the PUMa study Maria Montes de Oca1 Carlos aguirre2 Maria Victorina lopez  Varela3 Maria e laucho-Contreras1 alejandro Casas2 Filip surmont4 1service of Pneumology, hospital  Universitario de Caracas, Facultad  de Medicina, Universidad Central  de Venezuela, Caracas, Venezuela;   2Colombian Pneumological  Foundation, Bogotá, Colombia;   3Universidad de la república, Facultad  de Medicina, hospital Maciel,   Montevideo, Uruguay; 4Medical affairs,   astraZeneca latin america, Coral  gables, Fl, UsaBackground:  COPD, asthma, and asthma–COPD overlap increase health care resource  consumption, predominantly because of hospitalization for exacerbations and also increased  visits to general practitioners (GPs) or specialists.",Non-OADS,/arxiv_data1/oa_pdf/60/d2/copd-11-3059.PMC5153276.pdf
"COPD and asthma are two major  causes of morbidity and mortality worldwide.1–9 These conditions impair quality of  life, generate permanent work disabilities, and have considerable direct and indirect  health care system costs.9–17Correspondence: Maria Montes de Oca hospital Universitario de Caracas,  Facultad de Medicina, los Chaguaramos,  1030, Universidad Central de Venezuela,  Caracas, Venezuela Tel/fax +58 212 552 6088 email montesdeoca.maria@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Montes de Oca et al Running head recto: Exacerbations and health care utilization in primary care DOI: http://dx.doi.org/10.2147/COPD.S120776",Non-OADS,/arxiv_data1/oa_pdf/60/d2/copd-11-3059.PMC5153276.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/60/d2/copd-11-3059.PMC5153276.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/d2/copd-11-3059.PMC5153276.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3109–3119International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3109OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11885 6 how do general practitioners implement  decision-making regarding COPD patients with  exacerbations?",Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
"Keywords:  COPD exacerbation, antibiotics, oral corticosteroids, hospitalization, primary care,  decision-making Introduction Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) account  for the accelerated decline of lung function, loss of health-related quality of life, high  morbidity, mortality, and health costs.1 It is estimated that hospitalizations due to COPD  exacerbations account for 50%–75% of total health costs in the US and Europe.2 A key  policy objective in many countries is to reduce costly hospitalizations, which can be  achieved by prevention of exacerbations and early and optimal therapy in primary Correspondence: Johanna laue general Practice research Unit,  Department of Community Medicine,  UiT, The arctic University of norway,  9037, Tromsø, norway Tel +47 7762 3348 email johanna.laue@uit.n o Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Laue et al Running head recto: Treatment decision-making for COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S118856",Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
Available from: http://www.goldcopd.or g.  Accessed August 2016.,Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
Available from: https://www.mindjet.com/ mindmanager /.,Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/11/copd-11-3109.PMC5153277.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/68/ndt-12-3111.PMC5153278.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3111–3118Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3111OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12153 3 Diminished autonomic neurocardiac function  in patients with generalized anxiety disorder Kyungwook Kim1 seul lee2 Jong-hoon Kim1–3 1gachon University school of  Medicine, 2Department of Psychiatry,   gil Medical center, gachon University  school of Medicine, gachon  University, 3Neuroscience research  institute, gachon University, incheon,   republic of KoreaBackground:  Generalized anxiety disorder (GAD) is a chronic and highly prevalent disorder  that is characterized by a number of autonomic nervous system symptoms.",Non-OADS,/arxiv_data1/oa_pdf/f8/68/ndt-12-3111.PMC5153278.pdf
"Keywords:  generalized anxiety disorder, heart rate variability, parasympathetic modulation Introduction Generalized anxiety disorder (GAD) is a chronic and highly prevalent disorder that is  characterized by uncontrollable excessive worry, chronic anxiety, and tension.1 Typi - cally, GAD is accompanied by a number of physical symptoms that result in significant  impairment of daily social and occupational functioning.2,3 In addition to various  cognitive and emotional anxiety symptoms, it is further characterized by autonomic  nervous system (ANS) symptoms, including hot flashes, palpitations, perspiration,  and shaking.2–4 The increased cardiovascular morbidity associated with GAD may in  fact be related to the ANS dysregulation underlying the disorder.5,6  The analysis of heart rate variability (HRV), that is, the variation in the cardiac  interbeat interval over time, has proven to be both practical and useful in evaluating  ANS dysregulation, since its measurement is noninvasive, easy to perform, and  reproducible.7–9 Recently, novel nonlinear measures of HRV gave rise to a new  approach to the understanding of the complex phenomena surrounding neurocardiac  processes and have provided clinically useful information regarding the hidden correspondence: Jong-hoon Kim Department of Psychiatry, gil Medical  center, gachon University school  of Medicine, 1198 guwol-dong,  Namdong-gu, incheon 405-760,  republic of Korea Tel +82 32 460 2696 Fax +82 32 472 8813 email jhnp@chol.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kim et al Running head recto: Autonomic function in generalized anxiety disorder DOI: http://dx.doi.org/10.2147/NDT.S121533",Non-OADS,/arxiv_data1/oa_pdf/f8/68/ndt-12-3111.PMC5153278.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f8/68/ndt-12-3111.PMC5153278.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/68/ndt-12-3111.PMC5153278.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3983–3994Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3983Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S12163 0 Use of bedaquiline and delamanid in diabetes  patients: clinical and pharmacological considerations Minhui Hu1 Chunlan Zheng1 Feng Gao2 1Department of internal  Medicine – Section 5, wuhan  Pulmonary Hospital ( wuhan  T uberculosis Control institute),   2Department of endocrinology,   Union Hospital, Tongji Medical  College, Huazhong University  of Science and T echnology, wuhan,   People’s Republic of ChinaAbstract:  Antituberculosis (anti-TB) treatment may be affected by both diabetes and hypoglycemic  agents in patients with these 2 comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
"Salindri et al found that type 2 DM  was associated with an increased risk of primary MDR-TB, and among 52 patients Correspondence: Feng Gao Department of endocrinology, Union  Hospital, Tongji Medical College,  Huazhong University of Science and  Technology, 1277 Jiefang Avenue, wuhan  430022, People’s Republic of China Tel +86 139 7152 5208 email gaofengwh@aliyun.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Hu et al Running head recto: Bedaquiline and delamanid in diabetes DOI: http://dx.doi.org/10.2147/DDDT.S121630",Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
"Available from: http://www.fda.gov/ downloads / AdvisoryCommittees /CommitteesMeetingMaterials/Drugs/Anti-   InfectiveDrugsAdvisoryCommittee/UCM329258.pd f. Accessed  August 27, 2016.",OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
Available from: http://www.drugbank.ca/drugs/DB0125 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/9d/dddt-10-3983.PMC5153280.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 683–689International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  683OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11868 7 a cost-effectiveness evaluation comparing  originator follitropin alfa to the biosimilar for  the treatment of infertility salvatore gizzo1 Juan a garcia-Velasco2 Franca Heiman3 claudio ripellino3 Klaus Bühler4 1Department of Woman and child  Health, University of Padua, Padua,   Italy; 2Department of Obstetrics  and gynecology, rey Juan carlos  University Madrid, Madrid, spain; 3IMs  Health Information solutions Italy srl,   Milan, Italy; 4centre for gynaecology,   endocrinology, and reproductive  Medicine, Ulm and stuttgart, germanyObjectives:  To perform a cost-effectiveness evaluation comparing the originator follitropin alfa  (Gonal-f®) to the biosimilar (Bemfola®) in the Italian and Spanish contexts, with an assessment  of the German and UK backgrounds.",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"It is the first recombinant follicle-stimulating hormone (FSH) correspondence: claudio ripellino IMs Health Information solutions Italy srl,  Via Fabio Filzi 29, Milan 20124, Italy Tel +39 02 69 78 6291 Fax +39 02 70 03 9919 email cripellino@it.imshealth.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Gizzo et al Running head recto: Evaluation comparing originator follitropin alfa to biosimilar DOI: http://dx.doi.org/10.2147/IJWH.S118687",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"Available from: http://www.fda.gov/drugs/developmentapproval - process/howdrugsaredevelopedandapproved/approvalapplications/thera - peuticbiologicapplications/biosimilars/default.ht m. Accessed March 1,  2016.",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
Available from: http://www.salute.,Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
Available  from: https://www.msssi.gob.es/estadEstudios/estadisticas/cmbdhome.,Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"[Online] Barcelona:  Oblikue Consulting; 2016. http://www.oblikue.com/en/index.ht m.  Accessed March 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
All Wales Medicines Strategy Group; 2014. http://www.awmsg.org/ awmsgonline/app/appraisalinfo/208 8.,Non-OADS,/arxiv_data1/oa_pdf/b6/77/ijwh-8-683.PMC5153281.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3069–3078International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3069RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11737 8 Interpreting patient-reported outcomes from  clinical trials in COPD: a discussion Paul w Jones1,2 Stephen Rennard3,4 Maggie Tabberer5 John H Riley2 Mitra vahdati-Bolouri2 Neil C Barnes2,6 1Institute for Infection and Immunity,   University of London, London,   2Global Respiratory Franchise,   GlaxoSmithKline, Uxbridge, UK;   3Division of Pulmonary, Critical  Care, Sleep and Allergy, Nebraska  Medical Center, Omaha, N e,   USA; 4Clinical Discovery Unit,   AstraZeneca, Cambridge, 5Global  R&D, GlaxoSmithKline, Uxbridge,   6william Harvey Institute, Bart’s and  the London School of Medicine and  Dentistry, London, UKAbstract:  One of the challenges faced by the practising physician is the interpretation of  patient-reported outcomes (PROs) in clinical trials and the relevance of such data to their  patients.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"In contrast, physicians generally make decisions to modify Correspondence: Paul w Jones Institute for Infection and Immunity,  University of London, London,  Sw17 0Re, UK Tel +44 7881 269 013 email pjones@sgul.ac.u k Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Jones et al Running head recto: Interpreting PROs in COPD DOI: http://dx.doi.org/10.2147/COPD.S117378 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
Or use: http://youtu.be/VtzmFwWgVh kvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"Chronic Obstructive Pulmonary Disease Pathway; 2015.  http://pathways.nice.org.uk/pathways/chronic-obstructive-pulmonary- diseas e. Accessed August 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"Silver Spring, MD; 2016. http://www.fda.gov/ucm/groups/ fdagov-public/@fdagov-drugs-gen/documents/document/ucm071575.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/ac/copd-11-3069.PMC5153282.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3137–3143International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3137OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11815 3 COPD assessment test score and serum  C-reactive protein levels in stable COPD patients hyung Koo Kang1,2,* Kang Kim1,* hyun lee1 Byeong-ho Jeong1 Won-Jung Koh1 hye Yun Park1 1Division of Pulmonary and Critical  Care Medicine, Department of  Medicine, samsung Medical Center,   sungkyunkwan University school  of Medicine, seoul, 2Division of  Pulmonary and Critical Care  Medicine, Department of Internal  Medicine, Ilsan Paik hospital, Inje  University school of Medicine,   goyang, gyeonggi, south Korea *These authors contributed equally  to this workBackground:  An eight-item questionnaire of the COPD assessment test (CAT) is widely  used to quantify the impact of COPD on the patient’s health status.",Non-OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
"Keywords:  chronic obstructive pulmonary disease assessment test, C-reactive protein, quality  of life, inflammation Background COPD is a chronic inflammatory lung disease characterized by progressive airflow  limitation and parenchymal destruction.1 It often causes remarkable symptom burden,  including chronic cough, sputum production, breathlessness, and exercise intolerance.1–3  The Global Initiative for Chronic Obstructive Lung Disease guideline recommends  multiple symptomatic assessments rather than just measuring breathlessness with lung  function.1 Among several questionnaires measuring health-related quality of life, the  COPD assessment test (CAT) is widely used in routine practice.4–6 It is an easy and  simple measurement with an eight-item questionnaire, which is designed to quantify  the impact of COPD symptoms on the patient health status with scores of 0–40.4 In  clinically stable COPD patients, the CAT is also closely related to the St George’s  Respiratory Questionnaire.7,8 C-reactive protein (CRP) is a representative systemic biomarker reflecting the total  systemic burden of inflammation in individuals.9 Serum CRP is elevated in stable  COPD, and it correlates with disease severity and adverse health outcomes of patients  with mild-to-moderate COPD.10 The Copenhagen City Heart Study and Copenhagen  General Population Study showed that increased levels of CRP and other systemic Correspondence: hye Yun Park Division of Pulmonary and Critical Care  Medicine, Department of Medicine,  samsung Medical Center, sungkyunkwan  University school of Medicine,   81 Irwon-ro, gangnam-gu, seoul 06351,  south Korea Tel +82 2 3410 3429 Fax +82 2 3410 3849 email hyeyunpark@skku.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kang et al Running head recto: CAT score and serum C-reactive protein DOI: http://dx.doi.org/10.2147/COPD.S118153",Non-OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
"Available from: http://www.goldcopd.or g.  Accessed May 1, 2016.",OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/4a/copd-11-3137.PMC5153283.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bc/10/ndt-12-3119.PMC5153284.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3119–3128Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3119OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11614 8 relationship between suicide rate and economic  growth and stock market in the People’s republic  of china: 2004–2013 honglei Yin1,2 lin Xu3 Yechang shao2,4 liping li5 chengsong Wan2 1Department of Psychiatry, Nanfang  hospital, southern Medical University,   guangzhou, People’s republic of  china; 2school of Public health,   southern Medical University,   guangzhou, People’s republic of  china; 3Department of Finance,   school of economics and commerce,   south china University of T echnology,   guangzhou, People’s republic of  china; 4guangdong academy of  Medical sciences, guangdong general  hospital, guangzhou, People’s  republic of china; 5injury Prevention  research center, shantou University  Medical college, shantou, People’s  republic of chinaObjectives:  The objective of this study was to estimate the features of suicide rate and its  association with economic development and stock market during the past decade in the People’s  Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/bc/10/ndt-12-3119.PMC5153284.pdf
"Previous  studies have found that suicides in the People’s Republic of China showed a unique correspondence: chengsong Wan school of Public health, southern  Medical University, 1023 south shatai  road, guangzhou, 510515, People’s  republic of china email gzwcs@126.co m  liping li injury Prevention research center,  shantou University Medical college, 22  Xinling road, shantou 515041, People’s  republic of china email lpli@stu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Yin et al Running head recto: Relationship between suicide rate and economic growth and stock market DOI: http://dx.doi.org/10.2147/NDT.S116148",Non-OADS,/arxiv_data1/oa_pdf/bc/10/ndt-12-3119.PMC5153284.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bc/10/ndt-12-3119.PMC5153284.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/10/ndt-12-3119.PMC5153284.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1179–1189Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1179 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115068Combining pain therapy with lifestyle:   the role of personalized nutrition and nutritional  supplements according to the SIMPAR Feed Y our  Destiny approach Manuela De Gregori,1–3  Carolina Muscoli,2,4,5 Michael  E Schatman,2,6 Tiziana  Stallone,2,7 Fabio Intelligente,2,8  Mariangela Rondanelli,2,9  Francesco Franceschi,2,10  Laura Isabel Arranz,2,11 Silvia  Lorente-Cebrián,2,12 Maurizio  Salamone,2,13,14 Sara Ilari,2,5 Inna  Belfer,2,15 Massimo Allegri2,16,17 1Pain Therapy Service, Fondazione IRCCS  Policlinico San Matteo, Pavia, Italy; 2Study  in Multidisciplinary Pain Research Group,   3Y oung Against Pain Group, Parma, Italy;   4Department of Health Sciences, Institute  of Research for Food Safety and Health,   University “Magna Graecia” of Catanzaro,    Parma, Italy; 5IRCCS San Raffaele Pisana,   Roccelletta di Borgia, Catanzaro, Italy;   6US Pain Foundation, Bellevue, WA, USA;   7ENPAB, Rome, 8Chronic Pain Service  Anestesia Day-Surgery, IRCCS Humanitas  Research Hospital, Rozzano, 9Department  of Public Health, Section of Human Nutrition and Dietetics, Azienda di Servizi  alla Persona di Pavia, University of Pavia,   Pavia,  10Institute of Internal Medicine,   Catholic University of Rome, Rome,  Italy;  11Department of Nutrition, Food  Sciences and Gastronomy, University of Barcelona, Barcelona,  12Department of  Nutrition, Food Science and Physiology,  Center for Nutrition Research, University  of Navarra, Pamplona, Spain;  13Metagenics  Italia srl, Milano, 14Italian Lifestyle Medicine  Association, Bari, Italy; 15Faculty of  Dentistry, McGill University, Montreal, QC,   Canada; 16Department of Surgical Sciences,   University of Parma, 17Anesthesia, Intensive  Care and Pain Therapy Service, Azienda Ospedaliero, Universitaria of Parma,    Parma, ItalyAbstract:  Recently, attention to the lifestyle of patients has been rapidly increasing in the  field of pain therapy, particularly with regard to the role of nutrition in pain development and  its management.",Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"The workshop also integrated a diverse array of  Correspondence: Manuela De Gregori   Pain Therapy Service, Fondazione IRCCS  Policlinico San Matteo, Viale Golgi 19, 27100  Pavia, Italy  Tel +39 382 501 228   Fax +39 382 502 226   Email manuela.degregori@unipv.itJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: De Gregori et alRunning head recto: First SIMPAR workshop on pain, nutrition, and nutraceuticalsDOI: http://dx.doi.org/10.2147/JPR.S115068",Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"Approximately 39% of adults (18 years and  older) worldwide are overweight, with 13% obese (World Health Organization, 2015, http://www.who.int/mediacen-tre/factsheets/fs311/en/).",Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
Available from: http://www.fda.gov/regulatoryinformation/guidances/ucm257563.htm.,Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1189 First SIMPAR workshop on pain, nutrition, and nutraceuticals  132.",Non-OADS,/arxiv_data1/oa_pdf/e4/13/jpr-9-1179.PMC5153285.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/3e/cia-11-1781.PMC5153286.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1781–1790Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1781OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11399 4 The influence of frailty syndrome on medication  adherence among elderly patients with  hypertension Beata Jankowska-Polańska1 Krzysztof Dudek2 Anna Szymanska- Chabowska3 Izabella Uchmanowicz1 1Department of Clinical Nursing,   Faculty of Health Science, Wroclaw  Medical University, 2Department  of Logistic and Transport Systems,   Faculty of Mechanical Engineering,   Wroclaw University of T echnology,   3Department of Internal Medicine,   Occupational Diseases, Hypertension  and Clinical Oncology, Wroclaw  Medical University, Wroclaw, PolandBackground:  Hypertension affects about 80% of people older than 80 years; however,  diagnosis and treatment are difficult because about 55% of them do not adhere to treatment  recommendations due to low socioeconomic status, comorbidities, age, physical limitations,  and frailty syndrome.",Non-OADS,/arxiv_data1/oa_pdf/07/3e/cia-11-1781.PMC5153286.pdf
"If the observed increase continues, the Correspondence: Beata Jankowska- Polańska Department of Clinical Nursing, Faculty  of Health Science, Wroclaw Medical  University, 5 Bartla Street, 51-618  Wroclaw, Poland Tel +48 71 9347 7007 email bianko@poczta.onet.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Jankowska-Pola ńska et al Running head recto: Frailty syndrome and medication adherence DOI: http://dx.doi.org/10.2147/CIA.S113994",Non-OADS,/arxiv_data1/oa_pdf/07/3e/cia-11-1781.PMC5153286.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/07/3e/cia-11-1781.PMC5153286.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/07/3e/cia-11-1781.PMC5153286.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/21/ijn-11-6507.PMC5153287.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6507–6516International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6507OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11951 9 Biomechanical and histological evaluation of the  osseointegration capacity of two types of zirconia  implant Jian-min han1,2 guang hong3 hong lin1 Y oshinaka shimizu4 Yuhan Wu2 gang Zheng1 hongyu Zhang5 Keiichi sasaki2 1Department of Dental Materials,   National engineering laboratory  for Digital and Material Technology  of stomatology, Peking University  school and hospital of stomatology,   Beijing, People’s republic of china;   2Division of advanced Prosthetic  Dentistry, 3liaison center for  Innovative Dentistry, 4Department of  Oral Pathology, graduate school of  Dentistry, T ohoku University, sendai,   Japan; 5state Key laboratory of  Tribology, Department of Mechanical  engineering, Tsinghua University,   Beijing, People’s republic of chinaAbstract:  The purpose of this study was to evaluate the biomechanical and histological behavior  of a ceria-stabilized zirconia–alumina nanocomposite (NanoZr) in comparison with that of 3  mol% yttria-stabilized tetragonal zirconia polycrystalline (3Y-TZP) in Sprague  Dawley rats.",Non-OADS,/arxiv_data1/oa_pdf/ce/21/ijn-11-6507.PMC5153287.pdf
"Various studies have verified  that 3Y-TZP induces no or a slight inflammatory reaction and protein adsorption,  osteoblast/osteoblast-like cell attachment, spreading, proliferation, differentia - tion, bone–implant contact (BIC) rates, and bone–implant bond strength (push-in correspondence: guang hong liaison center for Innovative Dentistry,  graduate school of Dentistry, Tohoku  University, 4-1 seiryo-machi, aoba-ku,  sendai, Miyagi 980-8575, Japan Tel/fax +81 22 717 8278 email hong@m.tohoku.ac.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Han et al Running head recto: Osseointegration capacity of zirconia implants DOI: http://dx.doi.org/10.2147/IJN.S119519",Non-OADS,/arxiv_data1/oa_pdf/ce/21/ijn-11-6507.PMC5153287.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ce/21/ijn-11-6507.PMC5153287.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/21/ijn-11-6507.PMC5153287.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/37/cia-11-1791.PMC5153288.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1791–1795Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1791OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12212 2 Are older people more vulnerable to long-term  impacts of disasters?",Non-OADS,/arxiv_data1/oa_pdf/3b/37/cia-11-1791.PMC5153288.pdf
"According to the maturation theory, older adults have more Correspondence: Yadollah Abolfathi  Momtaz Iranian research Center on Aging,  University of social Welfare and  rehabilitation sciences, Kodakyar Ave,   Daneshjo Blvd, evin 1985713834,  Tehran, Iran email yabolfathi@gmail.co m  sharifah Azizah haron Malaysian research Institute on Ageing  (MyAgeing) Universiti Putra Malaysia,  serdang, selangor 43400 UPM, Malaysia email sh.azizah@upm.edu.m y Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Rafiey et al Running head recto: Long-term impacts of disaster among the elderly DOI: http://dx.doi.org/10.2147/CIA.S122122",Non-OADS,/arxiv_data1/oa_pdf/3b/37/cia-11-1791.PMC5153288.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3b/37/cia-11-1791.PMC5153288.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3b/37/cia-11-1791.PMC5153288.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7397–7407OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7397Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11423 0 Identification of feature genes for smoking-related  lung adenocarcinoma based on gene expression  profile data Ying liu ran ni hui Zhang lijun Miao Jing Wang Wenqing Jia Yuanyuan Wang respiration Department, The First  Affiliated Hospital of Zhengzhou  University, Zhengzhou, Henan  Province, People’s Republic of ChinaAbstract:  This study aimed to identify the genes and pathways associated with smoking-related  lung adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"NEK2  and CENPF  have also been found to be differentially expressed  in smoking-related lung cancer.7 Additionally, polymorphisms of  CYPIA1  and OST1  have been suggested to be associated with susceptibility to lung cancer in relation to  cigarette smoking.8 A recent study by Vucic et al9 found that microRNAs disrupted in a  smoking status-dependent manner affected distinct cellular pathways and differentially correspondence: Jing Wang respiration Department, The First  Affiliated Hospital of Zhengzhou  University, no 1, Jianshe east road,  450052, Zhengzhou, Henan Province,  People’s Republic of China Tel +86 371 6629 5081 Fax +86 371 6629 5083 email wangjing@zzu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Feature genes for smoking-related lung cancer DOI: http://dx.doi.org/10.2147/OTT.S114230",Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"Data and methods Microarray data We searched the expression profile datasets from the Gene  Expression Omnibus ( http://www.ncbi.nlm.nih.gov/geo /)  database based on the keywords of lung cancer, homo sapiens,  and smoke.",OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"Data preprocessing and feature gene  identification In the original microarray data in CEL format, background  correction,11 and quartile data normalization12 using the Affy  package ( http://www.bioconductor.org/packages/release/ bioc/html/affy.htm l)13 in R were carried out.",OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
Then  the data in GSE10072 and GSE43458 were integrated and  the differentially expressed genes (DEGs) were selected  using the limma package ( http://www.bioconductor.org/ packages/release/bioc/html/lim ma.htm l).14 The P-value was  adjusted according to the Benjamini-Hochberg15 method.,OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"PPI network construction Human protein reference database (HPRD, http://www.hprd.",OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
The PPI network was  visualized using the Cytoscape ( http://www.cytoscape.,OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"( http://www.kegg.jp/ kegg-bi n/show_ pathway?hsa04014 +7936734 +7967034 +8Table 1  The top 10 nodes with high cc Gene CC Degree logFC P-value Adjusted  P-value ANK3 1 1 −0.74139 2.01E-06 1.65E-05 EPHA4 1 1 −0.6707 7.49E-04 2.70E-03 FGFR2 1 1 −0.75881 7.30E-06 5.02E-05 MID1 1 1 −0.59786 1.66E-04 7.39E-04 MID1IP1 1 1 −0.45603 5.77E-04 2.16E-03 MLPH 1 1 −0.6076 3.68E-04 1.47E-03 NGFRAP1 1 1 −0.47394 1.02E-05 6.70E-05 PLA2G1B 1 1 −0.64766 1.47E-02 3.43E-02 PTPN13 1 1 −0.65054 6.96E-03 1.82E-02 RAB27B 1 1 −0.79346 4.23E-03 1.19E-02 Abbreviations:  CC, closeness centrality; FC, fold change.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/98/ott-9-7397.PMC5153289.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 443–446Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 443 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S123244 Acarbose promotes remission of both early and  late dumping syndromes in post-bariatric patients Flavio A Cadegiani1 Osvalmir Sá Silva2 1Division of Endocrinology and  Metabolism, Department of Medicine,   Escola Paulista de Medicina,  Universidade Federal de São Paulo,  São Paulo, SP ,  2Corpometria Institute,   an Obesity and Endocrinology Center,  Brasilia, DF , BrazilObjective: Acarbose is a glucosidase inhibitor that slows carbohydrate digestion.",Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
"1–7 Current approaches for DS treatment comprise dietary recommendations3,4,6 such  as small and frequent meals, inclusion of fiber and protein in every meal, and  ingestion Correspondence: Flavio A Cadegiani Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, R. Pedro de Toledo 781, 04039-032 São Paulo, SP, BrazilTel +55 61 98139 5395Fax +55 61 3346 4733Email flaviounb@gmail.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Cadegiani and SilvaRunning head recto: Acarbose improves dumping syndromeDOI: http://dx.doi.org/10.2147/DMSO.S123244",Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 446 Cadegiani and Silva placebo-controlled double-blind clinical trials with monitor - ing of vital signs and glucose should be performed in order  to confirm our findings.,Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
Available from: http://   www.womenfitness.net/dumping_syndrome.htm https://sites.google.,Non-OADS,/arxiv_data1/oa_pdf/19/11/dmso-9-443.PMC5153290.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/03/opth-10-2443.PMC5153291.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2443–2453Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2443Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11400 6 Comorbidity and health care visit burden in   working-age commercially insured patients with   diabetic macular edema szilárd Kiss1 hitesh s Chandwani2 ashley l Cole2 Vaishali D Patel2 Orsolya e lunacsek3 Pravin U Dugel4 1Department of Ophthalmology, Weill  Cornell Medical College, new Y ork,   nY, 2global health economics and  Outcomes research, allergan, inc.,   irvine, C a, 3global health economics  and Outcomes research, Xcenda,   llC, Palm harbor, Fl, 4retinal  Consultants of arizona and UsC eye  institute, Phoenix, aZ, UsaPurpose:  To examine the comorbidity profile and update estimates of health care resource  utilization for commercially insured, working-age adults with diabetic macular edema (DME)  relative to a matched comparison group of diabetic adults without DME.",Non-OADS,/arxiv_data1/oa_pdf/1b/03/opth-10-2443.PMC5153291.pdf
"The complex comorbidity profile of diabetics translates into  higher medical service utilization, health care costs, and lost productivity compared to  nondiabetics.3 Although the overall economic impact of DM has been well documented  ($176 billion direct medical costs and $69 billion indirect costs, 2012 USD),2 there is a Correspondence:  szilárd Kiss Weill Cornell Medical College,  new York-Presbyterian hospital,  1305 York avenue, 11th Floor,  new York, nY 10021, Usa Tel +1 646 962 2217 Fax +1 646 962 0609 email szk7001@med.cornell.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kiss et al Running head recto: Comorbidity and visit burden in DME DOI: http://dx.doi.org/10.2147/OPTH.S114006",Non-OADS,/arxiv_data1/oa_pdf/1b/03/opth-10-2443.PMC5153291.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1b/03/opth-10-2443.PMC5153291.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/03/opth-10-2443.PMC5153291.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 301–311Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 301 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S120227A novel combination approach of human  polyclonal IVIG and antibiotics against  multidrug‑resistant Gram‑positive bacteria Mariam Madkour Sallam   Khaled Abou‑Aisha   Mohamed El‑Azizi Department of Microbiology,   Immunology, and Biotechnology,  Faculty of Pharmacy and Biotechnology, German University in Cairo, New Cairo City, Cairo, EgyptBackground: Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus  (MRSA) and enterococci, have shown a remarkable ability to develop resistance to antimicro- bial agents.",Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
"1–4 Infections caused by MDR Gram-positive bacteria, particularly  methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant  Enterococcus (VRE), are challenging to clinicians not only due to their resistance to conventional antibiotics but also due to the emergence of resistant strains to Correspondence: Mohamed El‑Azizi Department of Microbiology, Immunology, and Biotechnology, Faculty of Pharmacy and Biotechnology, German University in Cairo, New Cairo City, Main Entrance El‑Tagamoa El‑Khames, Postal Code 11835, Cairo, Egypt   Tel +20 2 2758 9990‑8 Fax +20 2 2758 1041   Email mohamed.el‑azizi@guc.edu.egJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Sallam et alRunning head recto: Enhancement of antibiotics efficacy by human polyclonal IVIGDOI: http://dx.doi.org/10.2147/IDR.S120227",Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection‑and‑drug‑resistance‑journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 311 Enhancement of antibiotics efficacy by human polyclonal IVIG 24.,Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
Available from: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html.,OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
Available from: http://www.eucast.org.,Non-OADS,/arxiv_data1/oa_pdf/93/61/idr-9-301.PMC5153292.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/42/dddt-10-3995.PMC5153293.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3995–4003Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3995Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12331 8 comparison of oral absorption models for  pregabalin: usefulness of transit compartment model Taegon hong1 seunghoon han2,3 Jongtae lee2,3 sangil Jeon4 Dong-seok Yim2,3 1Department of clinical  Pharmacology, severance hospital,   Y onsei University college of Medicine,   2Department of clinical Pharmacology  and Therapeutics, seoul st Mary’s  hospital, 3PiPeT (Pharmacometrics  institute for Practical education and  Training), college of Medicine, The  catholic University of Korea, 4c&r  research, seoul, republic of KoreaAbstract:  Pregabalin is an anticonvulsant used for the treatment of neuropathic pain and  partial seizure in adults.",Non-OADS,/arxiv_data1/oa_pdf/75/42/dddt-10-3995.PMC5153293.pdf
"However, in these studies, a common  trend to underestimate pregabalin concentrations around the time of maximum plasma  concentration (Tmax) was observed, which suggests the possibility of an inappropriate  choice of absorption model (first-order absorption).correspondence: Dong-seok Yim Department of clinical Pharmacology and  Therapeutics, seoul st Mary’s hospital,  222 Banpodaero, seochogu, seoul,  republic of Korea Tel +82 2 2258 7327 Fax +82 2 2258 7876 email yimds@catholic.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Hong et al Running head recto: Transit compartment absorption model for pregabalin DOI: http://dx.doi.org/10.2147/DDDT.S123318",Non-OADS,/arxiv_data1/oa_pdf/75/42/dddt-10-3995.PMC5153293.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/75/42/dddt-10-3995.PMC5153293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/42/dddt-10-3995.PMC5153293.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 241–242Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 241 LeTTer open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S125826 role of natural herbs and phytochemicals to  minimize tumor and economic burden in breast  cancer treatment  Maria Shoaib1 Syed Ahsanuddin Ahmed2 1Dow Medical College, Dow  University of Health Sciences, Karachi,   2Sindh Medical College, Jinnah Sindh  Medical University, Karachi, PakistanDear editor We read the article “Economic burden related to chemotherapy-related adverse  events in patients with metastatic breast cancer in an integrated health care system” by Rashid et al with great interest and would like to add some views in its support.",Non-OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
"4,5Correspondence: Maria Shoaib Dow Medical College, Dow University of Health Sciences, 176/Y Block 2 PeCHS Karachi, PakistanTel +92 333 328 9909email syedamariashoaib@gmail.comJournal name: Breast Cancer - Targets and Therapy Article Designation: LetterY ear: 2016V olume: 8Running head verso: Shoaib and AhmedRunning head recto: Natural herbs and phytochemicals to minimize tumorDOI: http://dx.doi.org/10.2147/BCTT.S125826",Non-OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 242 Shoaib and Ahmed Extracts and juices of medicinal plants like Withania  somnifera (rennet), Aphanamixis polystachya (Pithraj tree),   Dysoxylum binectariferum (rosewoods), V accinium macro- carpon  (cranberry), Glycyrrhiza glabra (liquorice), Uncaria  tomentosa (cat’ s claw), Panax ginseng (ginseng), Prunus armenaica (apricot), Echinacea (cone flower), Hedyotis diffusa (Oldenlandia), and Arctium lappa (greater burdock)  possess bioactive immunomodulators as their main con-stituents producing the anticancer effects via activation of lymphocytes (epigallocatechin-3-gallate, β-carotene, quinic acid, and ginsan) and anti-inflammatory agents (curcumin, glabridin, arctigenin, and ajoene).",Non-OADS,/arxiv_data1/oa_pdf/98/7f/bctt-8-241.PMC5153294.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1197–1204Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1197 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S122564Dysesthesia symptoms produced by sensorimotor  incongruence in healthy volunteers: an  electroencephalogram study Osamu Katayama1,2  Michihiro Osumi3  Takayuki Kodama4  Shu Morioka1,3 1Department of Neurorehabilitation,   Graduate School of Health Sciences,   Kio University, Nara, 2Department  of Rehabilitation, Watanabe Hospital, Aichi,  3Department of  Neurorehabilitation Research Center,  Kio University, Nara,  4Department  of Physical Therapy, Graduate School of Health Sciences, Kyoto Tachibana University, Kyoto, JapanObjectives:  Pathological pain such as phantom limb pain is caused by sensorimotor incongru- ence.",Non-OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
"7–17 Earlier studies were conducted with the use of active exercise-Correspondence: Osamu Katayama Department of Neurorehabilitation, Graduate School of Health Sciences, Kio University, 4-2-2 Umami-naka, Koryo-cho, Kitakatsuragi-gun, Nara 635-0832, Japan Tel +81 745 54 1601   Fax +81 745 54 1600   Email b6725634@kio.ac.jpJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Katayama et alRunning head recto: Symptoms of dysesthesia in healthy volunteersDOI: http://dx.doi.org/10.2147/JPR.S122564",Non-OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1204 Katayama et al  9.,Non-OADS,/arxiv_data1/oa_pdf/8e/b9/jpr-9-1197.PMC5153295.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3121–3136International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3121RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S12126 3 exercise training alone or with the addition of  activity counseling improves physical activity levels  in COPD: a systematic review and meta-analysis  of randomized controlled trials Aroub Lahham1,2 Christine F McDonald2–4 Anne e Holland1,2,5 1Discipline of Physiotherapy, La Trobe  University, 2Institute for Breathing and  Sleep, 3Department of Respiratory  and Sleep Medicine, Austin Health,   4Department of Medicine, The  University of Melbourne, 5Department  of Physiotherapy, Alfred Health,   Melbourne, vIC, AustraliaBackground:  Physical inactivity is associated with poor outcomes in COPD, and as a result,  interventions to improve physical activity (PA) are a current research focus.",Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
"Keywords:  pulmonary disease, chronic obstructive, physical activity, interventions Introduction Physical inactivity is a key predictor of increased hospitalization and all-cause mortality  in COPD.1,2 A systematic review comparing activity levels in COPD patients with age- matched controls showed a marked reduction in activity duration, intensity and daily  step counts, regardless of disease severity.3 Physical activity (PA) levels are strongly  correlated with functional exercise capacity.4 In addition, a large 5-year follow-up  study showed important associations between levels of PA and health-related quality  of life (HRQL) in COPD.5Correspondence: Aroub Lahham Discipline of Physiotherapy, La Trobe  University Clinical School, Alfred Health,  99 Commercial Road, Melbourne,  vIC 3004, Australia email a.lahham@latrobe.edu.a u Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Lahham et al Running head recto: Physical activity in COPD DOI: http://dx.doi.org/10.2147/COPD.S121263",Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
"Methods The systematic review protocol is registered in PROS - PERO (CRD42013004460, http://www.crd.york.ac.uk/ PROSPER O).",Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
Available from: http://goldcopd.org/global-strategy-diagnosis- management-prevention-copd-2016/.,Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/86/copd-11-3121.PMC5153296.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 385–387International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 385 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S117322An unfortunate case of acquired  hemochromatosis: a case report review of the  clinical presentation, diagnosis, management,  and prognosis Anam Tariq1 Kevin Westra2 Arben Santo3 1Department of Internal Medicine,   Pinnacle Health Internal Medicine,   2Department of Gastroenterology,   Harrisburg Gastroenterology,   Harrisburg, PA, 3Department of  Pathology, Virginia College of Osteopathic Medicine-Virginia T ech,  Blacksburg, VA, USABackground: While blood transfusions are commonly used for prophylaxis and treatment for  acute chest syndromes and strokes in sickle cell patients, accumulation of excess iron resulting  in secondary hemochromatosis remains a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
"3 In our case,  despite prophylactic chelation and phlebotomy, our asymptomatic patient  developed  significant hepatocellular iron deposition with fibrosis leading to mortality within a year.Correspondence: Anam Tariq Pinnacle Health Internal Medicine, 4300 Londonderry Rd, Harrisburg, PA 17109, USATel +1 410 810 4005Email atariq@pinnaclehealth.orgJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Tariq et alRunning head recto: An unfortunate case of acquired hemochromatosisDOI: http://dx.doi.org/10.2147/IMCRJ.S117322",Non-OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 387 An unfortunate case of acquired hemochromatosis with the severity of end-stage liver failure until proven by  liver biopsy and MRI, which still could not deter the sequelae and the mortality exactly 1 year after the diagnosis of second-ary hemochromatosis.",Non-OADS,/arxiv_data1/oa_pdf/25/40/imcrj-9-385.PMC5153297.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 339–346Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 339 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S109875 Relationship among temporary separation,  attachment styles, and adjustment in   first-grade Iranian children Siyamak Tahmasebi1 Saman Mafakheri Bashmaq2 Mansoureh Karimzadeh3 Robab T eymouri4 Mahdi Amini5 Maryam Sadat M vaghefi6 M Ali Mazaheri7 1Department of Preschool Education,   University of Social Welfare and  Rehabilitation Sciences, T ehran, Iran;   2Department of Psychology and  Exceptional Children’s Education,  Faculty of Psychology and Educational Sciences, Allameh Tabataba’i University, T ehran, Iran;  3Department  of Preschool Education, Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, T ehran,  Iran;  4Pediatric Neurorehabilitation  Research Center, University of Social Welfare and Rehabilitation Sciences,  T ehran, Iran;  5Addiction Department,   Center of Excellence in Psychiatry and Clinical Psychology, School of Behavioral Sciences and Mental Health,  Institute of T ehran Psychiatry, Iran University of Medical Sciences, T ehran,  Iran;  6Department of Speech Therapy,   University of Social Welfare and Rehabilitation Sciences, T ehran, Iran;   7Department of Clinical Psychology,   Shahid Beheshti University, T ehran, IranAbstract:  If mothers work outside the home, some degree of mother–child separation will be  experienced and mother–child attachment will be affected.",Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
"2,3 Object relations theorists believe in the mother–child  relationship and the key role of the mother in child development to the extent that some of them, such as Winnicott, believe that, at the beginning of life, the baby without a Correspondence: Mansoureh Karimzadeh Department of Preschool Education, Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Avenue, Daneshjoo Boulevard, PO Box: 1985713834, Tehran, IranTel +98 21 2218 0099Email mkarimz2000@gmail.comJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Tahmasebi et alRunning head recto: Separation, attachment styles, and adjustment in childrenDOI: http://dx.doi.org/10.2147/PRBM.S109875",Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
Available from: http://www.behzisti.ir.,Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
Available from: http://www.behzistitehran.org.ir/.,Non-OADS,/arxiv_data1/oa_pdf/a5/31/prbm-9-339.PMC5153311.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0e/b6/ott-9-7409.PMC5153312.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7409–7414OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11807 0 association between CHFR  gene hypermethylation  and gastric cancer risk: a meta-analysis hua shi Xiaojing Wang Jianbo Wang Jundi Pan Junwei liu Bin Ye Department of gastroenterology,   lishui central hospital, The Fifth  affiliated hospital of Wenzhou  Medical University, lishui hospital  of Zhejiang University, lishui,   People’s  republic of chinaBackground:  The association between the hypermethylation of CHFR  gene and gastric cancer  risk has been investigated by a number of studies.",Non-OADS,/arxiv_data1/oa_pdf/0e/b6/ott-9-7409.PMC5153312.pdf
"However, cancer cells lacking CHFR  entered metaphase  without delay.8 The CHFR  protein possesses an N-terminal forkhead-associated  (FHA) domain, a central RING finger (RF) domain, and a C-terminal cysteine-rich correspondence: Bin Ye Department of gastroenterology, lishui  Central Hospital, The Fifth Affiliated  hospital of Wenzhou Medical University,  lishui hospital of Zhejiang University,  289 Kuocang road, lishui, Zhejiang  323000, People’s republic of china Tel +86 57 8228 6237 Fax +86 57 8213 3457 email binye.lsh@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shi et al Running head recto: CHFR  methylation and gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S118070",Non-OADS,/arxiv_data1/oa_pdf/0e/b6/ott-9-7409.PMC5153312.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0e/b6/ott-9-7409.PMC5153312.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/b6/ott-9-7409.PMC5153312.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 169–180Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 169 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S99161 The National Acupuncture Detoxification  Association protocol, auricular acupuncture  to support patients with substance abuse and  behavioral health disorders: current perspectives Elizabeth B Stuyt1  Claudia A Voyles2 1Department of Psychiatry, University  of Colorado Health Sciences Center,   Pueblo, CO, 2Department of Clinical  Studies, AOMA Graduate School of Integrative Medicine, Austin, TX,  USAAbstract:  The National Acupuncture Detoxification Association (NADA)-standardized 3- to  5-point ear acupuncture protocol, born of a community-minded response to turbulent times not  unlike today, has evolved into the most widely implemented acupuncture-assisted protocol, not  only for substance abuse, but also for broad behavioral health applications.",Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
"2 They included four of the same studies reviewed by  Alberto, two of which both reviews found to demonstrate positive outcomes,3,4 and two  both agreed had negative outcomes.5,6 Alberto included two other studies considered Correspondence: Elizabeth B Stuyt Department of Psychiatry, University of Colorado Health Sciences Center, 1600 W. 24th Street, Pueblo, CO 81003, USATel +1 719 546 4494 Fax +1 719 546 4792 Email elizabeth.stuyt@state.co.usJournal name: Substance Abuse and Rehabilitation Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Stuyt and V oylesRunning head recto: NADA auricular acupuncture in behavioral health treatmentDOI: http://dx.doi.org/10.2147/SAR.S99161 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
Or use: http://youtu.be/F4dfcN6GU_w,Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
Available from: http://wwwdasis.samhsa.gov/dasis2/nssats/2012_nssats_rpt.pdf.,OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 180 Stuyt and Voyles  41.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/sar-7-169.PMC5153313.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 285–295Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 285 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S117943 Physician distribution and attrition in the public  health sector of Ethiopia Tsion Assefa1 Damen Haile Mariam1 Wubegzier Mekonnen1 Miliard Derbew2 Wendimagegn Enbiale3 1School of Public Health, 2School of  Medicine, Addis Ababa University,   Addis Ababa, 3College of Medicine and  Health Science, Bahir Dar University,  Bahir Dar, EthiopiaBackground: Shortages and imbalances in physician workforce distribution between urban  and rural and among the different regions in Ethiopia are enormous.",Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
"Keywords: health workforce, physician retention, physician turnover/migration/attrition  Correspondence: Tsion Assefa School of Public Health, Addis Ababa University, PO Box 9086, Addis Ababa, EthiopiaEmail tsionassefa21@yahoo.com Journal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Assefa et alRunning head recto: Physician distribution and attrition in the public health sector of EthiopiaDOI: http://dx.doi.org/10.2147/RMHP .S117943",Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.hrhresourcecenter.org/node/2182.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/13824/82557.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.hrh-obser - vatory.afro.who.int/images/Document_Centre/Country_profile_Ethio-pia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available  from: http://www.who.int/workforcealliance/knowledge/resources/report3rd_GF_HRH.pdf.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.who.int/hrh/migration/code/WHO_global_code_of_prac-tice_EN.pdf.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://apps.who.int/iris/bitstream/10665/170250/1/9789240694439_eng.pdf.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.moe.gov.et/-/education-statistics-annual-abstract-2005-e-1?inheritRedirect=true.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.who.int/workforcealliance/knowl - edge/resources/kampala_declaration/en/.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 295 Physician distribution and attrition in the public health sector of Ethiopia 25.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.moh.gov.et/documents/26765/0/Health+and+Health+Related+Indicators+2005+E.C/1b5b2a9f-a960-4024-8d92-519195364023?version=1.0.,OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.ccghr.ca/wp-content/uploads/2013/11/national-research-ethics-review-guidline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: https://www.health-infonet.ecu.edu.au/key-resources/bibliography/?lid=28766.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.iza.org/MigrationHandbook/04_Grignon_Owusu_Sweetman_The%20Intern_Migration_of_Health_Profession-als.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: http://www.hrhresourcecenter.org/node/61.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
Available from: https://www.oecd.org/migration/mig/44783473.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/86/rmhp-9-285.PMC5153314.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/48/ppa-10-2437.PMC5153315.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2437–2447Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2437OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11726 9 relationship between patients’ knowledge and   medication adherence among patients  with hypertension Beata Jankowska-Polańska1 izabella Uchmanowicz1 Krzysztof Dudek2 grzegorz Mazur3 1Department of clinical nursing,   Wroclaw Medical University,   2Department of Transport systems,   Faculty of Mechanical engineering,   Wroclaw University of T echnology,   3Department and clinic of internal  and Occupational Diseases and  hypertension, Wroclaw Medical  University, Wroclaw, PolandObjective:  The purpose of this study was to investigate the relationship between knowledge on  arterial hypertension (AH) and its management, and adherence to pharmaceutical treatment.",Non-OADS,/arxiv_data1/oa_pdf/d1/48/ppa-10-2437.PMC5153315.pdf
"Published  studies indicate that ~60% of patients treated for hypertension discontinue treatment  within 6 months.2 Apart from adverse effects and inadequate blood pressure (BP)  control despite treatment, the most common causes of lack of adherence are believed correspondence: Beata Jankowska- Polańska Department of logistic and Transport  systems, Faculty of Mechanical  engineering, Wroclaw University of  Technology, 27 Wyspianski street,  50-370 Wroclaw, Poland Tel +48 71 784 1824 Fax +48 71 345 9324 email bianko@poczta.onet.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jankowska-Pola ńska et al Running head recto: Relationship between patients’ knowledge and medication adherence DOI: http://dx.doi.org/10.2147/PPA.S117269",Non-OADS,/arxiv_data1/oa_pdf/d1/48/ppa-10-2437.PMC5153315.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d1/48/ppa-10-2437.PMC5153315.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/26/ott-9-7415.PMC5153316.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7415–7424OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7415Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11708 9 Prediction of biological behavior and prognosis of  colorectal cancer patients by tumor Msi/MMr in  the chinese population Wen-Yue Yan1,* Jing hu1,2,* li Xie2 lei cheng2 Mi Yang2 li li2 Jiong shi3 Bao-rui liu2 Xiao-Ping Qian1,2 1The comprehensive cancer center,   nanjing Drum Tower hospital clinical  college of Traditional chinese  and Western Medicine, nanjing  University of chinese Medicine,   2The comprehensive cancer center  of Drum Tower hospital, Medical  school of nanjing University and  clinical cancer institute of nanjing  University, 3Department of Pathology,   Drum T ower hospital, Medical  school of n anjing University, Jiangsu,   People’s republic of china *These authors contributed equally  to this workAbstract:  Colorectal cancers (CRCs) exhibiting microsatellite instability (MSI) have special  biological behavior.",Non-OADS,/arxiv_data1/oa_pdf/13/26/ott-9-7415.PMC5153316.pdf
"And “others” (with mixed  features, 13%) represent a transition phenotype or intratumoral heterogeneity.3 Precise correspondence: Xiao-Ping Qian The comprehensive cancer center,  nanjing Drum Tower hospital clinical  college of Traditional chinese and  Western Medicine, nanjing University  of chinese Medicine, 321 Zhongshan  road, nanjing, Jiangsu 210000,  People’s republic of china email xiaopingqian@nju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y an et al Running head recto: MSI/MMR in the Chinese population DOI: http://dx.doi.org/10.2147/OTT.S117089",Non-OADS,/arxiv_data1/oa_pdf/13/26/ott-9-7415.PMC5153316.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/13/26/ott-9-7415.PMC5153316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/26/ott-9-7415.PMC5153316.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/7b/ott-9-7425.PMC5153317.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7425–7433OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7425Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12159 4 Prognostic value of p53 mutation for poor  outcome of asian primary liver cancer patients:  evidence from a cohort study and meta-analysis  of 988 patients Xiajie Wen1 Fengmin lu1,2 shuang liu3 1Department of epidemiology and  Biostatistics, college of Public health,   Zhengzhou University, Zhengzhou,   2Microbiology and infectious Disease  center, school of Basic Medical  sciences, Peking University health  science center, 3Beijing artificial  liver Treatment and Training center,   Beijing Y ouan hospital, capital Medical  University, Beijing, chinaAbstract:  Several previous studies have investigated the association between gene p53 (p53)  mutation and the poor outcome of primary liver cancer (PLC) patients; however, the results  remain inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/45/7b/ott-9-7425.PMC5153317.pdf
"However, the  prognostic significance of each single variable has been found to be unsatisfactory so  far; some findings even remain controversial.4–8 The gene of p53 residing on chromosome 17p13.1 is a well-known tumor suppres - sor gene that controls response to several different cellular stresses, including DNA  damage, hypoxia, and oncogene activation.9,10 The mutations of p53 had been found in correspondence: shuang liu Beijing Artificial Liver Treatment and  Training center, Beijing Youan hospital,  capital Medical University, 8 Xitoutiao,  Outer You’anmen, Fengtai District,  Beijing 100050, china Tel +86 10 6329 1007 Fax +86 10 6329 5285 email shuangliu186@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wen et al Running head recto: Association of p53 mutation with postsurgery OS in Asian PLC patients DOI: http://dx.doi.org/10.2147/OTT.S121594",Non-OADS,/arxiv_data1/oa_pdf/45/7b/ott-9-7425.PMC5153317.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/45/7b/ott-9-7425.PMC5153317.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/7b/ott-9-7425.PMC5153317.pdf
"http://e-jbm.org/   183Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Association of Serum Osteocalcin with Insulin  Resistance and Coronary Atherosclerosis Jee-Hyun Kang Department of Family Medicine, Konyang University Hospital, Daejeon, Korea Background:  To determine the associations between serum osteocalcin level and in - sulin resistance, coronary atherosclerosis by using dual-source coronary computed to - mography angiography.",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"[3] In addition, in a cross-sectional and a pro -Corresponding author Jee-Hyun Kang Department of Family Medicine, Konyang  University Hospital, 158 Gwanjeodong-ro,   Seo-gu, Daejon 35365, Korea Tel: +82-42-600-9240 Fax: +82-42-600-9095 E-mail: jeehyunkang@yahoo.co.kr Received:  July 28, 2016 Revised:  October 2, 2016 Accepted:  October 6, 2016 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2016;23:183-190 https://doi.org/10.11005/jbm.2016.23.4.183 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"Jee-Hyun Kang 184  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.183spective study involving human subjects, serum osteocal - cin concentration was observed to be inversely correlated  to fasting blood glucose, insulin resistance, and body fat  mass.",OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"Osteocalcin, IR, Coronary Atheroscloerosis https://doi.org/10.11005/jbm.2016.23.4.183  http://e-jbm.org/   185phy (Somatom Definition®; Siemens Healthcare, Forchheim,  Germany), coronary angiography was performed.",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
Jee-Hyun Kang 186  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.183Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"Osteocalcin, IR, Coronary Atheroscloerosis https://doi.org/10.11005/jbm.2016.23.4.183  http://e-jbm.org/   1870.027), ALP , and blood phosphorus concentration (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"Jee-Hyun Kang 188  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.183erosclerotic plaques, but osteocalcin was not significant  dependent variable in this model after controlling for oth - er variables (Table 5).",OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"Osteocalcin, IR, Coronary Atheroscloerosis https://doi.org/10.11005/jbm.2016.23.4.183  http://e-jbm.org/   189cification score as surrogate marker of atherosclerosis used  in above mentioned similar study.",Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
Jee-Hyun Kang 190  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.183Chinese postmenopausal women.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/jbm-23-183.PMC5153374.pdf
"http://e-jbm.org/   191Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Coronary Calcification Is Reversely Related with  Bone and Hair Calcium: The Relationship among  Different Calcium Pools in Body Sang-Hoon Lee1, Soo-Jung Park1, Kyu-Nam Kim1, Doo-Yeoun Cho2, Young-Sang Kim3, Bom-Taeck Kim1 1Department of Family Practice and Community Health, Ajou University School of Medicine, Suwon;     2Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University, Seongnam;   3Department of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea Background:  With aging, calcium efflux from bone is increased with age-related bone  loss, and it can reduce bone mineral density (BMD).",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"The authors thank Song-Eun Young, a dietitian in  Ajou University Hospital Health Promotion Center,  for helping analysis of dietary nutrition, and Tae- Hee Kim, an assistant in Ajou University Hospital  Medical Information System Team, for collecting  laboratory data of the study.Original ArticleJ Bone Metab 2016;23:191-197 https://doi.org/10.11005/jbm.2016.23.4.191 pISSN 2287-6375    eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
192  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.191distributed to intracellular pool and excreted through renal  clearance.,Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"Associations of Coronary, Bone and Hair Calcium https://doi.org/10.11005/jbm.2016.23.4.191  http://e-jbm.org/   193the focus.",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
194  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.191Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"Associations of Coronary, Bone and Hair Calcium https://doi.org/10.11005/jbm.2016.23.4.191  http://e-jbm.org/   195Early study that investigated relationship between CACS  and BMD reported negative result.",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"196  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.191cium pools such as bone, hair and blood vessel significant - ly correlated each other.",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"Associations of Coronary, Bone and Hair Calcium https://doi.org/10.11005/jbm.2016.23.4.191  http://e-jbm.org/   197atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/6f/c0/jbm-23-191.PMC5153375.pdf
"http://e-jbm.org/   199Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Health-related Quality of Life in Accordance with  Fracture History and Comorbidities in Korean  Patients with Osteoporosis Hye-Young Kwon1, Yong-Chan Ha2, Jun-Il Yoo3 1Division of Biology and Public Health, Mokwon University, Daejeon;   2Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul;   3 Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Background:  The purpose of this study was to explore health-related quality of life (HRQOL)  among Korean patients with osteoporosis and to measure the impact of fractures and  comorbidity on their quality of life (QOL) using the Korean National Health and Nutrition  Examination Survey (KNHANES) data with a nationwide representativeness.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
"This research was supported by a grant of the  Korea Health Technology R&D Project through the  Korea Health Industry Development Institute  (KHIDI), funded by the Ministry of Health & Welfare,  Republic of Korea (grant number: HC15C1189).Original ArticleJ Bone Metab 2016;23:199-206 https://doi.org/10.11005/jbm.2016.23.4.199 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
"200  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.199trend, residual disability after a fracture is still remains a  major concern.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
"EQ-5D Scores with Osteoporotic Fractures https://doi.org/10.11005/jbm.2016.23.4.199  http://e-jbm.org/   201egories; no problem, moderate problem, or extreme prob - lem.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
"202  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.199and comorbidities including OA, HTN, DM, COPD, and CV  events.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
EQ-5D Scores with Osteoporotic Fractures https://doi.org/10.11005/jbm.2016.23.4.199  http://e-jbm.org/   203Table 3.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
204  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.199±0.01; P=0.0016).,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
EQ-5D Scores with Osteoporotic Fractures https://doi.org/10.11005/jbm.2016.23.4.199  http://e-jbm.org/   2054.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
Available from: http://www.sam - hsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NS - DUH-FRR1-2014.pdf 21.,OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
206  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.19910:711-21.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/jbm-23-199.PMC5153376.pdf
"http://e-jbm.org/   207Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Attenuation of RANKL-induced Osteoclast  Formation via p38-mediated NFATc1 Signaling  Pathways by Extract of Euphorbia Lathyris  L Ju-Hee Kang*, Hyojung Lim*, Ji-Eun Jeong*, Mijung Yim College of Pharmacy, Sookmyung Women’s University, Seoul, Korea Background:  Osteoclasts are the only cell type capable of breaking down bone matrix,  and its excessive activation is responsible for the development of bone-destructive dis - eases.",Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
"* Ju-Hee Kang, Hyojung Lim, and Ji-Eun Jeong  contributed equally to this work and should be  considered co-first authors.Original ArticleJ Bone Metab 2016;23:207-214 https://doi.org/10.11005/jbm.2016.23.4.207 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
"208  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.207Osteoclasts, derived from hematopoietic precursors of  the monocyte/macrophage lineage, are bone-specialized  multinucleated cells.",Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
ELL Inhibits Osteoclastogenesis via NFATc1 https://doi.org/10.11005/jbm.2016.23.4.207  http://e-jbm.org/   2094.,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
210  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.207osteoclast differentiation using mouse BMMs.,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
ELL Inhibits Osteoclastogenesis via NFATc1 https://doi.org/10.11005/jbm.2016.23.4.207  http://e-jbm.org/   211els of those genes were dramatically increased in BMMs  challenged by RANKL and M-CSF for four days.,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
212  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.207the molecular mechanism of the inhibitory effect of ELL us - ing BMMs.,OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
"ELL Inhibits Osteoclastogenesis via NFATc1 https://doi.org/10.11005/jbm.2016.23.4.207  http://e-jbm.org/   213RANKL stimulation led to the degradation of IκB within 15  min, although ELL failed to interfere with this process (Fig.",Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
214  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.207teoclast differentiation and function by the new members  of the tumor necrosis factor receptor and ligand families.,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jbm-23-207.PMC5153377.pdf
"http://e-jbm.org/   215Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Bone Mineral Density and Fatty Degeneration of  Thigh Muscles Measured by Computed Tomography  in Hip Fracture Patients  Myung Hoon Hahn1, Ye-Yeon Won2 1Department of Orthopaedics, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Cheonan;  2Department of Orthopaedics, Ajou University School of Medicine, Suwon, Korea Background:  Recently, as an independent fracture factor from Bone mineral density  (BMD), muscle weakness due to the fatty degeneration of thigh muscles have been at - tracting attentions as causes of hip fracture.",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"[3,4] In the process of aging of these muscles, the degree of Corresponding author Ye-Yeon Won Department of Orthopaedics, Ajou University  school of Medicine, 164 World Cup-ro,  Yeongtong-gu, Suwon 16499, Korea  Tel: +82-31-219-5220 Fax: +82-31-219-4537 Email: thrtkr@ajou.ac.kr Received:  October 7, 2016 Revised:  November 22, 2016 Accepted:  November 23, 2016 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2016;23:215-221 https://doi.org/10.11005/jbm.2016.23.4.215 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"216  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.215intramuscular fatty degeneration increased, which is also  associated with a decrease in mobility function.",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"Bone Density and Fatty Degeneration of Thigh Muscles https://doi.org/10.11005/jbm.2016.23.4.215  http://e-jbm.org/   217Chicago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"218  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.215with BMD, weight, and BMI.",OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
Bone Density and Fatty Degeneration of Thigh Muscles https://doi.org/10.11005/jbm.2016.23.4.215  http://e-jbm.org/   219the intertrochanteric fracture group and BMD was higher  in femoral neck fracture group.,Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
220  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.215showed statistically significant decrease with age.,Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"Bone Density and Fatty Degeneration of Thigh Muscles https://doi.org/10.11005/jbm.2016.23.4.215  http://e-jbm.org/   221pose tissue, sarcopenia, and mobility function in older in - dividuals.",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/jbm-23-215.PMC5153378.pdf
"http://e-jbm.org/   223Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Relationship between Heavy Metal Exposure and  Bone Mineral Density in Korean Adult Hee-Sook Lim1,2, Hae-Hyeog Lee3, Tae-Hee Kim3, Bo-Ra Lee4 1Department of Clinical Nutrition, Soonchunhyang University Bucheon Hospital, Bucheon;   2Department of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan;   3Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon;   4Department of Biostatistics, Clinical Trial Center, Soonchunhyang Unversity Bucheon Hospital, Bucheon, Korea Background:  Exposure to heavy metals from environmental and industrial sources re - mains a concern of serious public health risk.",Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
"This research was supported by High Value-added  Food Technology development program, Ministry of  agriculture, Food and Rural Affairs, Republic of  Korea (114025-03-1-HD030).Original ArticleJ Bone Metab 2016;23:223-231 https://doi.org/10.11005/jbm.2016.23.4.223 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
224  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.223as cancer and fetal growth restriction.,Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
Relationship between Heavy Metal Exposure and BMD https://doi.org/10.11005/jbm.2016.23.4.223  http://e-jbm.org/   225ed by combining weights of 4-year survey data.,OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
226  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.223Table 2.,Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
Relationship between Heavy Metal Exposure and BMD https://doi.org/10.11005/jbm.2016.23.4.223  http://e-jbm.org/   227RESULTS 1.,OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
228  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.2233.,Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
"Relationship between Heavy Metal Exposure and BMD https://doi.org/10.11005/jbm.2016.23.4.223  http://e-jbm.org/   229centration levels, the concentrations of lead, mercury, and  cadmium were within the normal range by the WHO.",OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
230  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.22312.,Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
Available from: http://www.ksbmr.org/  image/journal/ 골다공증 %20지침서 2015_final_1002.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/92/1c/jbm-23-223.PMC5153379.pdf
"http://e-jbm.org/   233Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Replication of Caucasian Loci Associated with  Osteoporosis-related Traits in East Asians Beom-Jun Kim1,*, Seong Hee Ahn2,*, Hyeon-Mok Kim1, Shiro Ikegawa3, Tie-Lin Yang4, Yan Guo4,   Hong-Wen Deng5,6, Jung-Min Koh1, Seung Hun Lee1 1Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul;   2Department of Endocrinology, Inha University School of Medicine, Incheon, Korea   3Laboratory for Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo, Japan   4Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Molecular Genetics, School of Life Science and    Technology, Xi’an Jiaotong University, Xi’an;   5College of Life Sciences and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, People’s Republic of China   6Department of Biostatistics and Bioinformatics, Center for Bioinformatics and Genomics, School of Public Health and Tropical Medicine,    Tulane University, New Orleans, LA, USA Background:  Most reported genome-wide association studies (GWAS) seeking to iden - tify the loci of osteoporosis-related traits have involved Caucasian populations.",Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
This work  was supported under the framework of an international  cooperation program managed by the National Research  Foundation of Korea (Grant NRF-2015K2A2A2002107).Original ArticleJ Bone Metab 2016;23:233-242 https://doi.org/10.11005/jbm.2016.23.4.233 pISSN 2287-6375    eISSN 2287-7029,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
234  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.233osteoporosis because bone mass accounts for approximate - ly 70% of bone strength.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
Replication of Caucasian BMD-loci in Asians https://doi.org/10.11005/jbm.2016.23.4.233  http://e-jbm.org/   2351.10% for the FN.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
They were recruited from the BioBank Japan proj - ect (http://biobankjp.org/).,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
"236  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.233typed or imputed SNPs from 17 studies involving popula - tions across North America, Europe, East Asia, and Austra - lia.",Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
Replication of Caucasian BMD-loci in Asians https://doi.org/10.11005/jbm.2016.23.4.233  http://e-jbm.org/   237Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
238  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.233Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
Replication of Caucasian BMD-loci in Asians https://doi.org/10.11005/jbm.2016.23.4.233  http://e-jbm.org/   2390.048) (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
240  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.233biological pathways influencing osteoporo - sis and fracture susceptibility.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
"Replication of Caucasian BMD-loci in Asians https://doi.org/10.11005/jbm.2016.23.4.233  http://e-jbm.org/   241[3,20] Another possible explanation for the differences in  results between this study and the previous study (GEFOS-2)  could be the heterogeneity of the study design including  differences in the phenotype (osteoporosis, BMD, BMD site,  fracture, and fracture type), in the adjusted covariates (age,  wei ght, and height), and in the genetic model differences  (additive, dominant, and recessive models).",Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
242  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.233osteoporosis-related traits in both Caucasian and East Asian  populations.,Non-OADS,/arxiv_data1/oa_pdf/c9/f5/jbm-23-233.PMC5153380.pdf
"http://e-jbm.org/   243Copyright © 2016 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Prevalence of Sarcopenia Adjusted Body Mass Index  in the Korean Woman Based on the Korean National  Health and Nutritional Examination Surveys Hyoung-Moo Park1, Yong-Chan Ha2, Jun-Il Yoo3, Hyun-Jun Ryu2 1Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, Seoul;   2Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul;   3 Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Background:  The purpose of this study was to determine cut-off point of appendicular  skeletal muscle mass (ASM) adjusted body mass index (BMI) for sarcopenia in the Korean  women and evaluate the prevalence of sarcopenia in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
"This research was supported by a grant of the  Korea Health Technology R&D Project through the  Korea Health Industry Development Institute  (KHIDI), funded by the Ministry of Health & Welfare,  Republic of Korea (grant number, HC15C1189).Original ArticleJ Bone Metab 2016;23:243-247 https://doi.org/10.11005/jbm.2016.23.4.243 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
244  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.243ed based on a single criteria without confusion.,OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
"Sarcopenia Adjusted BMI in the Women https://doi.org/10.11005/jbm.2016.23.4.243  http://e-jbm.org/   24511,621 women aged 10 to 97 years.",Non-OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
246  http://e-jbm.org/  https://doi.org/10.11005/jbm.2016.23.4.243women older than 50 years was 15.6%.,OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
Sarcopenia Adjusted BMI in the Women https://doi.org/10.11005/jbm.2016.23.4.243  http://e-jbm.org/   247the overall prevalence was 15.6% in women 50 years.,Non-OADS,/arxiv_data1/oa_pdf/f2/ac/jbm-23-243.PMC5153381.pdf
"The reported IC 50for KDM1A/LSD1 ranges in clini- cally relevant concentrations from 0.6 to 1.2 μM (Data pre- sented at Sixth Annual EpiCongress, Boston, USA, July 2015, data available online at https://4SC.de ).",OADS,/arxiv_data1/oa_pdf/b3/81/11523_2016_Article_444.PMC5153417.pdf
"Keystone Symposium BStem Cells and Cancer ^2014, data available online at https://4SC.de).",OADS,/arxiv_data1/oa_pdf/b3/81/11523_2016_Article_444.PMC5153417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/7f/main.PMC5153419.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.11.004 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/9e/7f/main.PMC5153419.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/66/main.PMC5153420.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.11.003 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/2a/66/main.PMC5153420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/f8/main.PMC5153421.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.11.002 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/87/f8/main.PMC5153421.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.10.014 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/76/ae/main.PMC5153422.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/b9/main.PMC5153424.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.10.005 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a9/b9/main.PMC5153424.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ Indian Pacing and Electrophysiology Journal 16 (2016) 149 e151 http://dx.doi.org/10.1016/j.ipej.2016.11.012 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b4/27/main.PMC5153427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/4e/main.PMC5153428.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.07.005 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/5a/4e/main.PMC5153428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/bf/main.PMC5153429.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.10.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/b7/bf/main.PMC5153429.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/1a/main.PMC5153430.pdf
"This aspect  has  been  analyzed  in  several  studies,  as  the  hemorrhoidec- tomy  is  a  procedure  in  which  the  severe  pain  (opioid  requirements in  analgesic  management)  occurs  in  20–40%  of  patients  [4–6] ,  even http://dx.doi.org/10.1016/j.ijscr.2016.11.018 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/09/1a/main.PMC5153430.pdf
"L’Acta  Chirurgica Cataloniae  Num  1,  Revista  electrónica  Societat  Catalana  de  Cirurgia,  2016, Available on: http://www.sccirurgia.org/Actachirurgica/Resources/num1art1.",Non-OADS,/arxiv_data1/oa_pdf/09/1a/main.PMC5153430.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/5f/main.PMC5153431.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.09.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/47/5f/main.PMC5153431.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/42/main.PMC5153432.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.07.004 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/86/42/main.PMC5153432.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/67/main.PMC5153433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/67/main.PMC5153433.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.008Urology Case Reports 10 (2017) 57 e59,Non-OADS,/arxiv_data1/oa_pdf/c9/67/main.PMC5153433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/5f/main.PMC5153434.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.07.003 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/4f/5f/main.PMC5153434.pdf
Available from: http://dx.doi.org/10.1007/s11764-016-0545-4 .,Non-OADS,/arxiv_data1/oa_pdf/4f/5f/main.PMC5153434.pdf
Available from: http://www.bpac.org.nz/BT/ 2012/October/prostate.aspx .,Non-OADS,/arxiv_data1/oa_pdf/4f/5f/main.PMC5153434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/bc/main.PMC5153435.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/bc/main.PMC5153435.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.002Urology Case Reports 10 (2017) 60 e62,Non-OADS,/arxiv_data1/oa_pdf/fc/bc/main.PMC5153435.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ Indian Pacing and Electrophysiology Journal 16 (2016) 157 e158 http://dx.doi.org/10.1016/j.ipej.2016.11.011 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/aa/a6/main.PMC5153436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.09.002 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
Available from: http://www.aihw.,Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
Available from: http://seer.cancer.gov/csr/1975_2005/ .,Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
Available from: https://www.nhmrc.gov.au/_ ﬁles_nhmrc/publications/attachments/ men4d_psa_testing_asymptomatic_men_140304.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
Available from: http://wiki.cancer.org.au/australia/ Guidelines:PSA_Testing .,Non-OADS,/arxiv_data1/oa_pdf/5b/52/main.PMC5153437.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/main.PMC5153438.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.com http://dx.doi.org/10.1016/j.prnil.2016.07.002 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/main.PMC5153438.pdf
Available from: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/4c/main.PMC5153438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/a8/main.PMC5153439.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.11.009 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/e7/a8/main.PMC5153439.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ChildrenOutdoorPhysical activityPrescriptionsYouth 1.,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.12.005 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1038/ijo.2008.,OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1021/es102947t .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1542/peds.2015-1558 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1542/peds.2006-2697 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1016/S1040-2608(01)80011-3 .,OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
:1 –8.http://dx.doi.org/10.1136/bjsports-2013- 093080 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1136/jech.,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1136/jech.2008.079038 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1016/j.cppeds.2010.02.003 .,OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
1 (1):48 –53.http://dx.doi.org/10.1177/ 1559827606292796 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
33 (1):33 –54.http://dx.doi.org/10.1177/ 00139160121972864 .,Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
"(Retrieved June 15, 2016, from http://www.parkrx.org/ ).The National Physical Activity Plan Alliance.",Non-OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
"Re- trieved June 15, 2016, from http://www.physicalactivityplan.org/index.html U.S. Census Bureau, 2014.",OADS,/arxiv_data1/oa_pdf/91/70/main.PMC5153440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/3a/main.PMC5153441.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.12.001 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5c/3a/main.PMC5153441.pdf
(2016 Feb 29) http://dx.doi.org/10.1177/1457496915626838 pii: 1457496915626838.,Non-OADS,/arxiv_data1/oa_pdf/5c/3a/main.PMC5153441.pdf
GSH is synthesized by γ-glutamate cysteine ligase and GSH http://dx.doi.org/10.1016/j.redox.2016.12.006 Received 28 November 2016; Accepted 2 December 2016⁎Corresponding author.Redox Biology 11 (2017) 170–175 Available online 07 December 2016 2213-2317/ © 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/32/00/main.PMC5153445.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/00/main.PMC5153445.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
This  examination  revealed  numerous http://dx.doi.org/10.1016/j.ijscr.2016.11.033 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"17 (2011) 697–707, http://dx.doi.org/10.3748/wjg.v17.i6.697 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"45  (2014)  899–916, http://dx.doi.org/10.1016/j.humpath.2013.12.001 .",OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"Ferry, Burkitt’s lymphoma: clinicopathologic features and  differential diagnosis, Oncologist  11  (2006)  375–383,  http://dx.doi.org/10.1634/ theoncologist.11-4-375 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"6 (1981) 325–328, http://dx.doi.org/10.1007/BF01890278 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"35  (2012)  1000–1009, http://dx.doi.org/10.1111/j.1365-2036.2012.05062.x .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"163  (1994)  1118–1119, http://dx.doi.org/10.2214/ajr.163.5.7976886.C .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"198 (1983)  673–680 (accessed  October  30,  2016) http://www.ncbi.nlm.nih.gov/pubmed/6605728 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"44  (2007)  131–139,  http://dx.doi.org/10.1258/ 000456307780117993 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"205  (2009)  876–880,  http://dx.doi.org/10.1016/j.prp.2009.",OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
52  (2007)  296–300 http://www.ncbi.nlm.nih.gov/pubmed/18217437 .,Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"4  (2011) 119–121,  http://dx.doi.org/10.3329/bsmmuj.v4i2.8643 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"43  (2006)  30–34,  http://dx.doi.org/10.1097/01.mpg.0000226381.48989.f8 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"[16] D.  De  Jong,  Novel  lymphoid  neoplasms  −  the  borderland  between  diffuse large B-cell lymphoma and Burkitt’s  lymphoma,  Haematologica  94  (2009) 894–896, http://dx.doi.org/10.3324/haematol.2009.008128 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"Blum,  G.  Lozanski,  J.C.  Byrd,  Adult  Burkitt  leukemia  and  lymphoma,  Blood 104  (2004)  3009–3020,  http://dx.doi.org/10.1182/blood-2004-02-0405 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
"15 (1992) 128–135 (accessed  October  30,  2016)  http://www.ncbi.nlm.nih.gov/ pubmed/1401824 .",Non-OADS,/arxiv_data1/oa_pdf/82/e1/main.PMC5153446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/81/main.PMC5153447.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.11.015 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/81/main.PMC5153447.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 51 e54,Non-OADS,/arxiv_data1/oa_pdf/16/81/main.PMC5153447.pdf
"Care 18 (2014) e309, http://dx.doi.org/10.1186/cc13912 .",Non-OADS,/arxiv_data1/oa_pdf/16/81/main.PMC5153447.pdf
"(2014) 836246, http://dx.doi.org/10.1155/2014/836246 .",Non-OADS,/arxiv_data1/oa_pdf/16/81/main.PMC5153447.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inﬂuenza VaccineNPIsEfﬁcacy EffectivenessEpidemiologyObservational studySchoolchildren 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.12.002 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://www.cdc.gov/ vaccines/acip/ (accessed 5.18.16).,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://www.cdc.gov/ nonpharmaceutical-interventions/ (accessed 5.18.16).,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
"http://www.nih.go.jp/niid/images/idsc/disease/in ﬂu/ﬂudoco1415.pdf (accessed 5.18.16).Satomura, K., Kitamura, T., Kawamura, T., et al., 2005.",OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://www.who.int/csr/ resources/publications/in ﬂuenza/WHO_CDS_CSR_GIP_2005_5.pdf (accessed 5.18.16).,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
http://www.who.int/in ﬂuenza/en/ (accessed 5.18.16).91 M. Uchida et al.,OADS,/arxiv_data1/oa_pdf/aa/0d/main.PMC5153448.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/d2/main.PMC5153449.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.11.014 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/d2/main.PMC5153449.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 48 e50,Non-OADS,/arxiv_data1/oa_pdf/a8/d2/main.PMC5153449.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ecosystem servicesDomestic gardensGreen exerciseGreen infrastructureHorticultureNature experiencesPreventive healthcare Public health Urban greenspaceWellbeing Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/20/29/main.PMC5153451.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.007 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/20/29/main.PMC5153451.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/29/main.PMC5153451.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/20/29/main.PMC5153451.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.012 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ADHDCannabisMarijuanafMRIFunctional connectivityNeurocognitive 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
R-fMRI data preprocessing Data processing was performed using AFNI ( http://afni.nimh.nih.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
"gov/afni/ ), FSL ( http://fsl.fmrib.ox.ac.uk ), and ANTs ( http://stnava.",Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1038/npp.2013.27 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.02.064 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1371/journal.pone.0055821 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1089/cap.2015.0221 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1038/npp.2014.67 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.neuropharm.2013.05.027 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.pneurobio.2010.06.010 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/ 10.1016/j.tics.2005.05.001 Regul Ed.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.cub.2012.07.002 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
Cortex http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
16:17 –26.http://dx.doi.org/10.1016/j.tics.2011.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
Psychiatry 50:9 –21.http://dx.doi.org/10.1016/j.jaac.2010.09.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1176/appi.ajp.2012.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
25:22 –34.http://dx.doi.org/10.1002/hbm.20127 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.neuron.2014.08.050 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
29:91 –98.http://dx.doi.org/10.1111/j.1465-3362.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
6:80. http://dx.doi.org/10.3389/ fnsys.2012.00080 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
Primers:15020 –15023 http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
224: 37–47.http://dx.doi.org/10.1016/j.expneurol.2010.03.021 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.conb.2014.11.007 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
NeuroImage 48:63 –72.http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
40:46 –57.http://dx.doi.org/10.1503/jpn.130290 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.3109/00952990.2013.837914 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2012.271 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
1224:40 –62.http://dx.doi.org/10.1111/j.1749-6632.2011.05958.x .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1017/S135561771500020X .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1007/ s40429-014-0019-6 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2016.01.032 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
148:1 –16.http://dx.doi.org/10.1016/j.pharmthera.2014.11.009 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/ j.pscychresns.2009.12.004 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
"http://dx.doi.org/10.1007/s11065-014-9251-z .Proal, E., Reiss, P.T., Klein, R.G., Mannuzza, S., Gotimer, K., Ramos-Olazagasti, M.A., Lerch, J.P., He, Y., Zijdenbos, A., Kelly, C., Milham, M.P., Castellanos, F.X., 2011.",Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
: 1–11http://dx.doi.org/10.1007/s11682-015-9438-9 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1038/ npp.2014.241 .,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1016/j.drugalcdep.2013.08.001 .,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
Journal of child and adolescent psychopharmacology http://dx.doi.org/10.1089/cap.2015.0243 cap.2015.0243.,Non-OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
http://dx.doi.org/10.1093/brain/ aws136 .200 C. Kelly et al.,OADS,/arxiv_data1/oa_pdf/1b/5a/main.PMC5153452.pdf
Available at: ftp://ftp.fao.,Non-OADS,/arxiv_data1/oa_pdf/95/07/ejcn2016167a.PMC5153455.pdf
Available at: http://www.criticalcarenutrition.com/docs/tools/Propofol.pdf (last accessed 28 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/95/07/ejcn2016167a.PMC5153455.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016Relevance of Non-Nutritional Calories in ICU patients E Bousie et al 1450 European Journal of Clinical Nutrition (2016) 1443 –1450",Non-OADS,/arxiv_data1/oa_pdf/95/07/ejcn2016167a.PMC5153455.pdf
☆There are no con ﬂicts of interest ☆☆ No funding was received http://dx.doi.org/10.1016/j.ymgmr.2016.12.002 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5153459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/28/main.PMC5153459.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Social anxiety disorderFace evaluationSelf-face recognitionAttractivenessfMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/78/4a/main.PMC5153555.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.010 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/4a/main.PMC5153555.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/4a/main.PMC5153555.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Working memoryNeurodevelopmentBrain activationfMRI Neurodevelopmental disorders Schizophrenia 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.nicl.2015.12.002 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
Meta-analytic approach ALE is a robust method of quantitative meta-analysis of fMRI data implemented in “GingerALE 2.3.2 ”(http://www.brainmap.org/ale/ ).941 J. Andre et al.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"ALE results were overlaid onto an optimized individual anatomical T1-template ( www.brainmap.og/ale/ Colin1.1.nii ) and cluster centers were anatomically located in Mango (http://ric.uthscsa.edu/mango )(Lancaster et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"8 (2), 234 –238 (Retrieved from http://www.sciencedirect.com/science/article/pii/ S0959438898801451 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.brainres.2010.07.055 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neubiorev.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/ j.conb.2007.02.005 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.08.056 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"7, 60. http://dx.doi.org/10.3389/fncel.2013.00060 .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1093/brain/ awl004 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.07.028 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"9 (1), 1 –8.http://dx.doi.org/10.1111/j.1467-7687.2005.00454.x .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.6266-09.2010 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"134 (1), 31 –60.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"101 (1), 84 –99.http://dx.doi.org/10.1152/jn.90562.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1006/nimg.1999.0527 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"102, 18 –29.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"Neuroinformatics 10 (1), 67 –80.http://dx.doi.org/10.1007/ s12021-011-9125-y .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/ 10.1016/j.neuropsychologia.2005.11.019 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"14 (1), 1 –10.http://dx.doi.org/10.1162/ 089892902317205276 .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.bandc.2008.08.032 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1002/ hbm.20345 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1007/s12021-010-9074-x .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"Brain 137 (Pt 1), 12 –32.http://dx.doi.org/10.1093/brain/awt162 .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"http://dx.doi.org/10.1016/j.ijpsycho.2012.02.011 .Luciana, M., Conklin, H.M., Hooper, C.J., Yarger, R.S., 2005.",OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1111/j.1467-8624.2005.00872.x .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1006/nimg.2000.0743 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1038/nature09569 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/ 10.1038/nrn2478 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"Brain Cogn 82 (1), 58–68.http://dx.doi.org/10.1016/j.bandc.2013.02.007 .",OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1162/0898929041920441 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"18 (1), 48 –57.http://dx.doi.org/10.1016/j.cogbrainres.2003.",OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1093/cercor/bhl014 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"25 (1), 46 –59.http://dx.doi.org/10.1002/hbm.20131 .",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/ 10.1016/j.scog.2014.09.005.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1038/ nrn2513 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.tics.2011.02.002 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"11 (6), 663 –672 (Retrieved from http://www.sciencedirect.com/science/article/pii/ S0959 438801002665 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/ 10.1038/nrn1343 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.01.039 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.11.050 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2345-13.2013 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"1), S120 –S131 (Retrieved from http://www.sciencedirect.com/science/article/pii/ S1053811903005330 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1017/s1355617705050757 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"60 (2), 368– 378. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"95 (20), 12061 –12068 (Retrieved from http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1006/nimg.1999.0466 .,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1162/jocn.2008.21028 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"Neuroimage 16 (3 Pt 1), 765 –780 (Retrieved from http://www.sciencedirect.com/ science/article/pii/S1053811902911316 ).",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
"33 (1), 1 –13.http://dx.doi.org/10.1002/hbm.",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1523/jneurosci.1579-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/3b/main.PMC5153561.pdf
Ras and ras-related proteins are often dysregulated in cancers by oncogenic mutations of Rasisoforms or its effectors in about one-third of all humancancers (http://www.sanger.ac.uk/ge netics/CGP/cosmic).,Non-OADS,/arxiv_data1/oa_pdf/4b/ea/onc2016162a.PMC5153568.pdf
Reads alignment The whole-exome sequencing reads were mapped to the UCSC mm9reference genome (http://genome.ucsc.edu/) using the Burrows-Wheeler Aligner.,OADS,/arxiv_data1/oa_pdf/4b/ea/onc2016162a.PMC5153568.pdf
Enrichment analysis of KEGG pathways Somatically mutated genes identi ﬁed in tumors from genetic obese mice or control lean mice were subjected to KEGG pathway enrichment analysisusing the Gene Set Analysis Toolkit V2 (http://bioinfo.vanderbilt.edu/ webgestalt/).,OADS,/arxiv_data1/oa_pdf/4b/ea/onc2016162a.PMC5153568.pdf
The results shown here are in part based upon data generated bythe TCGA Research Network: http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/4b/ea/onc2016162a.PMC5153568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Mutations in obesity-associated HCC J Shen et al 6280 Oncogene (2016) 6271 –6280 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/4b/ea/onc2016162a.PMC5153568.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Oral malignant acanthosis nigricans HW Chu et al 249 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/35/ab/ijos20141a.PMC5153582.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Biodentine for root-end fillings G Caron et al 253 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/4e/2a/ijos201425a.PMC5153583.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Intratubular bacterial entombment by MTA obturation JS Yoo et al 232 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/71/f6/ijos201430a.PMC5153584.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Squamospheres in VX2 rabbit oral cancer YK Chen et al 218 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/57/e3/ijos201432a.PMC5153585.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Roughness of full-contour zirconia after treatment R Hmaidouch et al 246 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/09/b9/ijos201434a.PMC5153586.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Exposure of Streptococcus mutans to carbohydrates EM Decker et al 204 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/c5/6d/ijos201438a.PMC5153587.pdf
"Data analysis was performed using the web portal http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php.The positive value signifies upregulation, whereas the negative value indicates downregulation of genes.",OADS,/arxiv_data1/oa_pdf/20/21/ijos201446a.PMC5153588.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information for this article can be found on International Journal of Oral Science ’s website (http://www.nature.com/ijos).Bacterial colonization and immune response in BRONJ S Pushalkar et al 226 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/20/21/ijos201446a.PMC5153588.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Probiotics and biofilm-associated infections C Vuotto et al 194 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/c7/f0/ijos201452a.PMC5153589.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Effects of CGA on TRGN Kv channels YJ Zhang et al 240 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/dc/0f/ijos201458a.PMC5153590.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Epigenetics and tooth development LW Zheng et al 211 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/95/4d/ijos201460a.PMC5153591.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/a-SMA and tenascin-C expression in the periodontal ligament HX u et al 241 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/65/eb/ijos201526a.PMC5153592.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Micromolar sodium fluoride in periodontitis UK Bhawal et al 249 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/83/44/ijos201528a.PMC5153593.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Epigenetic regulators in osteogenic and adipogenic differentiation of MSCs P Deng et al 204 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/e0/d8/ijos201541a.PMC5153596.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Characterization of dental MSCs with cell surface markers R Alvarez et al 219 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/81/80/ijos201542a.PMC5153597.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/Bacterial challenge of osteoblast on implant materials B Zhao et al 258 International Journal of Oral Science",Non-OADS,/arxiv_data1/oa_pdf/9b/76/ijos201545a.PMC5153598.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Traumatic brain injuryResting-stateBrain connectivityfMRIS100B 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/65/main.PMC5153599.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.005 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/65/main.PMC5153599.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/65/main.PMC5153599.pdf
http://dx.doi.org/10.3389/fnsys.2010.00019 .,Non-OADS,/arxiv_data1/oa_pdf/b8/65/main.PMC5153599.pdf
” DOI of original article: http://dx.doi.org/10.1016/j.nicl.2015.05.014 .,OADS,/arxiv_data1/oa_pdf/79/51/main.PMC5153600.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.001 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/51/main.PMC5153600.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/51/main.PMC5153600.pdf
Due to theseNeuroImage: Clinical 12 (2016) 1045 –1047 http://dx.doi.org/10.1016/j.nicl.2016.08.002 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/fa/86/main.PMC5153601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/86/main.PMC5153601.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diffusion tensor imagingFractional anisotropyMajor depressive disorderBipolar disorderAnxiety disorders Meta-analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/49/c8/main.PMC5153602.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.001 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/c8/main.PMC5153602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/c8/main.PMC5153602.pdf
Foci reportedin Talairach space were converted to MNI space with Brett's transform (http://eeg.sourceforge.net/doc_m2h tml/bioelectromagnetism/mni2tal_ matrix.html ).,OADS,/arxiv_data1/oa_pdf/49/c8/main.PMC5153602.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DysphagiaNeurorehabilitationRecoveryStrokeSwallowing 1.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.006 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
We measured lesion volumes by manually drawing the border of the lesion in the high spatial resolution T1-weighted image for each slice and then calculating the resulting volume (cm3)w i t hM R I C r o n (http://www.sph.sc.edu/comd/rorden/mricron ).,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"The anterior and posterior insula were provided by Neuromorphometrics, Inc. ( http://neuromorphometrics.com ) under aca- demic subscription, taken from SPM12.",OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.007 .,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00455-009-9270-8 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.09.018 .,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
Stroke http://dx.doi.org/10.1161/01.STR.28.12.2518 .1020 P.G.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"6, 30 –34.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"6, 17–23.http://dx.doi.org/10.1044/1058-0360.0604.17 .",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00455-005-9007-2 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"43C, 48 –73.http://dx.doi.org/10.1016/j.neubiorev.",OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1161/STROKEAHA.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
23. http://dx.doi.org/10.1111/j.1365-2982.2011.01747.x .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
Dyspha- giahttp://dx.doi.org/10.1007/s00455-014-9525-x .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00455-009-9211-6 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1136/jnnp.2009.176214 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1177/1545968313508227 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1001/jama.292.20.2470-b .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1002/hbm.20743 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"http://dx.doi.org/10.1016/S1053- 8119(03)00169-1 .Martin, R.E., Goodyear, B.G., Gati, J.S., Menon, R.S., 2001.",OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1152/jn.01144.2003 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1136/jnnp.36.5.853 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"Michou, E., Williams, S., Vidyasagar, R., Downey, D., Mistry, S., Edden, R.a.E., Hamdy, S., 2015. fMRI and MRS measures of neuroplasticity in the pharyngeal motor cortex.Neuroimage 117, 1 –10.http://dx.doi.org/10.1016/j.neuroimage.2015.05.007 .",OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1152/ajpgi.00456.2012 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1002/hbm.22597 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"140, 280 –289.http://dx.doi.org/10.1007/s002210100813 .",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1097/00005537-199909000-00011 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/0028-3932(71)90067-4 .,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1177/ 1352458506073481 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
Cerebellum 767 –776 http://dx.doi.org/10.1007/ s12311-014-0584-1 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00455-008-9164-1 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2012.01.094 .,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
Dysphagia http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1001/archneur.55.8.1081 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.2443/skv-s-2012- 55020120201 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00247-006-0216-0 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"Dyspha- gia 18, 71 –77.http://dx.doi.org/10.1007/s00455-002-0088-x .",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
"10, 71. http://dx.doi.or g/10.1186/1471-2202-10-71 .",Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1007/s00221-004-2048-1 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1093/brain/118.4.1013 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1002/ana.410330208 .,Non-OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
http://dx.doi.org/10.1016/j.bbr.2015.03.,OADS,/arxiv_data1/oa_pdf/88/3f/main.PMC5153603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Positron emission tomography DTI MTLEHippocampusNerve net 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/main.PMC5153605.pdf
http://dx.doi.org/10.1016/j.nicl.2016.05.002 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/15/main.PMC5153605.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/15/main.PMC5153605.pdf
"The DTI data were preprocessed in the FMRIB's Software Library (FSL) software (FSL 4.0, http://www.fmrib.ox.ac.uk/fsl ).",OADS,/arxiv_data1/oa_pdf/c1/15/main.PMC5153605.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizophrenia Auditory verbal hallucinations Diffusion tensor imagingArcuate fasciculusWhite matterTractographyDTI 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.013 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"7, 9. http://dx.doi.org/10.3389/fnint.2013.00009 .",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"55, 78 –87.http://dx.doi.org/10.1016/j.neubiorev.",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1093/schbul/sbt172 .974 M. Psomiades et al.,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"161 (1), 29 –35.http://dx.doi.org/10.1016/j.schres.2014.05.031 .",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"130, 68 –77.http://dx.doi.org/10.1016/j.schres.2011.05.010 .",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1017/S0033291712002541 (Epub 2012 Nov 16).,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"108 (1 –3), 3 –10.http://dx.doi.org/10.1016/j.schres.",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.schres.2014.07.014 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"6, 6. http://dx.doi.org/10.3389/ fnhum.2012.00006 .",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/ 10.1016/j.pscychresns.2015.06.017 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.schres.2015.,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1093/schbul/sbu004 .,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"108, 33 –40.http://dx.doi.org/10.1016/j.schres.2008.11.024 .",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.05.086 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.jpsychires.2010.07.007 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.schres.2014.12.041 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.3109/ 15622975.2011.570789 .,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"107 (1), 30 –38.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.schres.2014.,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1111/j.1552-6569.2012.00779.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1001/ jamapsychiatry.2015.0505 .,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
"Neurobiol.93 (1), 13 –24.http://dx.doi.org/10.1016/j.pneurobio.2010.09.004 .",OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.1016/j.nicl.2015.10.008 .,OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/main.PMC5153606.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.011 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1148/radiol.2371041506 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.09.055 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1002/jmri.21995 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"30, 19 –30.http://dx.doi.org/10.3174/ajnr.A1400 .",Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.mri.2014.09.004 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"3, 41 –51.http://dx.doi.org/10.1111/j.1471-4159.1958.tb12607.",Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1002/jmri.24121 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1212/01.WNL.0000058901.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"2013, 639430. http://dx.doi.org/10.1155/ 2013/639430 (12).",Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1371/journal.pone.0035241 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"265, 74 –78.http://dx.doi.org/10.1006/abio.1998.2903 .",Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1002/hbm.22360 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.05.127 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"Imaging 42,23–41.http://dx.doi.org/10.1002/jmri.24768 .",Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1162/jocn.2009.,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1364/OL.28.001194 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.2214/AJR.14.13459 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/ 10.1080/14660820310011250 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.nbd.2003.12.012 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1002/ mrm.25189 .,Non-OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.07.019 .,OADS,/arxiv_data1/oa_pdf/f9/9c/main.PMC5153607.pdf
"6, 503 –511 http://dx.doi.org/10.1080/19490976.2016.1228517",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Science 1996; 274:97-9; PMID:8810255;http://dx.doi.org/10.1126/science.274.5284.97 [2] Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Cell 1992; 68:869- 77; PMID:1547488; http://dx.doi.org/10.1016/0092-8674 (92)90030-G [3] Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM,et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Cell1992; 68:855-67; PMID:1547487; http://dx.doi.org/10.1016/0092-8674(92)90029-C [4] Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, et al.Partial V(D)J recombination activity leads to Omennsyndrome.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Cell 1998; 93:885-96; PMID:9630231; http://dx.doi.org/10.1016/S0092-8674(00)81448-8 [5] Notarangelo LD, Kim MS, Walter JE, Lee YN.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Human RAG mutations: biochemistry and clinical implications.Nat Rev Immunol 2016; 16:234-46; PMID:26996199; http://dx.doi.org/10.1038/nri.2016.28 [6] Pai SY, Cowan MJ.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Clin Invest 1991; 87:1352-9; PMID:2010548; http://dx.doi.org/10.1172/JCI115139 [8] Rieux-Laucat F, Bahadoran P, Brousse N, Selz F, Fischer A, Le Deist F, De Villartay JP.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Clin Invest 1998; 102:312-21; PMID:9664072; http://dx.doi.org/10.1172/ JCI332 [9] Signorini S, Imberti L, Pirovano S, Villa A, Facchetti F, Ungari M, Bozzi F, Albertini A, Ugazio AG, Vezzoni P,et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Clin Invest 2015; 125:4135-48; PMID:26457731; http://dx.doi.org/10.1172/JCI80477 [11] Walter JE, Rucci F, Patrizi L, Recher M, Regenass S, Paganini T, Keszei M, Pessach I, Lang PA, Poliani PL,et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Exp Med 2010; 207:1541-54; PMID:20547827;http://dx.doi.org/10.1084/jem.20091927 [12] Cassani B, Poliani PL, Marrella V, Schena F, Sauer AV, Ravanini M, Strina D, Busse CE, Regenass S, WardemannH, et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Exp Med 2010; 207:1525-40;PMID:20547828; http://dx.doi.org/10.1084/jem.20091928 [13] Poliani PL, Vermi W, Facchetti F. Thymus microen- vironment in human primary immunode ﬁciency diseases.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Curr Opin All ergy Clin Immunol 2009; 9:489-95; PMID:19841578; http://dx.doi.org/10.1097/ACI.0b013e3283327e5c [14] Marrella V, Poliani PL, Casati A, Rucci F, Frascoli L, Gougeon ML, Lemercier B, Bosticardo M, Ravanini M,Battaglia M, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J ClinInvest 2007; 117:1260-9; PMID:17476358; http://dx.doi.org/10.1172/JCI30928 [15] Marrella V, Poliani PL, Fontana E, Casati A, Maina V, Cassani B, Ficara F, Cominelli M, Schena F, Paulis M, et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Blood 2012; 120:1005-14; PMID:22723555; http://dx.doi.org/10.1182/blood-2012-01-406827 [16] Cassani B, Poliani PL, Moratto D, Sobacchi C, Marrella V, Imperatori L, Vairo D, Plebani A, Giliani S, VezzoniP, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Nature2011; 479:538-41; PMID:22031325; http://dx.doi.org/10.1038/nature10554 [32] Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented ﬁlamentous bacteria drive auto- immune arthritis via T helper 17 cells.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Immunity2010; 32:815-27; PMID:20620945; http://dx.doi.org/10.1016/j.immuni.2010.06.001 [33] Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Science 2013; 339:1084-8; PMID:23328391; http://dx.doi.org/10.1126/science.1233521 [34] Wen L, Ley RE, Volchkov PY, Stranges PB, Ava- nesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL,Bluestone JA, et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
Nat Rev Immunol 2009; 9:246-58;PMID:19319143; http://dx.doi.org/10.1038/nri2527 [36] Wucherpfennig KW.,Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Immunity 2015; 43:343-53; PMID:26287682; http://dx.doi.org/ 10.1016/j.immuni.2015.07.014 [38] Wesemann DR, Portuguese AJ, Meyers RM, Gallagher MP, Cluff-Jones K, Magee JM, Panchakshari RA, RodigSJ, Kepler TB, Alt FW.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Microbial colonization in ﬂuences early B-lineage development in the gut lamina propria.Nature 2013; 501:112-5; PMID:23965619; http://dx.doi.org/10.1038/nature12496 [39] Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, Wardemann H. The majority of intesti-nal IgA Cand IgG Cplasmablasts in the human gut are antigen-speci ﬁc.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Clin Invest 2011; 121:1946-55; PMID:21490392; http://dx.doi.org/10.1172/JCI44447 [40] Cahenzli J, Koller Y, Wyss M, Geuking MB, McCoy KD.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
Cell Host Microbe 2013; 14:559-70; PMID:24237701; http://dx.doi.org/ 10.1016/j.chom.2013.10.004 [41] Omenn GS.,OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"N Engl J Med 1965; 273:427-32; PMID:14328107;http://dx.doi.org/10.1056/NEJM196508192730806 [42] Schuetz C, Pannicke U, Jacobsen EM, Burggraf S, Albert MH, Honig M, Niehues T, Feyen O, Ehl S, Debatin KM,et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Allergy Clin Immunol 2014;133:1211-5; PMID:24331380; http://dx.doi.org/10.1016/j.jaci.2013.10.021 [43] Belkaid Y, Segre JA.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Science 2014; 346:954-9; PMID:25414304;http://dx.doi.org/10.1126/science.1260144 [44] Zanvit P, Konkel JE, Jiao X, Kasagi S, Zhang D, Wu R, Chia C, Ajami NJ, Smith DP, Petrosino JF, et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Nat Commun 2015; 6:8424; PMID:26416167; http://dx.doi.org/10.1038/ncomms9424 [45] Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, Gill N, Blanchet MR, Mohn WW,McNagny KM, et al.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Cell2014; 158:705-21; PMID:25126780; http://dx.doi.org/10.1016/j.cell.2014.05.052 [47] Reinhardt C, Reigstad CS, Backhed F. Intestinal microbiota during infancy and its implications for obesity.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Pediatr Gastroenterol Nutr 2009; 48:249-56; PMID:19271298; http://dx.doi.org/10.1097/ MPG.0b013e318183187c [48] Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Sal- c e d oR ,K a s t e n m u l l e rW ,D e m i n gC ,Q u i n o n e sM ,Koo L, Conlan S, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Science2012; 337:1115-9; PMID:22837383; http://dx.doi.org/ 10.1126/science.1225152 [49] Oyoshi MK, Elkhal A, Scott JE, Wurbel MA, Hornick JL, Campbell JJ, Geha RS.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"J Clin Invest 2011;121:2210-20; PMID:21537081; http://dx.doi.org/10.1172/JCI43586 [50] Huang BL, Chandra S, Shih DQ.",OADS,/arxiv_data1/oa_pdf/f0/94/kgmi-07-06-1228517.PMC5153610.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"6, 533 –539 http://dx.doi.org/10.1080/19490976.2016.1239680",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Sex Roles 2011; 64:707-22; http://dx.doi.org/10.1007/s11199- 010-9927-7 [2] Kaufman JM, Vermeulen A.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Endocr Rev 2005; 26:833-76; PMID:15901667;http://dx.doi.org/10.1210/er.2004-0013 [3] Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"N Engl J Med 2010; 363:123-35; PMID: 20554979; http://dx.doi.org/10.1056/NEJMoa0911101 [4] Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: Endogenous testosteroneand mortality in men: a systematic review and meta-anal-ysis.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"J Clin Endocrinol Metab 2011; 96:3007-19; PMID:21816776; http://dx.doi.org/10.1210/jc.2011-1137 [5] Keating NL, O ’Malley AJ, Smith MR. Diabetes and cardio- vascular disease during androgen deprivation therapy forprostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
J Clin Oncol 2006; 24:4448-56; PMID:16983113; http://dx.doi.org/10.1200/JCO.2006.06.2497 [6] Comhaire F. Hormone replacement therapy and longev- ity.,Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Andrologia 2016; 48:65-8; PMID:25892327; http://dx.doi.org/10.1111/and.12419 [7] `Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2010;464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821 [8] Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, Caterson ID, Hunt NH, Storlien LH.Role of the gut in visceral fat in ﬂammation and metabolic disorders.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Obesity 2011; 19:2113-20; PMID:21881620; http://dx.doi.org/10.1038/oby.2011.68 [9] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature2006; 444:1027-31; PMID:17183312; http://dx.doi.org/10.1038/nature05414 [10] Ley RE, Turnbaugh PJ, Klein S, Gordon JI.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2006; 444:1022-3; PMID:17183309; http://dx.doi.org/10.1038/4441022a [11] Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiotacontrol metabolic endotoxemia-induced in ﬂammation in high-fat diet-induced obesity and diabetes in mice.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
Dia-betes 2008; 57:1470-81; PMID:18305141; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2009; 457:480-4; PMID:19043404;http://dx.doi.org/10.1038/nature07540 [13] Hartstra AV, Bouter KE, Backhed F, Nieuwdorp M. Insights into the role of the microbiome in obesity and type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Diabetes Care 2015; 38:159-65; PMID: 25538312; http://dx.doi.org/10.2337/dc14-0769 [14] Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoyKD, Macpherson AJ, Danska JS.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Science 2013; 339:1084-8; PMID:233-28391; http://dx.doi.org/10.1126/science.1233521 [15] Mauvais-Jarvis F. Sex differences in metabolic homeosta- sis, diabetes, and obesity.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"PMID:26339468; http://dx.doi.org/10.1186/s13293-015- 0033-y [16] Harada N, Hanaoka R, Horiuchi H, Kitakaze T, Mitani T, Inui H, Yamaji R. Castration in ﬂuences intestinal micro- ﬂora and induces abdominal obesity in high-fat diet-fed mice.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Sci Rep 2016; 6:23001; PMID:26961573; http://dx.doi.org/10.1038/srep23001 [17] Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2006; 444:881-7; PMID:17167477; http://dx.doi.org/10.1038/nature05488 [18] Inoue T, Zakikhani M, David S, Algire C, Blouin MJ, Pollak M. Effects of castration on insulin levels andglucose tolerance in the mouse differ from those in man.Prostate 2010; 70:1628-35; PMID:20564323; http://dx.doi.org/10.1002/pros.21198 [19] Smith MR. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Urol-ogy 2004; 63:742-5; PMID:15072892; http://dx.doi.org/10.1016/j.urology.2003.10.063 [20] Dubois V, Laurent MR, Jardi F, Antonio L, Lemaire K, Goyvaerts L, Deldicque L, Carmeliet G, Decallonne B,Vanderschueren D, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Endocrinology 2016; 157:648-65; PMID:26562264; http://dx.doi.org/10.1210/en.2015-1713 [21] Rose C, Parker A, Jefferson B, Cartmell E. The characteri- zation of feces and urine: a review of the literature toinform advanced treatment technology.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Crit Rev EnvironSci Technol 2015; 45:1827-79; PMID:26246784; http://dx.doi.org/10.1080/10643389.2014.1000761 [22] Anderson TJ, Ai Y, Jones RW, Houk RS, Jane JL, Zhao Y, Birt DF, McClelland JF.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"J Agric Food Chem 2013;61:1818-22; PMID:23360415; http://dx.doi.org/10.1021/jf3042616 [23] Huang EY, Leone VA, Devkota S, Wang Y, Brady MJ, Chang EB.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"JPEN J Parenter Enteral Nutr 2013; 37:746-54; PMID:23639897; http://dx.doi.org/10.1177/0148607113486931 [24] Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2016; 535:56-64;PMID:27383980; http://dx.doi.org/10.1038/nature18846 [25] Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
Atheroscle- rosis 2007; 191:235-40; PMID:16970951; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"org/10.1016/j.atherosclerosis.2006.08.021 [26] Takahashi Y, Soejima Y, Fukusato T. Animal models of non- alcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol 2012; 18:2300-8; PMID:22654421;http://dx.doi.org/10.3748/wjg.v18.i19.2300 [27] Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Clin Microbiol In fect 2013; 19:338-48; PMID: 23452163; http://dx.doi.org/10.1111/1469-0691.12140[28] Nikolaenko L, Jia Y, Wang C, Diaz-Arjonilla M, Yee JK, F r e n c hS W ,L i uP Y ,L a u r e lS ,C h o n gC ,L e eK ,e ta l .T e s t o s -terone replacement ameliorates nonalcoholic fatty liver dis-ease in castrated male rats.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Endocrinology 2014; 155:417-28;PMID:24280056; http://dx.doi.org/10.1210/en.2013-1648 [29] Senmaru T, Fukui M, Okada H, Mineoka Y, Yamazaki M, Tsujikawa M, Hasegawa G, Kitawaki J, Obayashi H, Nakamura N. Testosterone de ﬁciency induces markedly decreased serum triglycerides, increased small denseLDL, and hepatic steatosis mediated by dysregulation oflipid assembly and secretion in mice fed a high-fat diet.Metabolism 2013; 62:851-60; PMID:23332447; http://dx.doi.org/10.1016/j.metabol.2012.12.007 [30] Machado MV, Cortez-Pinto H. Gut microbiota and non- alcoholic fatty liver disease.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Int J Obes 2006; 30:787-93; http://dx.doi.org/10.1038/sj.ijo.0803201 [32] Konrad D, Wueest S. The gut-adipose-liver axis in the metabolic syndrome.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Physiology 2014; 29:304-13; PMID:25180260; http://dx.doi.org/10.1152/physiol.00014.2014 [33] Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Carteni M, Nardone G. Gut –liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"NutrMetab Cardiovasc Dis 2012; 22:471-6; PMID:22546554;http://dx.doi.org/10.1016/j.numecd.2012.02.007 [34] Vernon G, Baranova A, Younossi ZM.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Circulation2009; 120:1640-5; PMID:19805654; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644 [37] Ding EL, Song Y, Malik VS, Liu S. Sex differences of endoge- nous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"JAMA 2006; 295:1288-99; PMID: 16537739; http://dx.doi.org/10.1001/jama.295.11.1288 [38] Keating NL, Liu PH, O ’Malley AJ, Freedland SJ, Smith MR. Androgen-deprivation therapy and diabetes controlamong diabetic men with prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Eur Urol 2014;65:816-24; PMID:23453420; http://dx.doi.org/10.1016/j.eururo.2013.02.023 [39] Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
Endocr Rev 2005; 26:439-51; PMID:15897298; http://dx.doi.org/10.1210/er.2005-0005538 N. HARADA ET AL.,OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Diabetes 2002; 51:2734-41; PMID:12196466;http://dx.doi.org/10.2337/diabetes.51.9.2734 [41] Laughlin GA, Barrett-Connor E, May S. Sex-speci ﬁc association of the androgen to oestrogen ratio with adi- pocytokine levels in older adults: the Rancho BernardoStudy.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Clin Endocrinol 2006; 65:506-13; http://dx.doi.org/10.1111/j.1365-2265.2006.02624.x [42] Laughlin GA, Barrett-Connor E, May S. Sex-speci ﬁc determinants of serum adiponectin in older adults: therole of endogenous sex hormones.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Int J Obes 2007; 31:457-65; http://dx.doi.org/10.1038/sj.ijo.0803427 [43] Lanfranco F, Zitzmann M, Simoni M, Nieschlag E. Serum adiponectin levels in hypogonadal males: in ﬂuence of testos- terone replacement therapy.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Clin Endocrinol 2004; 60:500-7;http://dx.doi.org/10.1111/j.1365-2265.2004.02007.x [44] Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S, Nawata H. Androgen receptor nullmale mice develop late-onset obesity caused by decreasedenergy expenditure and lipolytic activity but show nor- mal insulin sensitivity with high adiponectin secretion.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Diabetes 2005; 54:1000-8; PMID:15793238; http://dx.doi.org/10.2337/diabetes.54.4.1000 [45] Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C. Insulin and leptin resistance with hyperleptinemia in mice lackingandrogen receptor.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Diabetes 2005; 54:1717 -25; PMID: 15919793; http://dx.doi.org/10.2337/diabetes.54.6.1717 [46] Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2013; 500:541-6; PMID:23985870; http://dx.doi.org/10.1038/nature12506 [47] Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z, Khazaai H, Khodavandi A.The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Food Nutr Res 2015; 59:29273; PMID:26699936; http://dx.doi.org/10.3402/fnr.v59.29273 [48] Kim SW, Park KY, Kim B, Kim E, Hyun CK.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Biochem Bio-phys Res Commun 2013; 431:258-63; PMID:23313485;http://dx.doi.org/10.1016/j.bbrc.2012.12.121 [49] Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, Lusis AJ.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Nature 2012; 490:55-60;PMID:23023125; http://dx.doi.org/10.1038/nature11450[51] Harada N, Katsuki T, Takahashi Y, Masuda T, Yoshinaga M, Adachi T, Izawa T, Kuwamura M, Nakano Y, YamajiR, et al.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"J Cell Biochem 2015; 116:998-1006; PMID:25639671; http://dx.doi.org/10.1002/jcb.25054 [52] Morimoto S, Morales A, Zambrano E, Fernandez-Mejia C. Sex steroids effects on the endocrine pancreas.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"JSteroid Biochem Mol Biol 2010; 122:107-13; PMID:20580673; http://dx.doi.org/10.1016/j.jsbmb.2010.05.003 [53] Nishizawa M, Nakabayashi H, Uehara K, Nakagawa A, Uchida K, Koya D. Intraportal GLP-1 stimulates insulinsecretion predominantly through the hepatoportal-pan-creatic vagal re ﬂex pathways.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
Am J Physiol Endocrinol Metab 2013; 305:E376-87; PMID:23715725; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"J Nutr Sci Vitaminol 2014; 60:291-6; PMID:25297619; http://dx.doi.org/10.3177/jnsv.60.291 [55] Heitmann BL, Frederiksen P. Thigh circumference and risk of heart disease and premature death: prospective cohort study.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Int J Biochem CellBiol 2013; 45:2186-90; PMID:23831839; http://dx.doi.org/10.1016/j.biocel.2013.06.021 [57] Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, et al.",OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Hepatology 2008; 47:1924-35;PMID:18449947; http://dx.doi.org/10.1002/hep.22252 [58] McInnes KJ, Smith LB, Hunger NI, Saunders PT, Andrew R, Walker BR.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"Dia- betes 2012; 61:1072-81; PMID:22415878; http://dx.doi.org/10.2337/db11-1136 [59] Ophoff J, Van Proeyen K, Callewaert F, De Gendt K, De Bock K, Vanden Bosch A, Verhoeven G, Hespel P,Vanderschueren D. Androgen signaling in myocytes con-tributes to the maintenance of muscle mass and ﬁber type regulation but not to muscle strength or fatigue.",Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
Cancer Sci 2012; 103:1022-7; PMID:22360658; http://dx.doi.org/10.1111/j.1349-7006.2012.02250.xGUT MICROBES 539,Non-OADS,/arxiv_data1/oa_pdf/8c/00/kgmi-07-06-1239680.PMC5153613.pdf
"1, e1093065 (4 pages)http://dx.doi.org/10.1080/21597081.2015.1093065",Non-OADS,/arxiv_data1/oa_pdf/6b/87/kbac-06-01-1093065.PMC5153855.pdf
Available from: http://www.pharmacy.gov.my/ html/research_n_development_senarai_abstrak.,Non-OADS,/arxiv_data1/oa_pdf/a7/92/JBCP-7-105.PMC5153886.pdf
Available from:  http://www.un.org/en/development/desa/population/publications/ pdf/ageing/WorldPopulationAgeing2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/ca/JBCP-7-110.PMC5153887.pdf
Available from:  http://www.prb.org/Publications/Reports/2012/india -older -population.,Non-OADS,/arxiv_data1/oa_pdf/c7/ca/JBCP-7-110.PMC5153887.pdf
Available from: http://www.pharmacistsletter.therapeuticresearch.com/ pl/ArticlePDF.aspx?cs=&s=PL&DocumentFileID=0&DetailID=3002 01&SegmentID=0.,OADS,/arxiv_data1/oa_pdf/c7/ca/JBCP-7-110.PMC5153887.pdf
*Appendix 1: Frequency of cardiovascular diseases  among patients ( n =236) Cardiovascular disease Percentage  Angina pectoris 83.1 Hypertension 75.9 Heart failure 25.4 Rheumatic heart disease 3.0 Left ventricular failure 1.8 Arrhythmias 1.0 Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/c7/ca/JBCP-7-110.PMC5153887.pdf
Available from: http://www.ginasthma.org.,Non-OADS,/arxiv_data1/oa_pdf/29/f7/JBCP-7-116.PMC5153888.pdf
Available from: http://www.pharmanewsonline.com/enhancing- asthma-control-in-nigeria/.,Non-OADS,/arxiv_data1/oa_pdf/29/f7/JBCP-7-116.PMC5153888.pdf
Available from: http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/29/f7/JBCP-7-116.PMC5153888.pdf
Available from: http://www.who-umc.org/ Graphics/24734.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/eb/JBCP-7-120.PMC5153889.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/48/45/JBCP-7-97.PMC5153890.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/48/45/JBCP-7-97.PMC5153890.pdf
The reporting of data follows the CONSORT guidelines(http://www.consort-statement.org/consort-2010).,OADS,/arxiv_data1/oa_pdf/5b/40/JVIM-30-1138.PMC5153962.pdf
"Footnotes aSystat, Cranes Software International, Ltd. San Jose, California bSPSS, IBM Corporation, Armonk, New York cMorris Animal Foundation Golden Retriever Lifetime Study http://caninelifetimehealth.org Acknowledgments The authors acknowledge the Tufts Harrington Oncology program for providing cases and assistancewith study design.",Non-OADS,/arxiv_data1/oa_pdf/ab/55/JVIM-30-1179.PMC5153966.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanS869Case Report An unusual case of repeated intracranial hemorrhage in vestibular  schwannoma Saeed Banaama, Jacobus van Overbeeke, Yasin Temel Department of Neurosurgery, Maastricht University Medical Center, Debyelaan, The Netherlands E‑mail:  Saeed Banaama ‑ s.banaama@student.maastrichtuniversity.nl; Jacobus van Overbeeke ‑ jj.van.overbeeke@mumc.nl;   *Yasin T emel ‑ y.temel@maastrichtuniversity.nl   *Corresponding author Received: 25 July 16  Accepted: 11 August 16  Published: 21 November 16 Abstract Background:  Symptomatic intratumoral hemorrhage (ITH) in vestibular  schwannoma (VS) is rare.",Non-OADS,/arxiv_data1/oa_pdf/0d/94/SNI-7-869.PMC5154193.pdf
"http://surgicalneurologyint.com/An-unusual-case-of-repeated-intracranial- hemorrhage-in-vestibular-schwannoma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/0d/94/SNI-7-869.PMC5154193.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowS889 OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanCase Report Secretory paraspinal paraganglioma of thoracolumar spine: Case  report and review of literature Saad Akhtar, Sidra Sattar, Ehsan Bari, Naila Kayani1, Sarosh Moeen1 Departments of Neurosurgery, 1Histopathology, Aga Khan University Hospital, Karachi, Pakistan E‑mail:  Saad Akhtar ‑ saad.akhtar@aku.edu; Sidra Sattar ‑ sidra.sattar91@gmail.com; *Ehsan Bari ‑ ehsan.bari@aku.edu; Naila Kayani ‑ naila.kayani@aku.edu;  Sarosh Moeen ‑ sarosh.moeen@aku.edu   *Corresponding author Received: 20 January 16  Accepted: 28 September 16  Published: 21 November 16 Abstract Background: Pheochromocytomas are catecholamine secreting tumors of the  adrenal medulla chromaffin cells, however, when present extra‑adrenally they are  called paragangliomas.",Non-OADS,/arxiv_data1/oa_pdf/6f/86/SNI-7-889.PMC5154198.pdf
"http://surgicalneurologyint.com/Secretory-paraspinal-paraganglioma-of- thoracolumar-spine:-Case-report-and-review-of-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6f/86/SNI-7-889.PMC5154198.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanS893Case Report Primary cerebral echinoccocosis in a child: Case report – Surgical  technique, technical pitfalls, and video atlas Ahmed M. A. Altibi1,†, Raed A. H. Qarajeh1,†, Telmo A.",Non-OADS,/arxiv_data1/oa_pdf/18/02/SNI-7-893.PMC5154201.pdf
"http://surgicalneurologyint.com/Primary-cerebral-echinoccocosis-in-a-child:-Case- report---Surgical-technique,-technical-pitfalls,-and-video-atlas/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/18/02/SNI-7-893.PMC5154201.pdf
Available at: http://www.cdc.gov/parasites/echinococcosis/epi.html.,Non-OADS,/arxiv_data1/oa_pdf/18/02/SNI-7-893.PMC5154201.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowS883 OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanCase Report Hypervascular glioblastoma multiforme or arteriovenous  malformation associated Glioma?",Non-OADS,/arxiv_data1/oa_pdf/56/b1/SNI-7-883.PMC5154202.pdf
"http://surgicalneurologyint.com/Hypervascular-glioblastoma-multiforme-or-arteriovenous-malformation-associated-Glioma?-A-diagnostic-and-therapeutic-challenge:-A-case-report/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/56/b1/SNI-7-883.PMC5154202.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS880 OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanSNI: Unique Case Observations, a supplement to  Surgical Neurology International Case Report Intracranial aneurysm formation after radiotherapy for  medulloblastoma Tomoya Kamide, Masanao Mohri, Kouichi Misaki, Naoyuki Uchiyama, Mitsutoshi Nakada Department of Neurosurgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan  E‑mail:  T omoya Kamide ‑ kamide@med.kanazawa‑u.ac.jp; Masanao Mohri ‑ mmohri@med.kanazawa‑u.ac.jp; Kouichi Misaki ‑ kouichimisaki0325@gmail.com;  Naoyuki Uchiyama ‑ naoyuki.uchiyama@med.kanazawa‑u.ac.jp; *Mitsutoshi Nakada ‑ mnakada@med.kanazawa‑u.ac.jp   *Corresponding author Received: 15 June 16    Accepted: 12 August 16  Published: 21 November 16 Access this article online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.194501  Quick Response Code: Abstract Background:  The development of an intracranial aneurysm after radiotherapy  is rare but secondary effect of cranial irradiation in a primary disease treatment.",Non-OADS,/arxiv_data1/oa_pdf/6d/ec/SNI-7-880.PMC5154203.pdf
"http://surgicalneurologyint.com/Intracranial-aneurysm-formation-after-radiotherapy- for-medulloblastoma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6d/ec/SNI-7-880.PMC5154203.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI:  Revista Argentina de Neurocirugia, a supplement to SNIS861T echnical Note Abordaje a la Cisterna Ambiens Microsurgical approach to the ambient cistern Pablo Ajler, Michael Cruz Bravo, Lucas Garategui, Ezequiel Goldschmidt, Gustavo Isolan1,  Álvaro Campero2 Servicio de Neurocirugía, Hospital Italiano de Buenos Aires, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina,  1Centro Avançado de Neurologia e Neurocirurgia (CEANNE), Graduate Course in surgery, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil,  2Servicio de Neurocirugía, Hospital Padilla, Tucumán, Argentina E‑mail: *Pablo Ajler ‑ pablo.ajler@hospitalitaliano.org.ar; Michael Cruz Bravo ‑ washington.cruz@hospitalitaliano.org.ar;  Lucas Garategui ‑ lucas.garategui@hospitalitaliano.org.ar; Ezequiel Goldschmidt ‑ ezequiel.goldschmidt@hospitalitaliano.org.ar;   Gustavo Rassier Isolan ‑ gisolan@yahoo.com.br; Álvaro Campero ‑ alvarocampero@yahoo.com.ar   *Corresponding autor Received: 16 July 16  Accepted: 31 August 16  Published: 21 November 16 Abstract Objective:  To describe a step‑by‑step approach to the ambient cistern by the  suboccipital retrosigmoid supracerebellar infratentorial (RSI) approach.",Non-OADS,/arxiv_data1/oa_pdf/f0/24/SNI-7-861.PMC5154204.pdf
"http://surgicalneurologyint.com/Abordaje-a-la-Cisterna-Ambiens/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/f0/24/SNI-7-861.PMC5154204.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS876 OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanSNI: Unique Case Observations, a supplement to  Surgical Neurology International Case Report Fibrin glue injection into the hematoma cavity for refractory  chronic subdural hematoma: A  case report Saiko Watanabe, Kenichi Amagasaki, Naoyuki Shono1, Hiroshi Nakaguchi Department of Neurosurgery, Mitsui Memorial Hospital, 1Department of Neurosurgery, T okyo University, T okyo, Japan E‑mail:  *Saiko Watanabe ‑ s‑watanabe@mitsuihosp.or.jp; Kenichi Amagasaki ‑ amagasaki@mitsuihosp.or.jp; Naoyuki Shono ‑ nshono@mbp.nifty.com;   Hiroshi Nakaguchi ‑ hnakaguti@gmail.com   *Corresponding author Received: 30 July 16  Accepted: 14 September 16  Published: 21 November 16 Abstract Background:  Repeat burr hole irrigation and drainage has been effective in most  cases of recurrent chronic subdural hematoma (CSDH), however, refractory cases  require further procedures or other interventions.",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/SNI-7-876.PMC5154205.pdf
"http://surgicalneurologyint.com/Fibrin-glue-injection-into-the-hematoma-cavity-for- refractory-chronic-subdural-hematoma:-A-case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/a4/fc/SNI-7-876.PMC5154205.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI:  Revista Argentina de Neurocirugia, a supplement to SNIS855Original Article Hemangioblastomas de fosa posterior: Reporte de 16 casos y revisión de la literatura Hemangioblastomas of the posterior fossa: Report of 16 cases  and literature review Alvaro Campero1,2, Pablo Ajler3,4, Julio Fernandez1, Gustavo Isolan5, Martin Paiz1,  Conrado Rivadeneira1,2 1Servicio de Neurocirugía, Hospital Padilla, Tucumán, Argentina, 2Servicio de Neurocirugía, Sanatorio 9 de Julio, Tucumán, Argentina, 3Servicio de Neurocirugía,  Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Departamento de  Cirugía, División de Post Graduación, Universidad Federal de Río Grande del Sur, Porto Alegre, Brasil E‑mail: *Alvaro Campero ‑ alvarocampero@yahoo.com.ar; Pablo Ajler ‑ pablo.ajler@hospitalitaliano.org.ar; Julio Fernandez ‑ jrofernandez@yahoo.com.ar;   Gustavo Isolan ‑ gisolan@yahoo.com.br; Martin Paiz ‑ martin_paiz@hotmail.com; Conrado Rivadeneira ‑ conradorivadeneira@gmail.com   *Corresponding author Received: 10 July 16  Accepted: 06 August 16  Published: 21 November 16 Abstract Objective: The aim of this study is to describe the results of 16 patients with  posterior fossa hemangioblastoma, treated with microsurgical techniques.",Non-OADS,/arxiv_data1/oa_pdf/2b/87/SNI-7-855.PMC5154206.pdf
"http://surgicalneurologyint.com/Hemangioblastomas-de-fosa-posterior:-Reporte-de-16-casos-y-revisión-de-la-literatura/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/2b/87/SNI-7-855.PMC5154206.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowS872 OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditor: S. A. Enam,  MD  Aga Khan University; Karachi,  Sindh, PakistanSNI: Unique Case Observations, a supplement to  Surgical Neurology International Case Report Rapidly progressing interhemispheric subdural empyema  showing a three‑fold increase in size within 12 hours: Case report Mehmet O. Yüksel, Mehmet S. Gürbüz1, Numan Karaarslan2, Tezcan Caliskan2 Department of Neurosurgery, Erzurum Bolge Training and Research Hospital, Erzurum, 1Department of Neurosurgery, Safa Hospital, Istanbul, Turkey,   2Department of Neurosurgery, Namık Kemal University Faculty of Medicine, T ekirdag, Turkey  E‑mail:  Mehmet O. Yüksel ‑ dr.onur_yksl@hotmail.com; *Mehmet S. Gürbüz ‑ mehmetsabrigurbuz@gmail.com;   Numan Karaarslan ‑ numikara@yahoo.com; T ezcan Caliskan ‑ dtzcan_07@hotmail.com   *Corresponding author Received: 26 April 16  Accepted: 28 July 16  Published: 21 November 16 INTRODUCTION Subdural empyema is an intracranial infection  characterized by the accumulation of infective material  between the inner layer of dura mater and outer layer  of arachnoid membrane.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/SNI-7-872.PMC5154207.pdf
"http://surgicalneurologyint.com/Rapidly-progressing-interhemispheric-subdural- empyema-showing-a-three-fold-increase-in-size-within-12-hours:-Case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/ea/35/SNI-7-872.PMC5154207.pdf
Available from: http://databank.worldbank.org/data/reports.,OADS,/arxiv_data1/oa_pdf/84/61/AJPS-13-166.PMC5154220.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/84/61/AJPS-13-166.PMC5154220.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/84/61/AJPS-13-166.PMC5154220.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/73/20/AJPS-13-175.PMC5154222.pdf
Available  from: http://www.news24.com.ng/National/News/ Minister‑decries‑rising‑child‑abuse‑20140128.,Non-OADS,/arxiv_data1/oa_pdf/da/86/AJPS-13-213.PMC5154232.pdf
Available from:  http://www.pedrad.org/Portals/5/Events/2012/Child%20Abuse/ NimkinVisceralTrauma.,Non-OADS,/arxiv_data1/oa_pdf/da/86/AJPS-13-213.PMC5154232.pdf
Available from: http://www.emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/61/26/AJPS-13-217.PMC5154233.pdf
Available from: http://www.emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/61/26/AJPS-13-217.PMC5154233.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)Role of MDM2 gene in the onset of RCC CG Stoehr et al 5 Oncogenesis (2016), 1 –5",Non-OADS,/arxiv_data1/oa_pdf/0e/61/oncsis201615a.PMC5154348.pdf
"Dev Cell 2015; 35:211-21; http://dx.doi.org/10.1016/j.devcel.2015.09.013 © 2016 Aisa Sakaguchi, Miyuki Sato, and Ken Sato.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"5, e1208325 (3 pages)http://dx.doi.org/10.1080/19420889.2016.1208325",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Ann Rev Biochem 2012; 81:637-59; PMID:22463690; http://dx.doi.org/10.1146/annurev-biochem-052810-093700 [2] Barr F, Lambright DG.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Curr Opin Cell Biol 2010; 22:461-70; PMID:20466531; http://dx.doi.org/10.1016/j.ceb.2010.04.007 [3] Welz T, Wellbourne-Wood J, Kerkhoff E. Orchestration of cell surface proteins by Rab11.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Trends Cell Biol 2014; 24:407-15; PMID:24675420; http://dx.doi.org/10.1016/j.tcb.2014.02.004 [4] Sato M, Grant BD, Harada A, Sato K. Rab11 is required for synchronous secretion of chondroitin proteoglycansafter fertilization in Caenorhabditis elegans .",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"J Cell Sci 2008; 121:3177-86; PMID:18765566; http://dx.doi.org/ 10.1242/jcs.034678 [5] Sinka R, Jankovics F, Somogyi K, Szlanka T, Lukacsovich T, Erdelyi M. poirot , a new regulatory gene of Drosophila oskar acts at the level of the short Oskar protein isoform.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Biochem Biophys Res Commun 1998; 245:337-43; http://dx.doi.org/10.1006/bbrc.1998.8420 [7] Qualmann B, Koch D, Kessels MM.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"EMBO J 2011;30:3501-15; PMID:21878992; http://dx.doi.org/10.1038/ emboj.2011.266 [8] Grant B, Hirsh D. Receptor-mediated endocytosis in the Caenorhabditis elegans oocyte.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Mol Biol Cell 1999; 10:4311-26; PMID:10588660; http://dx.doi.org/10.1091/ mbc.10.12.4311 [9] Sato K, Sato M, Audhya A, Oegema K, Schweinsberg P, Grant BD.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Mol Biol Cell 2006; 17:3085-94; PMID:16672374; http://dx.doi.org/10.1091/mbc.E06- 03-0211 [10] Skop AR, Bergmann D, Mohler WA, White JG.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Curr Biol 2001; 11:735-46; PMID:11378383; http://dx.doi.org/10.1016/S0960-9822(01)00231-7 [11] Wilson GM, Fielding AB, Simon GC, Yu X, Andrews PD, Hames RS, et al.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Mol Biol Cell 2005; 16:849-60; PMID:15601896; http://dx.doi.org/10.1091/mbc.E04-10- 0927 [12] Cabrera M, Ungermann C. Guanine nucleotide exchange factors (GEFs) have a critical but not exclu- sive role in organelle localization of Rab GTPases.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"JBiol Chem 2013; 288:28704-12; http://dx.doi.org/ 10.1074/jbc.M113.488213 [13] Bhuin T, Roy JK.",OADS,/arxiv_data1/oa_pdf/6e/4f/kcib-09-05-1208325.PMC5154356.pdf
"Curr Biol 2 015; 25:2879-88; http://dx.doi.org/10.1016/j.cub.2015.09.033 © 2016 Evan S. Hill, Sunil K. Vasireddi, Jean Wang, Angela M. Bruno, and William N. Frost.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"5, e1212142 (3 pages)http://dx.doi.org/10.1080/19420889.2016.1212142",Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Nat Rev Neurosci 2003; 4:885-900; PMID:14595400;http://dx.doi.org/10.1038/nrn1248 [2] Daoudal G, Debanne D. Long-term plasticity of intrinsic excitability: learning rules and mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
Learning &memory 2003; 10:456-65; PMID:14657257; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Nat Rev Neurosci 2014; 15:157-69; PMID:24496410; http://dx.doi.org/10.1038/nrn3667 [ 4 ] H i l lE S ,V a s i r e d d iS K ,W a n gJ ,B r u n oA M ,F r o s tW N .M e m - ory formation in tritonia via recruitment of variably commit- ted neurons.",Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Curr biol 2015; 25:2879-88; PMID:26549261; http://dx.doi.org/10.1016/j.cub.2015.09.033 [5] Hill ES, Vasireddi SK, Bruno AM, Wang J, Frost WN.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
PLoS ONE 2012; 7:e40579; PMID:22815768;http://dx.doi.org/10.1371/journal.pone.0040579 [6] Routtenberg A.,Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Hippocampus 2013; 23:202-6; PMID:23355389; http://dx.doi.org/10.1002/hipo.22088 [7] Rokni U, Richardson AG, Bizzi E, Seung HS.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Neuron 2007; 54:653-66.; PMID:17521576; http://dx.doi.org/10.1016/j.neuron.2007.04.030 [ 8 ] Z i vY ,B u r n sL D ,C o c k e rE D ,H a m e lE O ,G h o s hK K ,K i t c h LJ, El Gamal A, Schnitzer MJ.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Nat Neurosci 2013; 16:264-6.; PMID:23396101; http://dx.doi.org/10.1038/nn.3329 [9] Shakhawat AM, Gheidi A, Hou Q, Dhillon SK, Mar- rone DF, Harley CW, Yuan Q. Visualizing the engram: learning stabilizes odor representations in the olfactory network.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Science 2015; 350:1477-8; PMID: 26680183; http://dx.doi.org/10.1126/science.aad9467 [11] Katz PS, Getting PA, Frost WN.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"J Neurosci 2009; 29:268-79; PMID:19129403;http://dx.doi.org/10.1523/JNEUROSCI.4456-08.2009 [14] Yiu AP, Mercaldo V, Yan C, Richards B, Rashid AJ, Hsiang HL, Pressey J, Mahadevan V, Tran MM, KushnerSA, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Neuron 2014; 83:722-35; PMID:25102562;http://dx.doi.org/10.1016/j.neuron.2014.07.017 [15] Epsztein J, Brecht M, Lee AK.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Fron Neural Circuits 2013; 7:44; PMID:235 19079; http://dx.doi.org/ 10.3389/fncir.2013.00044 [17] Han JH, Kushner SA, Yiu AP, Cole CJ, Matynia A, Brown RA, Neve RL, Guzowski JF, Silva AJ, Josselyn SA.",OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
Science 2007; 316:457-60; PMID:17446403; http://dx.doi.org/ 10.1126/science.1139438COMMUNICATIVE & INTEGRATIVE BIOLOGY e1212142-3,Non-OADS,/arxiv_data1/oa_pdf/e4/8b/kcib-09-05-1212142.PMC5154357.pdf
"Neuron 2014, 81(2): 349-365; http://dx.doi.org/10.1016/j.neuron.2013.12.002 © 2016 Su Yang, Xiao-Jiang Li, and Shihua Li.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"1, e1223580 (5 pages)http://dx.doi.org/10.1080/21675511.2016.1223580",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Hum Mol Genet 1999; 8:2047-53; PMID:10484774;http://dx.doi.org/10.1093/hmg/8.11.2047 [3] Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, N a g a s h i m aT ,I k e d aS ,T s u j iS ,K a n a z a w aI .S C A 1 7 ,an o v e lautosomal dominant cerebellar ataxia caused by anexpanded polyglutamine in TATA-binding protein.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"HumMol Genet 2001; 10:1441-8; PMID:11448935; http://dx.doi.org/10.1093/hmg/10.14.1441 [4] Rubinsztein DC, Leggo J, Crow TJ, DeLisi LE, Walsh C, Jain S, Paykel ES.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
Am J Med Genet1996; 67:495-8; PMID:8886170; http://dx.doi.org/10.1002/(SICI)1096-8628(19960920)67:5%3c495::AID-AJMG12%3e3.0.CO;2-I [5] Tsuji S. Spinocerebellar ataxia type 17: latest member of polyglutamine disease group highlights unanswered questions.,Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Arch Neurol 2004; 61:183-4; PMID:14967764; http://dx.doi.org/10.1001/archneur.61.2.183 [6] Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Sch €ols L, Riess O.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Ann Neurol 2003; 54:367-75; PMID:12953269;http://dx.doi.org/10.1002/ana.10676 [7] Bruni AC, Takahashi-Fujigasaki J, Maltecca F, Foncin JF, Servadio A, Casari G, D ’Adamo P, Maletta R, Curcio SA, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
Arch Neurol 2004; 61:1314-20; PMID:15313853;http://dx.doi.org/10.1001/archneur.61.8.1314 [8] Manto MU.,Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Cerebellum 2005; 4:2-6; PMID:15895552; http://dx.doi.org/10.1080/14734220510007914 [9] Stevanin G, Brice A. Spinocerebellar ataxia 17 (SCA17) and Huntington ’s disease-like 4 (HDL4).",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Cerebellum 2008; 7:170-8; PMID:18418687; http://dx.doi.org/10.1007/s12311-008-0016-1 [10] Toyoshima Y, Yamada M, Onodera O, Shimohata M, Inenaga C, Fujita N, Morita M, Tsuji S, Takahashi H.SCA17 homozygote showing Huntington ’s disease-like phenotype.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Ann Neurol 2004; 55:281-6; PMID:14755733; http://dx.doi.org/10.1002/ana.10824 [11] Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, et al.Molecular genetics of hereditary spinocerebellar ataxia:mutation analysis of spinocerebellar ataxia genes andCAG/CTG repeat expansion detection in 225 Italian fam-ilies.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Arch Neurol 2004; 61:727-33; PMID:15148151;http://dx.doi.org/10.1001/archneur.61.5.727 [12] Craig K, Keers SM, Walls TJ, Curtis A, Chinnery PF.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"J Neurol Sci 2005; 239:105-9;PMID:16223509; http://dx.doi.org/10.1016/j.jns.2005.08.009 [13] Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, Li SH, Hwang JC, Fang K, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Clin Genet 2004; 65:209- 14; PMID:14756671; http://dx.doi.org/10.1111/j.0009-9163.2004.00213.x [14] Nikolov DB, Burley S.K.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"NatStruct Biol 1994; 1:621-37; PMID:7634102; http://dx.doi.org/10.1038/nsb0994-621 [15] Lee TI, Young RA.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
Ann Rev Genet 2000; 34:77-137; PMID:11092823; http://dx.doi.org/10.114 6/annurev.genet.34.1.77e1223580-4 S. YANG ET AL.,OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Science 2002; 298:1036-9; PMID:12411709; http://dx.doi.org/10.1126/science.1076327 [18] Friedman MJ, Wang CE, Li XJ, Li S. Polyglutamine expan- sion reduces the association of TATA-binding protein withDNA and induces DNA binding-independent neurotoxicity.J Biol Chem 2008; 283:8283-90; PMID:18218637; http://dx.doi.org/10.1074/jbc.M709674200 [19] Reid SJ, Rees MI, van Roon-Mom WM, Jones AL, Mac- Donald ME, Sutherland G, During MJ, Faull RL, Owen MJ, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"NeurobiolDis 2003; 13:37-45; PMID:12758065; http://dx.doi.org/10.1016/S0969-9961(03)00014-7 [20] Friedman MJ, Shah AG, Fang ZH, Ward EG, Warren ST, Li S, Li XJ.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Nat Neurosci 2007; 10:1519-28; PMID:17994014; http://dx.doi.org/10.1038/nn2011 [21] Shah AG, Friedman MJ, Huang S, Roberts M, Li XJ, Li S. Transcriptional dysregulation of TrkA associates withneurodegeneration in spinocerebellar ataxia type 17.Hum Mol Genet 2009; 18:4141-52; PMID:19643914;http://dx.doi.org/10.1093/hmg/ddp363 [22] Ren J, Jegga AG, Zhang M, Deng J, Liu J, Gordon CB, Aronow BJ, Lu LJ, Zhang B, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.Hum Mol Genet 2011; 20:3424-36; PMID:21653638;http://dx.doi.org/10.1093/hmg/ddr251 [23] Solaroglu I, Jadhav V, Zhang JH.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Front Biosci2007; 12:712-24; PMID:17127331; http://dx.doi.org/10.2741/2095 [24] Kelp A, Koeppen AH, Petrasch-Parwez E, Calaminus C, Bauer C, Portal E, Yu-Taeger L, Pichler B, Bauer P, RiessO, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"J Neurosci2013; 33:9068-81; PMID:23699518; http://dx.doi.org/10.1523/JNEUROSCI.5622-12.2013 [25] Huang S, Ling JJ, Yang S, Li XJ, Li S. Neuronal expression of TATA box-binding protein containing expanded poly- glutamine in knock-in mice reduces chaperone proteinresponse by impairing the function of nuclear factor-Ytranscription factor.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Brain 2011; 134:1943-58;PMID:21705419; http://dx.doi.org/10.1093/brain/awr146 [26] Yang S, Huang S, Gaertig MA, Li XJ, Li S. Age-dependent decrease in chaperone activity impairs MANF expression,leading to Purkinje cell degeneration in inducible SCA17 mice.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Cell Rep 2015; 13:196-208; PMID:26387956;http://dx.doi.org/10.101 6/j.celrep.2015.08.060 [28] Friedman MJ, Li S, Li XJ.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"J Biol Chem 2009; 284:27944-51; PMID:19656944; http://dx.doi.org/10.1074/jbc.M109.037937 [29] Lee LC, Chen CM, Wang HC, Hsieh HH, Chiu IS, Su MT, Hsieh-Li HM, Wu CH, Lee GC, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Role of theCCAAT-binding protein NFY in SCA17 pathogenesis.PloS one 2012; 7:e35302; PMID:22530004; http://dx.doi.org/10.1371/journal.pone.0035302 [30] Cvetanovic M, Patel JM, Marti HH, Kini AR, Opal P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Nat Med 2011; 17:1445-7; PMID:22001907;http://dx.doi.org/10.1038/nm.2494 [31] Ingram M, Wozniak EA, Duvick L, Yang R, Bergmann P, Carson R, O ’Callaghan B, Zoghbi HY, Henzler C, et al.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Neuron 2016; 89:1194-207; PMID:26948890; http://dx.doi.org/10.1016/j.neuron.2016.02.011 [32] Schole ﬁeld J, Wood MJ.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Trends Genet 2010; 26:29-38;PMID:19962779; http://dx.doi.org/10.1016/j.tig.2009.11.005 [33] Fiszer A, Krzyzosiak WJ.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Nucleic Acids Res2014; 42:6787-810; PMID:24848018; http://dx.doi.org/10.1093/nar/gku385 [34] Rodriguez-Lebron E, Costa Mdo C, Luna-Cancalon K, Peron TM, Fischer S, Boudreau RL, Davidson BL, Paul-son HL.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"MolTher 2013; 21:1909-18; PMID:23820820; http://dx.doi.org/10.1038/mt.2013.152 [35] Ramachandran PS, Boudreau RL, Schaefer KA, La Spada AR, Davidson BL.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Mol Ther 2014; 22:1635-42; PMID:24930601; http://dx.doi.org/10.1038/mt.2014.108 [36] Voutilainen MH, B €ack S, P €orsti E, Toppinen L, Lindgren L, Lindholm P, Per €anen J, Saarma M, Tuominen RK.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
JNeurosci 2009; 29:9651-9; PMID:19641128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"J Cereb Blood Flow Metab 2010;30:79-91; PMID:19773801; http://dx.doi.org/10.1038/jcbfm.2009.181 [38] Lindholm P, Saarma M. Novel CDNF/MANF family of neurotrophic factors.",OADS,/arxiv_data1/oa_pdf/35/ef/krad-04-01-1223580.PMC5154381.pdf
"Neuron 2016; 90:43-55; PMID: 26971948; http://dx.doi.org/10.1016/j.neuron.2016.02.021 © 2016 Matthew D. Rannals, Stephanie Cerceo Page, Morganne N. Campbell, Ryan A. Gallo, Brent May ﬁeld, and Brady J. Maher.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"1, e1220468 (5 pages)http://dx.doi.org/10.1080/21675511.2016.1220468",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
Am J HumGenet 2007; 80:988-93; PMID:17436254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"HumMol Genet 2012; 21:2873-88; PMID:22460224; http://dx.doi.org/10.1093/hmg/dds112 [5] Whalen S, H /C19eron D, Gaillon T, Moldovan O, Rossi M, Devillard F, Giuliano F, Soares G, Mathieu-Dramard M, Afenjar A, et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"HumMutat 2011; 33:64-72; PMID:22045651; http://dx.doi.org/10.1002/humu.21639 [6] Forrest M, Chapman RM, Doyle AM, Tinsley CL, Waite A, Blake DJ.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
2012; 33:1676-86; PMID:22777675; http://dx.doi.org/ 10.1002/humu.22160 [7] Sweatt JD.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"ExpMol Med 2013; 45:e21; PMID:23640545; http://dx.doi.org/10.1038/emm.2013.32 [8] Soileau B, Hasi M, Sebold C, Hill A, O ’Donnell L, Hale DE, Cody JD.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
J Genet Couns 2014; 24:663-74; PMID:25403900; http://dx.doi.org/10.1007/s10897-014-9793-5 [9] Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
Nat Genet 2011; 43:969- 76; PMID:21926974; http://dx.doi.org/10.1038/ng.940 [10] Schizophrenia Working Group of the Psychiatric Geno- mics Consortium.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Nature 2014; 511:421-7;PMID:25056061; http://dx.doi.org/10.1038/nature13595 [11] Quednow BB, Ettinger U, M €ossner R, Rujescu D, Gie- gling I, Collier DA, Schmechtig A, K €uhn KU, M €oller HJ, Maier W, et al.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Neuropsychophar-macology 2013; 38:683-9; PMID:23249814; http://dx.doi.org/10.1038/npp.2012.234 [13] Rannals MD, Hamersky GR, Page SC, Campbell MN, Briley A, Gallo RA, Phan BN, Hyde TM, KleinmanJE, Shin JH, et al.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Neu-ron 2016; 90:43-55; PMID:26971948; http://dx.doi.org/10.1016/j.neuron.2016.02.021 [14] Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Su /C19arez-Fari ~nas M, Schwarz C, Stephan DA, Surmeier DJ, et al.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Cell 2008; 135:738-48; PMID:19013281; http://dx.doi.org/10.1016/j.cell.2008.10.028 [15] Heiman M, Kulicke R, Fenster RJ, Greengard P, Heintz N. Cell type-speci ﬁc mRNA puri ﬁcation by translating ribosome af ﬁnity puri ﬁcation (TRAP).",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Nat Protoc 2014; 9:1282-91; PMID:24810037; http://dx.doi.org/10.1038/ nprot.2014.085 [16] Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, Bupp S, Shrestha P, Shah RD, Doughty ML,et al.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Cell 2008;135:749-62; PMID:19013282; http://dx.doi.org/10.1016/j.cell.2008.10.029 [17] Maher BJ, LoTurco JJ.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"PLoS One 2012; 7:e34053; PMID:22479520; http://dx.doi.org/10.1371/journal.pone.0034053 [18] Maher BJ, LoTurco JJ.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
in Neuromethods 2011; 113-128; http://dx.doi.org/10.1007/978-1-61779-533-6_6 [19] ENCODE Project Consortium.,OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Nature2012; 489:57-74; PMID:22955616; http://dx.doi.org/ 10.1038/nature11247 [20] Zhuang Y, Cheng P, Weintraub H. B-lymphocyte devel- opment is regulated by the combined dosage of threebasic helix-loop-helix genes, E2A, E2-2, and HEB.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"MolCell Biol 1996; 16:2898-905; PMID:8649400; http://dx.doi.org/10.1128/MCB.16.6.2898 [21] de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Nat Med 2016; 22:345-61; PMID:27050589; http://dx.doi.org/10.1038/nm.4071 [22] Mullins C, Fishell G, Tsien RW.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Neuron 2016; 89:1131-56; PMID:26985722;http://dx.doi.org/10.101 6/j.neuron.2016.02.017 [23] Ebert DH, Greenberg ME.",OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
Nature 2013; 493:327-37; PMID:23325215; http://dx.doi.org/10.1038/ nature11860RARE DISEASES e1220468-5,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/krad-04-01-1220468.PMC5154382.pdf
"Retrieved  from http://www.equator-network.org/2016/02/16/anni- versary-blog-series-1/ Armstrong, R., Hall, B. J., Doyle, J., & Waters, E. (2011).",Non-OADS,/arxiv_data1/oa_pdf/eb/e0/10.1177_1049732316679370.PMC5154391.pdf
"Retrieved from http://www.integrate-hta.eu/downloads/ Clark, A. M. (2016).",OADS,/arxiv_data1/oa_pdf/eb/e0/10.1177_1049732316679370.PMC5154391.pdf
"Retrieved from http://ijq.sage- pub.com/content/15/1/1609406916672741.full Coonan, M. (2010).",Non-OADS,/arxiv_data1/oa_pdf/eb/e0/10.1177_1049732316679370.PMC5154391.pdf
"Retrieved from http://www.wma.net/en/ 30publications/10policies/b3/ Zoia, S., Blason, L., D’Ottavio, G., Bulgheroni, M., Pezzetta, E.,  Scabar, A., & Castiello, U.",Non-OADS,/arxiv_data1/oa_pdf/37/47/10.1177_0956797616667447.PMC5154392.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/srep05046.PMC5154416.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5046 | DOI: 10.1038/srep05046 9",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/srep05046.PMC5154416.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/3b/srep05158.PMC5154428.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0/ © H Yang et al.",Non-OADS,/arxiv_data1/oa_pdf/38/c9/mt2016114a.PMC5154472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016) 1948 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/4b/e5/mt2016166a.PMC5154480.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016) Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/71/13/mt2016174a.PMC5154482.pdf
"As a result, several public databases of plant TFs have been established, such as PlantTFDB (v. 2.0, http://planttfdb.cbi.pku.edu.cn) 14and PlnTFBS (v. 3.0, http://plntfdb.bio.",OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
Detailed background information about these TF-families can be accessed in the database PlantTFDB (http://planttfdb.cbi.pku.edu.cn/).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5454 | DOI: 10.1038/srep05454 3,OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"To test the specificity ofour predicted TFBSs, our computationally determined TFBS motifswere then compared to the experimentally verified motifs in TRANSFAC (http://www.gene-regulation.com/index2) 24and PLACE(http://www.dna.affrc.go.jp/PLACE/)48using STAMP49.",Non-OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
and the preliminary regulatory network of N. oceanica IMET1 are displayed in a public website (http://www.singlecellcenter.,OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"Genomes, genes and proteins of N. gaditana CCMP526 and N. oceanica CCMP1779 were downloaded from http://nannochloropsis.genomeprojectsolutions-databases.com/ and http://www.bmb.",OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
Promoter sequences of all these Nannochloropsis strains can be accessed via our website (http://www.singlecellcenter.org/en/NannoRegulationDatabase/home.htm).,Non-OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"Phylogenetic tree for 36 plant species .The 18S sequences of 36 plant species were downloaded from Silva database (http://www.arb-silva.de/; released on August 23, 2013)60.",OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
GO terms were mapped to the GO slim (Generic GO slim) hierarchy proposed by the GO consortium based on the goslim_generic.obo (version 1.2) file (http://www.geneontology.org/GO.slims.shtml).,OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"Method to compare our network to the Arabidopsis thaliana regulatory network database AtRegNet .AtRegNet contains information on physical direct regulatory interactions between 8131 target genes, 64 TFs and three TF complexes, connected by 11355 edges, among which 769 interactions were classified as ‘‘confirmedconnections’’ (http://arabidopsis.med.ohio-state.edu/moreNetwork.html).",OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5454 | DOI: 10.1038/srep05454 11",Non-OADS,/arxiv_data1/oa_pdf/d0/59/srep05454.PMC5154493.pdf
"Here we introduce the use of the airSEMTM, http://www.b-nano.com/, a novel scanning electron microscope operating at ambient conditions and capable of measuring insulated, hydrated, non-coated biological samples (Figure 1a, Methods).",Non-OADS,/arxiv_data1/oa_pdf/0c/68/srep05987.PMC5154511.pdf
"and S.A. Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : Yes, there is potential Competing Interest.",Non-OADS,/arxiv_data1/oa_pdf/0c/68/srep05987.PMC5154511.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5987 | DOI: 10.1038/srep05987 7",Non-OADS,/arxiv_data1/oa_pdf/0c/68/srep05987.PMC5154511.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7360 | DOI: 10.1038/srep07360 9",Non-OADS,/arxiv_data1/oa_pdf/37/d5/srep07360.PMC5154539.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/53/srep07591.PMC5154567.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7591 | DOI: 10.1038/srep07591 5",Non-OADS,/arxiv_data1/oa_pdf/ce/53/srep07591.PMC5154567.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.08.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/60/da/main.PMC5154576.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 137 e140,Non-OADS,/arxiv_data1/oa_pdf/60/da/main.PMC5154576.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.03.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/2e/32/main.PMC5154577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 173 e175,Non-OADS,/arxiv_data1/oa_pdf/2e/32/main.PMC5154577.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.005 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/87/18/main.PMC5154578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 146 e150,Non-OADS,/arxiv_data1/oa_pdf/87/18/main.PMC5154578.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.05.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/32/66/main.PMC5154579.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 176 e178,Non-OADS,/arxiv_data1/oa_pdf/32/66/main.PMC5154579.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.08.004 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 141 e145,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
The study variables were analyzed by SPSS v17.0 and an onlinecalculator (Evan's Awesome- http://www.evanmiller.org/ab- testing/chi-squared.html# ).,OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
http://www.who.int/healthinfo/survey/ageingdefnolder/en/ .,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
http://www.tuik.gov.tr/PreTablo.do?alt_id ¼1059 .,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
http://dx.doi.org/10.1093/ageing/afp022 .,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
http://dx.doi.org/10.1007/s40520-013-0112-z .,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
2009;2(1):19 e24.http://dx.doi.org/10.1007/ s12245-009-0087-x .,Non-OADS,/arxiv_data1/oa_pdf/81/7c/main.PMC5154580.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.08.005 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/main.PMC5154583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 151 e154,Non-OADS,/arxiv_data1/oa_pdf/bb/81/main.PMC5154583.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.02.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/main.PMC5154584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 169 e170,Non-OADS,/arxiv_data1/oa_pdf/14/0b/main.PMC5154584.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.04.003 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/db/fd/main.PMC5154585.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 171 e172,Non-OADS,/arxiv_data1/oa_pdf/db/fd/main.PMC5154585.pdf
"SOSG kit, produced by Molecular Probes and commercialized by Life Technologies, product information: http://tools.lifetechnologies.com/content/sfs/ manuals/mp36002.pdf (‘‘Singlet Oxygen Sensor Green Reagent’’, revised 30/01/2004.",Non-OADS,/arxiv_data1/oa_pdf/a3/cc/srep07606.PMC5154586.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/cc/srep07606.PMC5154586.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Wang, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/26/59/srep07610.PMC5154588.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.008 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 16 (2016) 155 e168,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.2106/JBJS.I.00450 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1111/j.1742- 6723.2005.00778.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/S0735- 6757(00)90017-2 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/S0030-5898(05) 70142-5 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1302/0301- 620X.81B4.9005 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.3810/psm.2011.09.1931 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.5435/ JAAOS-22-12-761 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1097/ TA.0b013e318197ba95 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1097/ 00005373-199206000-00023 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/j.jse.2012.04.004 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1007/s00402-013-1769-7 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1097/00005373-198809000-00013 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/ 10.2106/JBJS.H.01434 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/j.injury.2004.12.004 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/j.jemermed.2010.11.054 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/ j.jse.2012.01.004 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/ 10.12659/AJCR.891269 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1177/036354659502300322 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.3944/AOTT.2012.2676 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/j.wem.2014.12.027 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1046/j.1442- 2026.2003.00512.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
1996;27:92 e94.http://dx.doi.org/10.1016/S0196-0644(96)70303-7 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/0736-4679(90)90460-D .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/ 10.1016/S0196-0644(05)80979-5 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/ 10.1016/j.jemermed.2005.02.012 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1097/00003086-198003000- 00035 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/ 10.1007/s00113-006-1119-0 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1097/00005131-199708000-00003 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://www.ncbi.nlm.nih.gov/pubmed/17200541 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10959924 .,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
http://dx.doi.org/10.1016/j.jse.2006.04.003 .,OADS,/arxiv_data1/oa_pdf/9c/ec/main.PMC5154590.pdf
(2013) Available at: http://www.araneae.unibe.ch/.,Non-OADS,/arxiv_data1/oa_pdf/2f/74/srep07611.PMC5154591.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/74/srep07611.PMC5154591.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/ed/srep07615.PMC5154593.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/1d/srep07614.PMC5154594.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7614 | DOI: 10.1038/srep07614 9",Non-OADS,/arxiv_data1/oa_pdf/36/1d/srep07614.PMC5154594.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/b5/srep07617.PMC5154596.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7617 | DOI: 10.1038/srep07617 8",Non-OADS,/arxiv_data1/oa_pdf/d0/b5/srep07617.PMC5154596.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/12/srep07619.PMC5154597.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5e/d7/srep07622.PMC5154600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7622 | DOI: 10.1038/srep07622 8",Non-OADS,/arxiv_data1/oa_pdf/5e/d7/srep07622.PMC5154600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7625 | DOI: 10.1038/srep07625 11",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/srep07625.PMC5154604.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7620 | DOI: 10.1038/srep07620 9",Non-OADS,/arxiv_data1/oa_pdf/61/57/srep07620.PMC5154606.pdf
at http://clinicaltrials.gov/show/NCT00224770 .,Non-OADS,/arxiv_data1/oa_pdf/4a/ff/nihms823825.PMC5154627.pdf
Working paper available here: http://goo.gl/bj6WHA .,Non-OADS,/arxiv_data1/oa_pdf/4a/ff/nihms823825.PMC5154627.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/e2/main.PMC5154631.pdf
"Although  dPCR is an  absolute  measurement  method,  there  are a  number  of  factors  that  could  affect  the  reliability  of  dPCR  quan- http://dx.doi.org/10.1016/j.bdq.2016.04.001 2214-7535/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/0a/e2/main.PMC5154631.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/e2/main.PMC5154631.pdf
E-mail  address:  valerie.taly@parisdescartes.fr (V. Taly) Available online 25 November  2016 http://dx.doi.org/10.1016/j.bdq.2016.10.003 2214-7535/© 2016  Published  by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/b3/1c/main.PMC5154632.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/1c/main.PMC5154632.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5154633.pdf
To  mimic  the  interfering  sequences  that  are  present  in  samples http://dx.doi.org/10.1016/j.bdq.2016.10.001 2214-7535/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5154633.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5154633.pdf
"The  work described  in  this  paper  was  funded  in  part  by  the  UK  govern-ment  Department  for  Business,  Energy  &  Industrial  Strategy  (BEIS) and  the European Metrology Research Programme (EMRP) joint research  project  (SIB54)  Bio-SITrace  (http://biositrace.lgcgroup.",Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5154633.pdf
"Supplementary data Supplementary data associated with this article can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.10.001 .",OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5154633.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/84/main.PMC5154634.pdf
http://dx.doi.org/10.1016/j.bdq.2016.05.002 2214-7535/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fe/84/main.PMC5154634.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/84/main.PMC5154634.pdf
Acknowledgments The work described in the manuscript  was  partially  funded  by the  United  Kingdom  National  Measurement  System  (NMS)  and  the European Metrology Research Programme (EMRP) joint  research project (SIB54)  Bio-SITrace  (http://biositrace.lgcgroup.com )  which is  jointly funded by the  EMRP  participating  countries  within EURAMET and  the  European  Union.,Non-OADS,/arxiv_data1/oa_pdf/fe/84/main.PMC5154634.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/82/main.PMC5154635.pdf
http://dx.doi.org/10.1016/j.bdq.2016.06.003 2214-7535/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/82/main.PMC5154635.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/82/main.PMC5154635.pdf
"Supplementary  data Supplementary data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.06.003 .References [1]  S.  Fredriksson,  M.  Gullberg,  J.  Jarvius,  et  al.,  Protein  detection  using proximity-dependent  DNA ligation assays,  Nat.",OADS,/arxiv_data1/oa_pdf/dd/82/main.PMC5154635.pdf
"2  (2013)  e62,  http://dx.doi.org/10.1038/emi.2013.62 .",Non-OADS,/arxiv_data1/oa_pdf/dd/82/main.PMC5154635.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
http://dx.doi.org/10.1016/j.bdq.2016.10.002 2214-7535/© 2016  Published  by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
Oligonucleotides  without  references  were  designed  using  the online  Primer3  design  tool  (http://simgene.com/Primer3 ).,OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
"A  Poisson model  was  ﬁt  to  the  data  using  a  single  parameter  /H9262,  representing the  mean  of  false  positive  droplets  and  evaluated  for  goodness- of-ﬁt  using  the  online  calculator  developped  by  H.  Arsham  at  the University  of  Baltimore  (http://home.ubalt.edu/ntsbarsh/Business- stat/otherapplets/PoissonTest.htm ).",OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.10.002 .",OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
"Huggett,  S.  Tzonev,  Fundamentals  of  multiplexing  with  digital PCR,  BDQ  (May)  (2016),  http://dx.doi.org/10.1016/j.bdq.2016.05.002 .",OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
[46] http://www.ema.europa.eu/docs/en  GB/document  library/EPAR  -  Product Information/human/001016/WC500036358.pdf .,Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC5154636.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
"Moreover,  digital  techniques,  and  therefore  the  methodology  we presented  here,  may  ﬁnd  use  in  quantitative  identiﬁcation  of  viral and  microbial  pathogens  in  physiological  samples  in  assays  pre- http://dx.doi.org/10.1016/j.bdq.2016.04.002 2214-7535/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
"The  schematic  picture  of  the human  body is based on graphics  available  at:  http://cliparts.co/ ,  and  https://commons.wikimedia.org/wiki/  File:Vein  art  near.png.",Non-OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.04.002 .",OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
"Quake,  The  Digital  Array  Response  Curve, Preprint, March 2007,  http://thebigone.stanford.edu/papers/ Weinstein%20DigResCurve.pdf .",OADS,/arxiv_data1/oa_pdf/51/de/main.PMC5154637.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/01/main.PMC5154671.pdf
"Additionally,  it  is  becoming increasingly  important  to  accurately  measure  the  amount  of  mod- http://dx.doi.org/10.1016/j.bdq.2016.06.002 2214-7535/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/90/01/main.PMC5154671.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/01/main.PMC5154671.pdf
http://dx.doi.org/10.1016/j.ygyno.2009.11.020 .,OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.org/10.3892/ijmm.2015.2230 .Gynecologic Oncology Reports 18 (2016) 57 –58 DOI of original article: http://dx.doi.org/10.1016/j.ygyno.2016.06.014 .,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.org/10.1016/j.gore.2016.09.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.org/10.1016/j.ygyno.2016.06.014 (pii: S0090 –8258(16)30825 –3).,OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
http://dx.doi.org/10.1056/NEJMoa020177 .,OADS,/arxiv_data1/oa_pdf/c2/1d/main.PMC5154672.pdf
"To improve reporting of prediction model DOIs of original article: http://dx.doi.org/10.1016/j.gore.2016.10.009 , http://dx.doi.org/10.1016/j.ygyno.2016.06.020 http://dx.doi.org/10.1016/j.gore.2016.09.003 2352-5789/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/dc/77/main.PMC5154673.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/77/main.PMC5154673.pdf
"TheseGynecologic Oncology Reports 18 (2016) 53 –54 DOIs of original article: http://dx.doi.org/10.1016/j.ygyno.2016.03.015 , http://dx.doi.org/10.1016/j.gore.2016.11.004 .",OADS,/arxiv_data1/oa_pdf/37/1d/main.PMC5154694.pdf
http://dx.doi.org/10.1016/j.gore.2016.11.003 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/1d/main.PMC5154694.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/1d/main.PMC5154694.pdf
https://www.esgo.org/wp- content/uploads/2015/12/summary-report-September-18-2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/37/1d/main.PMC5154694.pdf
"3 October 2016Gynecologic Oncology Reports 18 (2016) 59 DOIs of original article: http://dx.doi.org/10.1016/j.ygyno.2015.12.009, http:// dx.doi.org/10.1016/j.gore.2016.04.007.",OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC5154695.pdf
http://dx.doi.org/10.1016/j.gore.2016.10.007 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC5154695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/dd/main.PMC5154695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/28/main.PMC5154696.pdf
Despite numerous studies reporting direct anti-tumourContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.06.003 2212-1374/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/28/main.PMC5154696.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/28/main.PMC5154696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"In an attempt to answer this question, we conducted a large audit to identify if abaseline DEXA scan was requested at the time of starting adjuvantContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.05.007 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"65 (2015) 87 –108, http://dx.doi.org/10.3322/ caac.21262 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"24 (2015) 1495 –1506, http://dx.doi.org/ 10.1158/1055-9965.EPI-15-0535 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"378 (2011) 771 –784, http://dx.doi.org/10.1016/S0140-6736(11)60993-8 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, et al., Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials, Lancet 386 (2015) 1341 –1352, http://dx.doi.org/ 10.1016/S0140-6736(15)61074-1 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
〈https://www.nice.org.uk/gui dance/cg80/chapter/1-Guidance#follow-up 〉(accessed 08.04.16).,Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"(2015) , http://dx.doi.org/ 10.1093/annonc/mdv617 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"23 (2012) 2567 –2576, http://dx.doi.org/10.1007/ s00198-011-1870-0 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"25 (Suppl 3) (2014)iii124 –iii137, http://dx.doi.org/10.1093/annonc/mdu103 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"Oncol.21 (2003) 4042 –4057, http://dx.doi.org/10.1200/JCO.2003.08.017 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"Rep. (2015) , http://dx.doi.org/10.1136/ bmjquality.u209414.w3856 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"14 (2008)139 –145, http://dx.doi.org/10.1177/1078155208091866 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"Body, Aromatase inhibitors-induced bone loss in early breast cancer, Bone Rep. 1 (2012) 201, http://dx.doi.org/10.1038/bonekey.2012.201 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"102 (2009) 175 –179, http://dx.doi.org/10.1097/ SMJ.0b013e31818be99b .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"Oncol.23 (2012) 2027 –2033, http://dx.doi.org/10.1093/annonc/mdr600 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"9 (2008) 840 –849, http://dx.doi.org/10.1016/S1470-2045(08)70204-3 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"26 (2008) 4875 –4882, http://dx.doi.org/10.1200/JCO.2008.16.3832 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"3 (2014) 25 –35,http://dx.doi.org/10.1016/j.jbo.2013.12.001 .",OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"[24] R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, et al., Ad- juvant bisphosphonate treatment in early breast cancer: meta-analyses ofindividual patient data from randomised trials, Lancet 386 (2015) 1353 –1361, http://dx.doi.org/10.1016/S0140-6736(15)60908-4 .",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"2 (2013) 2 –10,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
"San Antonio Breast Cancer Symposium, 2015; Abstract S2-02 〈http://www.abstracts2view.com/sabcs15/ view.php?nu ¼SABCS15L_443 〉 .J.",Non-OADS,/arxiv_data1/oa_pdf/fb/17/main.PMC5154697.pdf
Patients with PFs often require http://dx.doi.org/10.1016/j.jbo.2016.07.003 Received 14 March 2016; Received in revised form 8 July 2016; Accepted 8 July 2016⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/2b/26/main.PMC5154698.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/26/main.PMC5154698.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/fa/main.PMC5154699.pdf
"Although OMX is a rare manifestation of CNC it is important to identify since symptoms of skeletal neoplasm are nonspeci ﬁc, often leading toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.07.002 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6d/fa/main.PMC5154699.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/fa/main.PMC5154699.pdf
"61 (1986) 508, http://dx.doi.org/ 10.1016/S0025-6196(12)61989-2 .",Non-OADS,/arxiv_data1/oa_pdf/6d/fa/main.PMC5154699.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
"Thus, to better understand the transcriptional status affected by EWSR1/FLI1 protein in Ewing sarcoma, we ﬁrst retrieved datasets from online database [14] and then analyze the data of transcriptome changes in Ewing sarcomaContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.05.006 2212-1374/ &2016 Published by Elsevier GmbH.",OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
"Retrieval of gene expression dataset from online database In this study, we ﬁrst downloaded the gene expression data series GSE27524 from GEO Datasets of NCBI ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
"Analysis of the TF-gene regulatory network based on gene ex- pression and transcriptional regulatory element database (TRED) The TRED ( http://rulai.cshl.edu/TRED ) provides an accurate and comprehensive knowledge involves transcriptional regulatory elements [16,17].",OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
Differentially expressed genes after EWSR1/FLI1 knockdown in Ewing sar- coma cell s.The gene expression datasets GSE27524 were downloaded from GEO Datasets of NCBI ( http://www.ncbi.nlm.nih.gov/gds/ ).,OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
Supporting information Supplementary data associated with this article can be found inthe online version at http://dx.doi.org/10.1016/j.jbo.2016.05.006 .,OADS,/arxiv_data1/oa_pdf/7d/e5/main.PMC5154700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/89/main.PMC5154701.pdf
"A previous study indicated that miR-125b was signiﬁcantly reduced in OS tissues, and that it suppresses pro- liferation and migration of OS cells through down-regulation ofContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.06.002 2212-1374/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/0f/89/main.PMC5154701.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/89/main.PMC5154701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/d4/main.PMC5154702.pdf
"In addition, the issue around the adjuvant use of bisphosphonates has become clinically challenging; initial animal models suggested bisphosphonates were most effective in a high bone turnover environment, how- ever a recent meta-analysis would suggest that the clinical bene ﬁtContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.07.001 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/d4/main.PMC5154702.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/d4/main.PMC5154702.pdf
"[22] NCT01847976, A Phase 2 Trial Exploring the Clinical and Correlative Effects of Combining Doxycycline With Bone-Targeted Therapy in Patients With Meta- static Breast Cancer, Available from: 〈https://clinicaltrials.gov/ct2/show/ NCT01847976 〉.",Non-OADS,/arxiv_data1/oa_pdf/5b/d4/main.PMC5154702.pdf
Available from: 〈https://clinicaltrials.gov/ct2/show/ NCT01847976 〉.,Non-OADS,/arxiv_data1/oa_pdf/5b/d4/main.PMC5154702.pdf
"Since the advent of genomics technology, proteomics provides a powerful tool to discover new biomarkers for early diagnosis [13] .I t http://dx.doi.org/10.1016/j.jbo.2016.05.002 Received 12 February 2016; Received in revised form 28 April 2016; Accepted 2 May 2016⁎Corresponding author at: Department of Pharmaceutical Chemistry, School of Pharmacy, Jilin University, FuJi Road, 130041 ChangChun, China.",OADS,/arxiv_data1/oa_pdf/e4/bc/main.PMC5154703.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/main.PMC5154703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/52/main.PMC5154704.pdf
"All patients approved the use of their data for this study, and this study was approved by the ethics committee at our institution.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/jboJournal of Bone Oncology http://dx.doi.org/10.1016/j.jbo.2016.06.001 2212-1374/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/71/52/main.PMC5154704.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/52/main.PMC5154704.pdf
"Indeed, with the use of relative risk calculation, such an approach improves the performance comparing to DOIs of original article: http://dx.doi.org/10.1016/j.gore.2016.09.003 , http://dx.doi.org/10.1016/j.ygyno.2016.06.020 .",Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.org/10.1016/j.gore.2016.10.009 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.org/10.1002/uog.17225 .,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.org/ 10.1038/bjc.2016.227 .,Non-OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.org/10.1016/j.ygyno.,OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
Gynecol Oncol Rep. http://dx.doi.org/10.1016/j.gore.2016.09.003 .,OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
http://dx.doi.org/10.1016/j.jclinepi.2015.12.005 .,OADS,/arxiv_data1/oa_pdf/f4/2d/main.PMC5154705.pdf
"12 (Jul,PubMed PMID: 27406097).DOIs of original article: http://dx.doi.org/10.1016/j.gore.2016.11.003 , http://dx.doi.org/10.1016/j.ygyno.2016.03.015 .",OADS,/arxiv_data1/oa_pdf/b1/64/main.PMC5154706.pdf
http://dx.doi.org/10.1016/j.gore.2016.11.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/64/main.PMC5154706.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/64/main.PMC5154706.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/62/main.PMC5154707.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.07.001 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/main.PMC5154707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 5 (2016) 54 e64,Non-OADS,/arxiv_data1/oa_pdf/5c/62/main.PMC5154707.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/ea/ijn-11-6679.PMC5154724.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6679–6692International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6679OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10969 5 silver nanoparticles inhibit the function of  hypoxia-inducible factor-1 and target genes:  insight into the cytotoxicity and antiangiogenesis Tieshan Yang1 Qian Yao1 Fei cao1 Qianqian liu1 Binlei liu2 Xiu-hong Wang1 1laboratory for Biomedical Photonics,   Institute of laser engineering, Beijing  University of T echnology, 2cancer  Institute and hospital, chinese  academy of Medical sciences and  Peking Union Medical college, Beijing,   People’s republic of chinaAbstract:  Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that is activated upon  exposure to hypoxic stress.",Non-OADS,/arxiv_data1/oa_pdf/51/ea/ijn-11-6679.PMC5154724.pdf
"HIF-1 α then translocates to the nucleus and binds, as part of a dimeric  complex with the constitutively expressed HIF-1 β protein, to hypoxia-responsive  elements (HREs) in promoters, modulating the expression of specific downstream  target genes.correspondence: Xiu-hong Wang laboratory for Biomedical Photonics,  Institute of laser engineering,  Beijing University of Technology,  PingleYuan 100, chaoyang District,  100124 Beijing, People’s republic  of china Tel +86 10 6739 1927 email wxh2012@bjut.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ang et al Running head recto: Silver nanoparticles inhibit HIF-1 function DOI: http://dx.doi.org/10.2147/IJN.S109695",Non-OADS,/arxiv_data1/oa_pdf/51/ea/ijn-11-6679.PMC5154724.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/51/ea/ijn-11-6679.PMC5154724.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/ea/ijn-11-6679.PMC5154724.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/fd/ijn-11-6693.PMC5154725.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6693–6702International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6693OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12266 6 Polyethylenimine-functionalized silver  nanoparticle-based co-delivery of paclitaxel  to induce hepg2 cell apoptosis Yinghua li1,* Min guo1,* Zhengfang lin1 Mingqi Zhao1 Misi Xiao1 changbing Wang1 Tiantian Xu1 Tianfeng chen2 Bing Zhu1 1center laboratory, guangzhou  Women and children’s Medical  center, guangzhou Medical University,   2Department of chemistry, Jinan  University, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Hepatocarcinoma is the third leading cause of cancer-related deaths around the  world.",Non-OADS,/arxiv_data1/oa_pdf/e9/fd/ijn-11-6693.PMC5154725.pdf
"Recently, nanobiotechnology plays an important role in cancer therapy.10,11 It  improves the efficiency of drug delivery, reduces side effects of drug, and strengthens  molecular targeting in biomedical applications.12–14 Nanomaterial is considered to be  a promising solution to overcome the above problems with the peculiar properties, correspondence: Bing Zhu center laboratory, guangzhou  Women and children’s Medical center,  guangzhou Medical University, No 318  renminzhong road Yuexiu District,  guangzhou 510120, People’s republic  of china Tel +86 20 8133 0740 Fax +86 20 8188 5978 email zhubing2016@hotmail.co m  Tianfeng chen Department of chemistry, Jinan  University, guangzhou 510632, People’s  republic of china Tel +86 20 8522 0223 Fax +86 20 8522 1263 email tianfengchen2016@hotmail.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Effect of Ag@PEI@PTX on HepG2 cells DOI: http://dx.doi.org/10.2147/IJN.S122666",Non-OADS,/arxiv_data1/oa_pdf/e9/fd/ijn-11-6693.PMC5154725.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e9/fd/ijn-11-6693.PMC5154725.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/fd/ijn-11-6693.PMC5154725.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/ijn-11-6635.PMC5154726.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6635–6649International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6635OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12184 7 Biofabrication of a novel biomolecule-assisted  reduced graphene oxide: an excellent biocompatible  nanomaterial Xi-Feng Zhang1 sangiliyandi gurunathan2 1college of Biological and  Pharmaceutical engineering,   Wuhan Polytechnic University,   Wuhan, People’s republic of china;   2Department of stem cell and  regenerative Biotechnology, Konkuk  University, seoul, republic of KoreaAbstract:  Graphene has been shown much interest, both in academics and industry due  to its extraordinary physical, chemical, and biological proprieties.",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/ijn-11-6635.PMC5154726.pdf
"Gra - phene possesses unique and exceptional physical and chemical properties such as high  electrical conductance, high fracture strength, thermal conductivity, mechanical strength  and stiffness, unique optical properties, extreme chemical stability, fast mobility of  charge carriers, large surface area, elasticity, biocompatibility, cytocompatibility, and  degradability.1–8 Besides these characteristics, graphene has other fascinating proper - ties, including high tunable amphiphilicity, photoconversion efficiency, excellent drug  loading capacity, flexibility in size, and low cytotoxicity used for nanomaterial-based  biomedical applications such as cancer and stem cell therapies.1–12correspondence: sangiliyandi gurunathan Department of stem cell and  regenerative Biotechnology,  Konkuk University, seoul 143-701,  republic of Korea Tel +82 2 450 0457 Fax +82 2 544 4645 email gsangiliyandi@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang and Gurunathan Running head recto: Biofabrication of a novel biomolecule-assisted reduced graphene oxide DOI: http://dx.doi.org/10.2147/IJN.S121847",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/ijn-11-6635.PMC5154726.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ca/d1/ijn-11-6635.PMC5154726.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/d1/ijn-11-6635.PMC5154726.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6667–6678International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6667OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11623 0 a novel double-targeted nondrug delivery system  for targeting cancer stem cells shupei Qiao1,* Yufang Zhao1,* shuai geng2,* Y ong li1,* Xiaolu hou1,3 Yi liu1 Feng-huei lin4,5 lifen Yao6 Weiming Tian1 1school of life science and  T echnology, harbin Institute of  T echnology, 2Department of  Pharmacology, harbin Medical  University, 3Department of cardiology,   The Fourth affiliated hospital of  harbin Medical University, harbin,   People’s republic of china; 4Institute  of Biomedical engineering, National  Taiwan University, Taipei, Taiwan;   5Institute of Biomedical engineering  and Nanomedicine, National health  research Institutes, Miaoli, Taiwan;   6Department of Neurology, The First  affiliated hospital of harbin Medical  University, harbin, People’s republic  of china *These authors contributed equally  to this workAbstract:  Instead of killing cancer stem cells (CSCs), the conventional chemotherapy used for  cancer treatment promotes the enrichment of CSCs, which are responsible for tumor growth,  metastasis, and recurrence.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
"However, most of the CSC  therapeutic agents can only kill a small proportion of CSCs by targeting one or two  cell surface markers or dysregulated CSC pathways, which are usually shared with  normal stem cells (NSCs).10–14correspondence: Weiming Tian Bio-X center, school of life science  and Technology, harbin Institute of  Technology, No 2 Yikuang street,  Nangang District, harbin 150080,  People’s republic of china Tel/fax +86 451 8640 3484 email tianweiming@hit.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Qiao et al Running head recto: A novel double-targeted nondrug delivery system DOI: http://dx.doi.org/10.2147/IJN.S116230",Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
"All animal  care and experiments were guided in line with the standards  of the Animal Research Committee of the School of Life  Science and Technology, Harbin Institute of Technology,  and conducted in accordance with Chinese National Guide - lines for Animal Welfare which were issued in 1988 and  revised in 2013 ( http://www.gov.cn/gongbao/content/2014/ content_2692743.ht m).",Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/ijn-11-6667.PMC5154727.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/78/16/ijn-11-6651.PMC5154728.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6651–6666International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6651OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11577 3 Novel guanidinylated bioresponsive  poly(amidoamine)s designed for short hairpin  rNa delivery Jiankun Yu1 Jinmin Zhang1 haonan Xing1 Yanping sun1 Zhen Yang1 Tianzhi Yang2 cuifang cai1 Xiaoyun Zhao3 li Yang1 Pingtian Ding1 1school of Pharmacy, shenyang  Pharmaceutical University, shenyang,   china; 2Department of Basic  Pharmaceutical sciences, school  of Pharmacy, husson University,   Bangor, M e, Usa; 3Department of  Microbiology and cell Biology, school  of life science and Biopharmaceutics,   shenyang Pharmaceutical University,   shenyang, chinaAbstract:  Two different disulfide (SS)-containing poly(amidoamine) (PAA) polymers were  constructed using guanidino (Gua)-containing monomers (ie, arginine [Arg] and agmatine  [Agm]) and N,N′-cystamine bisacrylamide (CBA) by Michael-addition polymerization.",Non-OADS,/arxiv_data1/oa_pdf/78/16/ijn-11-6651.PMC5154728.pdf
"Therefore, the development of efficient and safe deliv - ery systems that have the capability to deliver siRNAs to action sites is essential for correspondence: li Yang; Pingtian Ding school of Pharmacy, shenyang  Pharmaceutical University, 103 Wenhua  road, shenhe, shenyang, liaoning  110016, china Tel +86 24 2398 6349/6305 Fax +86 24 2398 6349/6305 email ylsnowle@126.co m;   267204521@qq.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yu et al Running head recto: Novel PAA polymers for shRNA delivery  DOI: http://dx.doi.org/10.2147/IJN.S115773",Non-OADS,/arxiv_data1/oa_pdf/78/16/ijn-11-6651.PMC5154728.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/78/16/ijn-11-6651.PMC5154728.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/16/ijn-11-6651.PMC5154728.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/ijn-11-6591.PMC5154729.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6591–6608International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6591OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12061 1 stimuli-responsive hybrid nanocarriers developed  by controllable integration of hyperbranched  PeI with mesoporous silica nanoparticles for  sustained intracellular sirNa delivery Neeraj Prabhakar1,2 Jixi Zhang3 Diti Desai1 eudald casals1 Tina gulin-sarfraz1 T uomas Näreoja2,4 Jukka Westermarck5,6 Jessica M rosenholm1 1Pharmaceutical sciences laboratory,   Faculty of science and engineering,   Åbo akademi University, 2laboratory  of Biophysics, Faculty of Medicine,   University of T urku, T urku, Finland;   3college of Bioengineering,   chongqing  University, chongqing,   People’s republic of china;   4Department of Neuroscience,   Karolinska Institute, stockholm,   sweden; 5centre for Biotechnology,   University of T urku and Åbo akademi,   6Department of Pathology, University  of T urku, T urku, FinlandAbstract:  Small interfering RNA (siRNA) is a highly potent drug in gene-based therapy with  the challenge being to deliver it in a sustained manner.",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/ijn-11-6591.PMC5154729.pdf
"First, as siRNA-mediated tar - get inhibition takes considerably longer time than direct small molecular targeting of correspondence: Jessica M rosenholm Pharmaceutical sciences laboratory,  Faculty of science and engineering,  Åbo akademi University, FI-20520  Turku, Finland Tel +358 2 215 3255 email jessica.rosenholm@abo.fi   Jixi Zhang college of Bioengineering, chongqing  University, chongqing 400044,  People’s republic of china Tel +86 186 2331 6698 email jixizhang@cqu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Prabhakar et al Running head recto: Stimuli-responsive MSN nanocarriers for siRNA delivery DOI: http://dx.doi.org/10.2147/IJN.S120611",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/ijn-11-6591.PMC5154729.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/ijn-11-6591.PMC5154729.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/7c/ijn-11-6591.PMC5154729.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/64/nihms833419.PMC5154769.pdf
").3Present address: Department of Cell and Developmental Biology, 601 South Goodwin Avenue, University of Illinois, Urbana- Champaign, IL 61801, USA4Present address: Department of Biology, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6,  Canada SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three figures, and two movies and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2016.03.061 .",Non-OADS,/arxiv_data1/oa_pdf/79/64/nihms833419.PMC5154769.pdf
"13  3025–3039 https://doi.org/10.1084/jem.201516203025Introduct Ion Marginal zone B (MZ B) cells are considered to be one of  the primary cells responsible for the antibody response to  type 2 thymus-independent (TI-2) antigens, such as poly - saccharide of encapsulated bacteria (Fagarasan and Honjo,  2000; Martin et al., 2001; Balázs et al., 2002; Oganesyan  et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/76/fe/JEM_20151620.PMC5154933.pdf
13  3041–3056 https://doi.org/10.1084/jem.201516363041Introduct Ion The thymus plays a critical role in adaptive immunity as the  site where hematopoietic progenitors give rise to naive T  cells ready to respond to antigen stimulation and undergo  effector differentiation.,Non-OADS,/arxiv_data1/oa_pdf/95/85/JEM_20151636.PMC5154934.pdf
"13  2967–2988 https://doi.org/10.1084/jem.201516652967Introduct Ion Solid human tumors such as breast cancer and pancreatic  ductal adenocarcinoma (PDAC) are characterized by a pro ­ nounced stromal reaction termed the desmoplastic response  that can promote tumor progression and aggression (Liotta  and Kohn, 2001; Orimo et al., 2005; Karnoub et al., 2007;  Shiao and Coussens, 2010).",Non-OADS,/arxiv_data1/oa_pdf/a5/f6/JEM_20151665.PMC5154935.pdf
"13  2897–2911 https://doi.org/10.1084/jem.201601672897Introduct Ion Memory CD8 T cells have traditionally been classified as  either central memory cells (CCR7hiCD62Lhi; Tcm) that  recirculate through the blood and secondary lymphoid or - gans, or effector memory cells (CCR7loCD62Llo; T em) that  transit through blood and peripheral tissues, such as the  lung (Sallusto et al., 1999; Masopust et al., 2001; Jameson  and Masopust, 2009; Sathaliyawala et al., 2013; Thome et  al., 2014).",Non-OADS,/arxiv_data1/oa_pdf/5f/cc/JEM_20160167.PMC5154936.pdf
"13  2931–2947 https://doi.org/10.1084/jem.201603032931Introduct Ion During viral infection, recognition of pathogen-associated  molecular patterns activates transcription factors IFN regu - latory factor 3/7 (IRF3/7) and NF- κB, leading to cytokine  and IFN- α/β gene expression (Honda and Taniguchi, 2006;  Brennan and Bowie, 2010).",Non-OADS,/arxiv_data1/oa_pdf/4b/92/JEM_20160303.PMC5154937.pdf
"13  2871–2883 https://doi.org/10.1084/jem.201605972871Introduct Ion In cross-presentation, exogenous antigens taken up by  APCs are processed for presentation by MHCI (Bevan,  1976; Ackerman and Cresswell, 2004; Rock and Shen,  2005).",Non-OADS,/arxiv_data1/oa_pdf/ce/44/JEM_20160597.PMC5154939.pdf
"13  2885–2896 https://doi.org/10.1084/jem.201606622885Introduct Ion Mycobacterium ulcerans , the causative agent of Buruli ul - cers (BUs), infects and destroys human skin without alerting  the host immune system (Demangel et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/5d/4a/JEM_20160662.PMC5154940.pdf
"13  3007–3024 https://doi.org/10.1084/jem.201607123007Introduct Ion In humans, B cell chronic lymphocytic leukemia (CLL) with  CD5+ phenotype is a common form of adult leukemia with  an incidence that increases with advancing age.",Non-OADS,/arxiv_data1/oa_pdf/c3/ff/JEM_20160712.PMC5154941.pdf
"13  2989–3005 https://doi.org/10.1084/jem.201608172989Introduct Ion Synovial sarcoma (SS) is the most common soft-tissue sar - coma in adolescents and young adults (Herzog, 2005).",Non-OADS,/arxiv_data1/oa_pdf/1c/c8/JEM_20160817.PMC5154942.pdf
"13  2949–2966 https://doi.org/10.1084/jem.201608772949Introduct Ion Chronic pain, a debilitating syndrome that occurs after nerve  damage or severe inflammation, can lead to hypersensitivity  in the peripheral and central nervous systems (Woolf and  Salter, 2000; Baron et al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/d3/86/JEM_20160877.PMC5154943.pdf
"13  3075–3086 https://doi.org/10.1084/jem.201608883075Introduct Ion Tissue-resident memory CD8+ T cells (T RM) reside within  epithelial barriers of nonlymphoid tissues and provide ac - celerated protection from local reinfection (Schenkel and  Masopust, 2014; Park and Kupper, 2015; Mueller and Mackay,  2016).",Non-OADS,/arxiv_data1/oa_pdf/38/b8/JEM_20160888.PMC5154944.pdf
13  2851–2860 https://doi.org/10.1084/jem.201609002851Introduct Ion Nucleotide-binding domain and leucine-rich repeat (NLR)  proteins are well-established hub proteins regulating a di - versity of inflammatory and host defense responses in the  immune system.,Non-OADS,/arxiv_data1/oa_pdf/b5/03/JEM_20160900.PMC5154945.pdf
13  3057–3073 https://doi.org/10.1084/jem.201609383057Introduct Ion Nonlymphoid tissues (NLTs) that have experienced infec - tions are subsequently surveyed by at least two subpopula - tions of memory T cells: tissue-resident memory T cells (T RM  cells) and effector memory T cells (T EM cells).,OADS,/arxiv_data1/oa_pdf/54/66/JEM_20160938.PMC5154946.pdf
"13  2861–2870 https://doi.org/10.1084/jem.201611352861Introduct Ion DCs are specialized antigen-presenting cells that initiate T  cell–mediated immune responses and function as key media - tors of immunity and tolerance (Steinman and Hemmi, 2006;  Steinman and Banchereau, 2007; Manicassamy and Pulendran,  2011).",OADS,/arxiv_data1/oa_pdf/d7/dd/JEM_20161135.PMC5154947.pdf
13  2913–2929 https://doi.org/10.1084/jem.201612892913Introduct Ion Most viral pathogens enter the host via mucosal barriers that  must properly discriminate between harmful and beneficial  antigens.,Non-OADS,/arxiv_data1/oa_pdf/aa/f9/JEM_20161289.PMC5154948.pdf
"13  2835–2840 https://doi.org/10.1084/jem.201614622835Introduction Immunotherapy with anti–programmed death-1 (PD-1) or  anti–PD-1 ligand 1 (PD-L1) antibodies has been approved for  the treatment of several cancers because of impressive durable  responses; however, overall, only a small percentage of patients  currently benefit from PD-1 blockade therapy alone (T opa - lian et al., 2012; Herbst et al., 2014; Powles et al., 2014; Ansell  et al., 2015; Garon et al., 2015; Postow et al., 2015; Robert et  al., 2015a,b; Weber et al., 2015; Nghiem et al., 2016; Ribas et  al., 2016).",Non-OADS,/arxiv_data1/oa_pdf/78/75/JEM_20161462.PMC5154949.pdf
"http://dx.doi.org/10.1158/2159-8290.CD-16-1223 Sznol, M., and L. Chen.",OADS,/arxiv_data1/oa_pdf/78/75/JEM_20161462.PMC5154949.pdf
"13  2841–2850 https://doi.org/10.1084/jem.201617762841Introduct Ion Microorganisms within the mammalian gastrointestinal tract  have developed complex relationships with the host, such that  the host provides a nutrient-rich microbial niche while the  microbes provide vitamins, metabolites, and other nutrients  otherwise inaccessible to the host (Hooper et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/59/cd/JEM_20161776.PMC5154950.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/f0/main.PMC5154961.pdf
1936-5233/17 http://dx.doi.org/10.1016/j.tranon.2016.11.002,Non-OADS,/arxiv_data1/oa_pdf/9d/f0/main.PMC5154961.pdf
Brain metastases in small cell lung cancer; 2004 [( http://www.cancernetwork.com/lung-cancer/brain-metastases- small-cell-lung-cancer ).,Non-OADS,/arxiv_data1/oa_pdf/9d/f0/main.PMC5154961.pdf
This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.11.005,OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1148/radiol.2371041444 .,OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1002/jmri.22880 .,OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1148/radiology.153.1.6089263 .,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/ 10.1097/RLI.0b013e318289a70b .,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/ 10.1097/RLI.0000000000000118 .,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1148/radiology.201.3.8939219 .,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1016/j.jvir.2009.08.013 .,OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
http://dx.doi.org/10.1148/radiol.2312021639 .,Non-OADS,/arxiv_data1/oa_pdf/91/30/main.PMC5154962.pdf
"Case #2 A 54 year old male with past medical history of chronic low back pain, osteoarthritis, nicotine dependence, polysubstance abuse and http://dx.doi.org/10.1016/j.mmcr.2016.12.003 Received 11 November 2016; Received in revised form 28 November 2016; Accepted 1 December 2016⁎Corresponding author at: Department of Medicine/Division of Infectious Diseases,University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.Medical Mycology Case Reports 14 (2016) 17–19 Available online 02 December 2016 2211-7539/ © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/main.PMC5154963.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/a5/main.PMC5154963.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/41/main.PMC5154965.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.11.009 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/8d/41/main.PMC5154965.pdf
http://dx.doi.org/10.1016/j.mmcr.2016.11.005 Received 23 November 2016; Accepted 24 November 2016⁎Corresponding author.Medical Mycology Case Reports 14 (2016) 1–3 Available online 26 November 2016 2211-7539/ © 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/1b/main.PMC5154966.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/1b/main.PMC5154966.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: VLCADVery long chain acyl-CoA dehydrogenase de ﬁ- ciency ECMO ACADVL 1.,Non-OADS,/arxiv_data1/oa_pdf/36/44/main.PMC5154967.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.11.008 2214-4269/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/36/44/main.PMC5154967.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/44/main.PMC5154967.pdf
"[11] New England Consortium of Metabolic Programs, acute illness protocols, available onhttp://newenglandconsortium.org/for-professionals/acute-illness-protocols .",Non-OADS,/arxiv_data1/oa_pdf/36/44/main.PMC5154967.pdf
"He was working as super- intendent overseeing maintenance of pipes at the time of diagnosis, but http://dx.doi.org/10.1016/j.mmcr.2016.11.006 Received 15 November 2016; Received in revised form 27 November 2016; Accepted 28 November 2016⁎Corresponding author.Medical Mycology Case Reports 14 (2016) 4–7 Available online 29 November 2016 2211-7539/ © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/53/e6/main.PMC5154969.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/53/e6/main.PMC5154969.pdf
"The CT-scans and the chest radiographies performed during http://dx.doi.org/10.1016/j.mmcr.2016.11.002 Received 10 October 2016; Received in revised form 23 November 2016; Accepted 24 November 2016⁎Corresponding author at: Institut de Parasitologie et de Pathologie Tropicale, EA 7292, Fédération de Médecine Translationnelle, Université de Strasbourg, 3 Rue Koeberlé, 67000 Strasbourg, France.Medical Mycology Case Reports 14 (2016) 8–11 Available online 30 November 2016 2211-7539/ © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC5154970.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC5154970.pdf
"ncbi.nlm.nih.gov/genbank , accession number for closest hitKM588309.1 ) and CBS ( http://www.cbs.knaw.nl , accession number for closest hit CBS 10896_ex24366_12125_ITS) databases.",OADS,/arxiv_data1/oa_pdf/f5/c2/main.PMC5154970.pdf
"First, the latency period between inocula- tion of the pathogen and manifestation of overt symptoms may be very http://dx.doi.org/10.1016/j.mmcr.2016.12.002 Received 14 November 2016; Received in revised form 30 November 2016; Accepted 1 December 2016⁎Corresponding author at: Department for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria .",Non-OADS,/arxiv_data1/oa_pdf/88/89/main.PMC5154971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/88/89/main.PMC5154971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Parasitic plantMonotropa hypopitysTranscriptomeRNA-Seq Speciﬁcations 1.,Non-OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
Direct link to deposited data https://www.ncbi.nlm.nih.gov/sra/SRP069226 .2.,OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
"Organism/cell line/tissueMonotropa hypopitys /ﬂowers, ﬂower bracts, and roots Sex N/A Sequencer or array typeIllumina HiSeq2500 Data format Raw data: FASTQ ﬁle Experimental factorsDe novo transcriptome assembly of Monotropa hypopitys Experimental featuresFlowers and leaves ( ﬂower bracts) of two individual Monotropa hypopitys plants and two pooled samples of roots with haustoria were harvested for total RNA extraction,sequencing, de novo transcriptome assembly and annotation Consent N/ASample source locationSample was collected in Kaluga region, Russia http://dx.doi.org/10.1016/j.gdata.2016.11.020 2213-5960/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
"A total of 103,025,683 high quality reads were ﬁltered after removing of adapter sequences and quality trimming with Cutadapt [11] and Sickle (https://github.com/najoshi/sickle ), respectively.",Non-OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
Coding regions prediction in the assembled transcripts was performed by the TransDecoder program ( http://transdecoder.github.io ) implemented in the Trinity software.,OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
"Trinotate ( https://trinotate.github.io /) was used to assign hits from TrEMBL and Swiss-Prot databases ( http://www.uniprot.org/ uniprot/ ), and to assign GO terms and pfam domains.",OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
"3) (2016) 238, http://dx.doi.org/10.1186/s12870-016-0929-7 .",Non-OADS,/arxiv_data1/oa_pdf/db/79/main.PMC5154972.pdf
Keyword: Food scienceReceived: 14 September 2016 Revised: 21 October 2016 Accepted: 18 November 2016 Heliyon 2 (2016) e00201 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
"Shiroyutaka for starch production, 240 kg)were squeezed, without the addition of water, by an attritor fitted with a centrifugal Article No~e00201 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Ingredients Composition (%) Milk Casein 24.5 Egg Albumen powder 5.0L-cystine 0.43 Beef fat powder 15.88 Safflower oil 20.0 Crystalline cellulose 5.5 Malto dextrin 8.25 Lactose 6.928 Sucrose 6.75 AIN96 vitamin mixture 1.4 AIN96 mineral mixture 5.0 Choline bitartrate 0.36 tert-butylhydroquinone 0.002 Article No~e00201 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
"The predominance of small, dense LDL has been accepted as an important cardiovascular risk factor ( Lamarche et al., 1997 ; Article No~e00201 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
Article No~e00201 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00201 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8a/main.PMC5154978.pdf
LE motor impairment also improved.Received: 24 June 2016 Revised: 8 November 2016 Accepted: 24 November 2016 Heliyon 2 (2016) e00208 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
"After participants completed the study, separate informed consent Article No~e00208 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
"To verify the intervention ’s potential use, we looked to ensure that the desired bilateral LE movements could be completed by the Article No~e00208 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Since MCIDs Article No~e00208 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Despite the negative changes in Article No~e00208 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
"Stam, Mirror therapy improves hand function in subacute Article No~e00208 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
Article No~e00208 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00208 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/76/main.PMC5154979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy Leukemia (2016) 30,2397 –2401; doi:10.1038/leu.2016.221 Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a blockage in the differentiation of myeloid cellsat different stages of maturity and by an increase in theirproliferation.",Non-OADS,/arxiv_data1/oa_pdf/cf/dc/leu2016220a.PMC5155028.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients Leukemia (2016) 30,2419 –2422; doi:10.1038/leu.2016.245 Chronic lymphocytic leukemia (CLL) is a neoplastic disease of mature B cells that express a functional immunoglobulin (Ig) B-cellreceptor (Ig-BCR) on the cell surface.1The Ig-BCR includes the binding site (idiotype) for the epitope of cognate antigen, whichresults from the stochastic and productive Ig variable genesrearrangement and possible somatic hypermutation.",Non-OADS,/arxiv_data1/oa_pdf/dc/4e/leu2016245a.PMC5155031.pdf
"(%)dStereotypicsubseteMimotopenameMimotope aa sequenceK D (nM)f CLL#1 CLL1 mIgCLL1 V3-11/D3-10/J6 κV1-39(1D-39)/J2 17 AREGLWFGELSYYGMDV 100 NA pCLL1 CSPAKELGC 34.03 CLL#2 CLL2 mIgCLL2-1 V3-73/D3-3/J6 κV1-33(1D-33)/J1 20 TFDFWSGYYDGY YYYY GMDV 80 NA pCLL2-1 CNTYSVSLC 10.81 mIgCLL2-2 TFDFWSGYYDGY YYYYGLDF 20 pCLL2-2 CKSYSVSLC 7.57 CLL#3 CLL3 mIgCLL3-1 V3-23/D3-22/J4 κV1-8(1D-8)J3 17 AKRDYSHRSDYAPLFEY 90 NA pCLL3-1 CPPQSVTEC 22.14 mIgCLL3-2 GKRDYSHSSDYAPLFEY 10 NA pCLL3-2 CDVWHSAYC 5.64 CLL#4-1 CLL4-1 mIgCLL4-1 V4-34/D7-27/J2 κV1-33(1D-33)/J1 17 ARRGTGDPPYWYFDL 77 NA pCLL4-1 CTTNPADSC 5.50 CLL#4-2 CLL4-2 mIgCLL4-2 V4-4/D6-19/J2 κV2-28(2D-28)J1 21 ARGTVGQQWLEVLDWYFGL 23 NA pCLL4-2 CVLWWSPIC 3.90 CLL#5-1 CLL5-1 mIgCLL5-1 V4-34/D3-22/J4 κV1D-12/J1 20 ARGGNNDKIVMLLYYFDF 57 NA pCLL5-1 CFSDDEWWC 7.08 CLL#5-2 CLL5-2 mIgCLL5-2 V4-59/D3-22/J3 κV1-13(1D-13)/J2 18 ARDYDYDTRKSDAFDIW 43 NA pCLL5-2 CPPFTNYEC 7.32 CLL#6-1 CLL6-1 mIgCLL6-1 V1-46/D3-10/J6 κV3D-15/J1 22 ARDWVATMVRGVIESRPTGMDV 65 NA pCLL6-1 CNQDWHKKC 57.53 CLL#6-2 CLL6-2 mIgCLL6-2 V4-34/D2-2/J6 κV1D-17/J1 24 ASRFYCSGSSCEAPRYYYYYGLDV 35 16 pCLL6-2 CTTV IPERC 22.67 aName of the CLL-derived monoclonal Ig γ1 antibodies expressing the indicated V HDJHand V LJLrearrangements.bNumber of amino acids of the VH CDR3.cVH CDR3 amino acid sequence according to the International ImMunoGeneTics information system (http://www.imgt.org).dPercentage of analyzed cells expressing the indicated VH CDR3.eStereotypic subset according to Agathangelidis et al.5NA, not attributable to a currently de ﬁned stereotypic subset.fKD values for the mimotope binding to the cognate mIgCLL, as estimated by the Scatchard plot analysis.",Non-OADS,/arxiv_data1/oa_pdf/dc/4e/leu2016245a.PMC5155031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome Leukemia (2016) 30,2422 –2426; doi:10.1038/leu.2016.247 The diagnosis of myelodysplastic syndrome (MDS) requires persistent cytopenias, not otherwise explained, and evidence of morphologic dysplasia in the bone marrow.",Non-OADS,/arxiv_data1/oa_pdf/dc/4e/leu2016245a.PMC5155031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/21/main.PMC5155038.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/21/main.PMC5155038.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.005Urology Case Reports 10 (2017) 54 e56,Non-OADS,/arxiv_data1/oa_pdf/a2/21/main.PMC5155038.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LCHADLong-chain hydroxyacyl-CoA dehydrogenasedeﬁciency Umbilical cord blood 1.,Non-OADS,/arxiv_data1/oa_pdf/28/f3/main.PMC5155040.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.11.007 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/28/f3/main.PMC5155040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/f3/main.PMC5155040.pdf
"Botto, M. Pasquali, N. Longo, Diagnossis, treatment, and clinical outcome of patients with mitochondrial trifunctional pro- tein/long-chain 3-Hydroxy acyl-CoA dehydrogenase de ﬁciency, JIMD Reports DOI (2016) http://dx.doi.org/10.1007/8904_2016_558 .",OADS,/arxiv_data1/oa_pdf/28/f3/main.PMC5155040.pdf
http://dx.doi.org/10.1016/j.mmcr.2016.12.004 Received 20 October 2016; Received in revised form 3 December 2016; Accepted 6 December 2016⁎Corresponding author.Medical Mycology Case Reports 14 (2016) 20–23 Available online 07 December 2016 2211-7539/ © 2016 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/56/b3/main.PMC5155041.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/b3/main.PMC5155041.pdf
http://dx.doi.org/10.1128/AAC.00088-08 (Epub 2008 Jun 30).,Non-OADS,/arxiv_data1/oa_pdf/56/b3/main.PMC5155041.pdf
http://dx.doi.org/ 10.1128/AAC.00690-11 (Epub 2011 Aug 22).,Non-OADS,/arxiv_data1/oa_pdf/56/b3/main.PMC5155041.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mus spretusPCSK9Genetic variation LDLR LipoproteinCholesterolPromoter 1.,Non-OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.11.006 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
SIFT analysis (http://sift.bii.a-star.edu.sg ) predicted that all the amino acid difference between SPRET and B6 PCSK9 were tolerable.,OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
"PolyPhen-2 analysis (http://genetics.bwh.harvard.edu ), on the other hand, concluded that the H556Y variation was possibly damaging i.e.",Non-OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
5 shows putative high af ﬁnity binding sites identi ﬁed therein by Transcription Factor Af- ﬁnity Prediction (TRAP) algorithm ( http://trap.molgen.mpg.de ).,OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
"Among other putative high af ﬁnity binding sites, HIC1 which is present in B6 promoter is of some interest because it is abrogated in SPRET promoter and the differ- ence scored as most signi ﬁcant ( P= 5.1 × 10−5) by TRAP comparative analysis ( http://www.bitnos.com/transcription-factors-analysis ).",Non-OADS,/arxiv_data1/oa_pdf/99/b5/main.PMC5155046.pdf
e-mail: hiraga@equinst.go.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/7f/27/jes-27-131.PMC5155131.pdf
e-mail: kyamada@azabu-u.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/a9/ab/jes-27-143.PMC5155132.pdf
e-mail: ynambo@obihiro.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/d5/e1/jes-27-149.PMC5155133.pdf
"Gene expression microarray systems are commercially available for several species, including horses (https://earray.chem.agilent.com/earray/).",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/jes-27-157.PMC5155134.pdf
A high-quality draft sequence of the horse genome is  available through the Broad Institute (http://www.broad.mit.edu/mammals/horse/) as a result of the international efforts on the Horse Genome Project.,OADS,/arxiv_data1/oa_pdf/7b/e0/jes-27-157.PMC5155134.pdf
e-mail: ttozaki@lrc.or.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/7b/e0/jes-27-157.PMC5155134.pdf
The analysis was conducted using the cclust package in R v. 3.1.2 (http://cran.at.r-project.org).,OADS,/arxiv_data1/oa_pdf/7b/e0/jes-27-157.PMC5155134.pdf
"Available from http://www.iceep.org/pdf/ iceep2/_1129101114_001.pdf (accessed on June 17, 2011).",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/jes-27-157.PMC5155134.pdf
e-mail: s.azarpeykan@massey.ac.nz ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/ca/53/jes-27-165.PMC5155135.pdf
"Primers were designed according to primer sequences  previously published [12, 13] or using NCBI primer BLAST (http://www.ncbi.nlm.nih.gov/nucleotide) to design primers.",OADS,/arxiv_data1/oa_pdf/ca/53/jes-27-165.PMC5155135.pdf
The best primer set was selected and the PCR amplicon sequence tested for secondary structures at 60°C using the mFold program (http://mfold.rit.albany.edu/?q=mfold).,OADS,/arxiv_data1/oa_pdf/ca/53/jes-27-165.PMC5155135.pdf
"In this study the HKGs expression stability data were analysed with two software packages; geNorm (qbase + 3.0, Biogazelle,  Zwijnaarde, Belgium) [10, 20], and NormFinder (MOMA, Aarhus University Hospital, Denmark http://moma.dk/normfinder-software) [2].",OADS,/arxiv_data1/oa_pdf/ca/53/jes-27-165.PMC5155135.pdf
e-mail: Hirotaka_Tokushige@jra.go.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/02/28/jes-27-169.PMC5155136.pdf
6(3): 234-237  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.1 2    _____________________________________________________________________________________________________ ___  *Corresponding Author: Enrico Pierluigi Spugnini .,Non-OADS,/arxiv_data1/oa_pdf/10/1e/OpenVetJ-6-234.PMC5155137.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/10/1e/OpenVetJ-6-234.PMC5155137.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/10/1e/OpenVetJ-6-234.PMC5155137.pdf
http://dx.doi.org/10.1155/2013/891413 .,Non-OADS,/arxiv_data1/oa_pdf/10/1e/OpenVetJ-6-234.PMC5155137.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/10/1e/OpenVetJ-6-234.PMC5155137.pdf
6(3): 238-241  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.13     _____________________________________________________________________________________________________ ___  *Corresponding Author: Yasuyuki Momoi .,Non-OADS,/arxiv_data1/oa_pdf/73/47/OpenVetJ-6-238.PMC5155138.pdf
http://www.openveterinaryjournal.com   T. Iwanaga  et al.,Non-OADS,/arxiv_data1/oa_pdf/73/47/OpenVetJ-6-238.PMC5155138.pdf
http://www.openveterinaryjournal.com   T. Iwanaga  et al.,Non-OADS,/arxiv_data1/oa_pdf/73/47/OpenVetJ-6-238.PMC5155138.pdf
http://www.openveterinaryjournal.com   T. Iwanaga  et al.,Non-OADS,/arxiv_data1/oa_pdf/73/47/OpenVetJ-6-238.PMC5155138.pdf
"World J  Gastroenterol  2016; 22(46): 10077-10083  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i46/10077.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i46.10077 INTRODUCTION Esophageal cancer is the 6th leading cause of cancer  related mortality death worldwide[1,2].",Non-OADS,/arxiv_data1/oa_pdf/96/b6/WJG-22-10077.PMC5155166.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. David I Watson, Professor,  Department  of Surgery, Flinders Centre for Innovation in Cancer, Flinders  University, Room 3D211, Bedford Park, South Australia 5042,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/96/b6/WJG-22-10077.PMC5155166.pdf
"The asymptomatic EDITORIAL 10077 December 14, 2016 |Volume 22 |Issue 46 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i46.10077World J Gastroenterol   2016 December 14; 22(46): 10077-10083  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/96/b6/WJG-22-10077.PMC5155166.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   6",Non-OADS,/arxiv_data1/oa_pdf/96/b6/WJG-22-10077.PMC5155166.pdf
